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15B:  Flies carrying a deletion on the Ube3a gene 
A3:  Flies overexpressing the Ube3a E3 ligase protein 
AIB1:  Amplified in breast cancer 1 protein 
ALK:  Anaphase lymphoma kinase protein 
AMPAR: α-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid receptor 
APC/C: Anaphase-promoting complex/cyclosome E3 ligase 
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bioUb:  Biotinylated ubiquitin/flies expressing the UAS(bioUb)6-BirA construct 
BirA:  Biotin holoenzyme synthetase enzyme/flies expressing the BirA enzyme 
CP:   Proteasome core particle 
Cul1:  Cullin1 protein 
Ddi1:  DNA-damage inducible protein 1 protein 
Di-gly: Di-glycine signature of ubiquitin left after trypsin digestion 
DMEM: Dulbecco’s modified Eagle medium 
DPSC:  Dental pulp stem cell 
DRSC:  Drosophila RNAi Screening Center 
DSHB:  Developmental Studies of Hybridoma Bank 
DTT:  Dithiothreitol 
DUB:  Deubiquitinating enzyme 
E1:  Ubiquitin-activating enzyme 
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E2:  Ubiquitin-conjugating enzyme 
E3:  Ubiquitin-ligase enzyme 
EIF-1A: Eukaryotic initiation factor 1A protein 
elavGAL4: embryonic lethal abnormal vision-GAL4 driver 
Eps-15: Epidermal growth factor receptor pathway substrate clone 15 
ESI:  Electrospray ionization 
Fabp:  Fatty acid binding protein 
Fax:  Failed axon connections protein 
FBS:  Fetal bovine serum 
GFP:  Green fluorescence protein 
GMRGAL4: Glass multimer reporter-GAL4 driver 
HECT:  Homologous to the E6-AP carboxyl terminus 
HHR23A: Human homologue of Rad23 
HRP:  Horseradish peroxidase 
HsGAL4: Heat shock inducible-GAL4 driver 
hTERT:  Human telomerase reverse transcriptase  
IBR:  In-between RING domain 
JAMM: JAB1/MPN/MOV3 protease 
L1:  Drosophila first instar larva 
L2:  Drosophila second instar larva 
L3:  Drosophila third instar larva 
LFQ:  Label free quantification 
Lqf:  Liquid facets protein 
Mcm7: Multicopy maintenance 7 subunit protein 
MDC:  Max Delbrück Center for Molecular Medicine 
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MJD:  Machado-Joseph disease protease 
MS:  Mass spectrometry 
m/z:  Mass-to-charge ratio 
NCS:  Newborn calf serum 
Nedd4: Neural precursor cell expressed, developmentally down-regulated 4 E3 
NEM:  N-ethylmaleimide 
Nrt:  Neurotactin protein 
nSyb:  Neuronal synaptobrevin protein 
OK371GAL4: Vesicular glutamate transporter-GAL4 driver 
OTU:  Ovarian tumour protease 
Pbl:  Pebble protein 
PBS:  Phosphate buffered saline 
PWS:  Prader-Willi syndrome 
Rad23: Radiation sensitivity abnormal 23 protein 
Ras:  Raspberry protein 
RBR:  RING between RING 
Rbx1:  RING-box protein 1 
RhoGEF: Rho-guanine-nucleotide exchange factor 
RING:  Really interesting new gene 
Rngo:  Rings lost protein. Drosophila homologue of Ddi1 
RP:  Proteasome regulatory particle 
Rpn10: Regulatory particle non-ATPase 10 protein 
Rpn10DN: C-terminal half of the Regulatory particle non-ATPase 10 protein 
Rps10b: Ribosomal protein S10b 
SCF:  Skp1-Cul1-F-box E3 ligase 
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SDS:  Sodium dodecyl sulfate 
Skp1:  S-phase kinase associate protein 
Snap25: Synaptosomal-associated protein 25 
SNARE: N-ethylmaleimide-sensitive factor attachment protein receptor 
Syx1A: Syntaxin 1A protein 
T:  Cysteine peptidase Tan protein 
TBPH:  TAR DNA-binding protein 43 
TubGAL4: Tubulin-GAL4 driver 
TubGAL80ts: Tubulin-GAL80 temperature sensitive driver 
UAS:  Upstream activating sequence  
UBA:  Ubiquitin-associated domain 
UBE3A: E6-associated protein (E6-AP) E3 ligase enzyme  
UBC:  Ubiquitin-conjugating catalytic domain 
UBD:  Ubiquitin-binding domain  
UCH:  Ubiquitin C-terminal hydrolase enzyme 
Uch-L5: Ubiquitin carboxy-terminal hydrolase L5 orthologue 
UIM:  Ubiquitin-interacting motif 
UPD:  Uniparental disomy 
UPS:  Ubiquitin-proteasome system 
USP:   Ubiquitin-specific protease enzyme 
UTHSC: University of Tennessee Health Science Center 
VWFA: Von Willebrand factor A domain 
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The post-translational modification of proteins with ubiquitin, a process known as 
ubiquitination, regulates a wide range of cellular processes. In the nervous system it is 
essential for the development of neurons and their correct functioning. Indeed, its 
failure is associated to a number of neurological disorders. The identification of the 
proteins that are being ubiquitinated in vivo in neurons, or that are differentially 
ubiquitinated under certain circumstances, can greatly contribute to better understand 
the roles that this modification plays in the brain. However, the low stoichiometry at 
which ubiquitin-modified proteins are found within the cells makes the study of this 
modification quite challenging.  
 
Dr. Mayor’s lab developed a strategy, based on the in vivo biotinylation of ubiquitin, 
that allowed the isolation and enrichment of hundreds of ubiquitin conjugates from the 
embryonic nervous system of the fruit fly. During this Thesis project, we have expanded 
this strategy to Drosophila photoreceptor cells, providing an in vivo system for the study 
of neuronal ubiquitination pathways in the context of a mature neuron. Furthermore, we 
have confirmed that this strategy can be combined with fly mutants in order to detect 
changes in the ubiquitin proteome. Using this approach we have identify the first in vivo 
substrate of the Drosophila Ube3a, an ubiquitin E3 ligase that in humans is involved in 
the Angelman syndrome. On the other hand, we have developed a GFP-pulldown assay 
that favours the isolation of just one specific protein, in order to facilitate the 
characterization of its ubiquitinated fraction. By the application of this protocol in a 
neuron-like cell system, four additional substrates of the fly Ube3a have been 
biochemically validated. 
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Both methodologies used during this Thesis have proven to be suitable approaches 
for the in vivo analysis of ubiquitinated proteins. In addition, they offer unique 
advantages that complement other strategies for ubiquitome study. The combination of 
these two protocols with disease models in which the ubiquitin proteasome system is 
affected will contribute to provide further insight into the mechanisms underlying these 
pathologies.  
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Proteinen aldaketak ubikuitina molekularekin, ubikuitinazioa izenarekin ezagutzen 
den prozesua, bidezidor ugari kontrolatzen ditu zelulen barnean. Nerbio sisteman, 
adibidez, neuronen garapenerako eta funtzionamendurako ezinbesteko da. Hori dela 
eta, ubikuitina eranstean gertatzen diren akatsak zenbait gaixotasunekin erlazionatu 
dira. Neuronetan ubikuitina itsatsita daukaten proteinen identifikazioak asko lagunduko 
luke prozesu honek garunean dituen zereginak hobeto ulertzeko. Baina ubikuitinatuak 
dauden proteinak kopuru oso txikian aurkitu ohi direnez, haien identifikazioa lan zaila 
da. 
 
Ugo Mayor Doktorearen laborategiak ubikuitinak kontrolatzen dituen proteinak 
ikertzeko estrategia eraginkor bat garatu du. Hain zuzen ere, estrategia ubikuitina 
biotinarekin markatzean datza. Horren bidez, ubikuitina lotuta daukaten ehunka 
proteina identifikatu ziren ozpin euliaren embrio-nerbio sisteman. Tesi honetan zehar, 
estrategia hori Drosophila-ren foto-errezeptoreetara hedatu dugu, ubikuitinazio 
bidezidorrak neurona heldu baten markoan ikertzeko in vivo eredu bat hedatuz. 
Bestalde, estrategia hori euli mutanteekin elkar daitekeela konfirmatu dugu. Horrela, 
ubikuitinatutako proteoman gertatzen diren aldaketak ere aurkitu daitezke. Hain zuzen 
ere, metodologia horren bidez Drosophila Ube3aren lehendabiziko in vivo substratua 
aurkitu dugu. E3 ligasa hori gizakietan Angelman sindromearen arduraduna da. Gainera, 
GFP-erauzketa metodo bat garatu dugu proteina bakarra isolatu eta bere 
ubikuitinatutako frakzioaren ikerkuntza errazten duena. Protokolo horretaz baliatuz, 
Ube3aren beste lau substratu biokimikoki balioztatu ditugu neurona-antzeko zelula 
sistema batean.  
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Tesi honetan garatutako bi metodologiak in vivo ubikuitinatutako proteinak 
aztertzeko oso baliogarriak dira. Horrez gain, ubikuitinazioa ikertzeko dauden beste 
estrategiak osatzen dituzten abantaila apartak eskaintzen dituzte. Protokolo bi hauen 
eta ubikuitinazioan arazoak dituzten gaixotasun animali ereduen konbinazioak, 
patologia hauen mekanismoak hobeto ulertzen lagunduko du etorkizunean.  
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1. Ubiquitin-Proteasome System 
 
At the beginning of the twentieth century it was generally believed that the proteins 
of an organism were predominantly stable and that only those coming from the diet 
were subjected to catabolism. In 1939, however, experiments performed with 
isotopically labelled compounds (Schoenheimer et al., 1939) demonstrated that the 
proteins of an organism were rather in constant renewal, and so they must also be 
exposed to degradation. This notion was strengthened by the discovery of the lysosomes 
in the mid 50’s (De Duve et al., 1955), but the presence of a cellular organelle containing 
various hydrolytic enzymes did not fully explain the energy requirement of protein 
breakdown (Etlinger and Goldberg, 1977) or the different degradation rates at which 
certain proteins were removed (Goldberg and St John, 1976). Instead, it suggested the 
existence of other, non-lysosomal, proteolytic system (Etlinger and Goldberg, 1977). It 
was not until the description in the late 70’s of an ATP-dependent reaction in which 
proteins were covalently modified with a small heat-stable polypeptide (Hershko et al., 
1980), known as ubiquitin (Wilkinson et al., 1980), that all these questions started to be 
elucidated.  
 
The post-translational modification of proteins with ubiquitin, referred to as 
ubiquitination, is nowadays known to be the main cellular mechanism by which the 
majority of intracellular proteins are targeted for degradation (Ciechanover, 2013). This 
process, conserved among eukaryotes, is brought about by the orchestrated activity of 
three different enzymes: an ubiquitin-activating E1, an ubiquitin-conjugating E2 and an 
ubiquitin-ligase E3 (Figure 1). Briefly, ubiquitin is initially activated by the E1 in an 
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ATP-requiring reaction. This step is followed by the transfer of the activated ubiquitin to 
an E2 enzyme, which next attaches ubiquitin to substrates with the assistance of an E3 
ligase (Figure 1), typically on a lysine residue of the target protein (Glickman and 
Ciechanover, 2002). With some types of E3s, known as HECT-type (see Figure 1 and 
Introduction section 1.1.4: Ubiquitin-ligase enzymes), ubiquitin is instead transferred 
once again from the E2 to the E3 before it is conjugated to proteins. In this case, the 
attachment of this small polypeptide relies exclusively on the ligase enzyme (Berndsen 
and Wolberger, 2014).  
 
Ubiquitin has itself seven lysine residues along its sequence that can also be 
ubiquitinated. By successive repetitions of the E1-E2-E3 cycle, therefore, more 
ubiquitins can be attached to the previously conjugated ubiquitin to give rise to a poly- 
ubiquitin chain on the targeted protein (Komander and Rape, 2012). Classically, 
ubiquitin chains that are formed through the lysine at position 48 of ubiquitin (known 
as K48 ubiquitin chains) trigger the transport of the modified proteins to a 
multicatalytic enzyme complex, known as the proteasome (Finley et al., 2016), where 
they are subjected to degradation (Figure 1) (Glickman and Ciechanover, 2002). The 
fate of these proteins, however, is not completely written yet as its degradation can still 
be prevented by the counteracting activity of the so called deubiquitinating (DUBs) 
enzymes (Figure 1), which remove the attached ubiquitins from the modified proteins 
(Komander et al., 2009a). Collectively, the whole pathway is usually designated in the 
literature as the ubiquitin-proteasome system (UPS), as ubiquitinated proteins are often 
targeted to the proteasome for degradation. However, the research performed on the 
field since this system was first described (Hershko et al., 1980), has revealed that the
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Figure 1. The ubiquitin-proteasome system cycle. 
Ubiquitin is activated by the ubiquitin-activating enzyme E1 in an ATP dependent reaction to generate an 
E1~ubiquitin thioester intermediate. Subsequently, the activated ubiquitin molecule is transferred to the 
active cysteine residue of an ubiquitin-conjugating enzyme E2, forming a thioester bond. Ubiquitin-
charged E2s can then interact with an ubiquitin-ligase E3 enzyme so the ubiquitin is conjugated to a lysine 
on the target protein via an isopeptide bond. According to the type of E3 that is implicated, ubiquitin can 
be directly conjugated to the substrate from the E2 (if a RING-type E3 is involved) or transferred once 
more to a cysteine residue of a HECT-type E3 ligase. The final outcome is the conjugation of one ubiquitin 
molecule on the target protein, which can be transformed into a poly-ubiquitin chain by the successive 
repetitions of the E1-E2-E3 cycle. The most common type of ubiquitin chain in the cell is the K48-linked 
chains, which usually targets tagged proteins to the proteasome where they are degraded and ubiquitin is 
recycled. Ubiquitinated proteins can also be subjected to the activity of deubiquitinating enzymes (DUBs), 
in which case their degradation is prevented. Modified from Ciechanover, 2013. 
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modification of proteins with ubiquitin go far beyond the removal of old or misfolded 
cellular proteins (Komander and Rape, 2012).  
 
1.1. Components of the Ubiquitin-Proteasome System 
 
1.1.1. Ubiquitin 
 
Ubiquitin is a small polypeptide (8.5 kDa) composed of 76 amino-acids that was first 
isolated in the search for thymic hormones (Goldstein et al., 1975). However, it was not 
linked with protein degradation until 1980, when it was shown that the ATP-dependent 
proteolysis factor 1 (APF-1) described by Rose and co-workers (Hershko et al., 1980) 
was indeed ubiquitin (Wilkinson et al., 1980). In the genome of eukaryotes ubiquitin is 
encoded by several genes. In all the cases, it is translated as a precursor, either in the 
form of a single ubiquitin molecule fused to a ribosomal protein or as a linear poly-
ubiquitin chain, which needs to be later digested by DUBs to produce free ubiquitin 
entities (Kimura and Tanaka, 2010). The attachment of ubiquitin is typically mediated 
by an isopeptide linkage formed between the carboxyl group of its C-terminal glycine 
residue and the ε-NH2-group of an internal lysine of the target protein (Glickman and 
Ciechanover, 2002). Less commonly, however, ubiquitin can also be attached to the α-
NH2-terminal group of the substrate by a peptide bond (Ciechanover and Ben-Saadon, 
2004), as well as to cysteine or serine/threonine residues by thio- or oxy-ester bonds, 
respectively (Wang et al., 2012).  
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Conjugation of ubiquitin is not restricted to cellular proteins, but it can be 
additionally bound to ubiquitin molecules that are already associated with a protein. 
The attachment between distinct ubiquitins can be mediated either through the N-
terminus or any of the seven lysines that are found within its sequence (K6, K11, K27, 
K29, K33, K48 and K63). Consequently, ubiquitin chains of different topology can be 
built up (Komander and Rape, 2012). This versatility of ubiquitin provides the system 
with a high complexity capable of regulating not only the degradation of proteins, but 
also a wide range of biological processes (see Introduction section 1.2: Roles of protein 
ubiquitination). 
 
1.1.2. Ubiquitin-activating enzyme (E1) 
 
Conjugation of ubiquitin requires an initial step in which ubiquitin becomes activated 
(Glickman and Ciechanover, 2002). This reaction, which entails energy consumption, 
was discovered to be carried out by an enzyme designated as the ubiquitin-activating 
enzyme or E1 (Ciechanover et al., 1981; Haas et al., 1982). The E1 is conserved from 
yeast to humans, but while in yeast only one gene encodes for it (McGrath et al., 1991), 
in humans two genes are found to do so (Pelzer et al., 2007). Activation of ubiquitin by 
this enzyme is carried out in a two-step reaction. In the first step, the E1 binds ATP and 
ubiquitin in order to generate a transient ubiquitin-adenylate intermediate. In the 
second step, ubiquitin is transferred to a conserved catalytic cysteine of the E1 to which 
ubiquitin is linked through a thioester bond (Haas et al., 1982; Schulman and Wade 
Harper, 2009). The E1 plays an essential role in the UPS pathway, since in the absence of 
ubiquitin activation protein ubiquitination is impeded. In fact, deletion of the E1 has 
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been shown to cause lethality in yeast (McGrath et al., 1991), while in humans, missense 
and synonymous mutations on the E1 gene have been associated with the X-linked 
Infantile Spinal Muscular Atrophy (Ramser et al., 2008). 
 
1.1.3. Ubiquitin-conjugating enzymes (E2s) 
 
The next family of proteins required for the attachment of ubiquitin molecules are the 
ubiquitin-conjugating enzymes or E2s. This enzymes accept the activated ubiquitin from 
the E1 and form another thioester bond with ubiquitin (Hershko et al., 1983; Glickman 
and Ciechanover, 2002). There are dozens of genes encoding for E2s throughout the 
genome of eukaryotes. In humans for instance, 37 genes have been described (Michelle 
et al., 2009). At first, they were considered to be mere transporters of ubiquitin with 
auxiliary roles. However, it is now known that they have an active role in ubiquitination 
by determining the length and the topology of the ubiquitin chain that is formed, 
thereby, determining the fortune of the modified proteins (Ye and Rape, 2009). 
 
Members of this family are characterized by a conserved (~150 amino-acids) 
ubiquitin-conjugating catalytic (UBC) domain, which embraces a key cysteine that 
serves as a docking site for ubiquitin (Wijk and Timmers, 2010). Additionally, this 
domain provides a binding platform for the E1 and E3 enzymes (Burroughs et al., 2008). 
Some E2s present further extensions to the UBC domain, a characteristic that has been 
historically used to classify them into four categories. Those composed only of the UBC 
domain, are grouped into the class I enzymes, while those containing extensions either 
at the N-terminal, C-terminal, or at both sides of the UBC domain, are classified as class 
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II, III and IV, respectively (WENZEL et al., 2010; Wijk and Timmers, 2010). These 
extensions are involved in functional differences among E2 enzymes, having a role in 
their subcellular localization, stabilization of the interaction with E1 or in the regulation 
of the interacting E3 activity (Wijk and Timmers, 2010). 
 
1.1.4. Ubiquitin-ligase enzymes (E3s) 
 
The final step of ubiquitination is carried out by the ubiquitin-ligase enzymes or E3s 
(Hershko et al., 1983; Glickman and Ciechanover, 2002). Among the three types of 
enzymes involved in ubiquitin conjugation this is by far the largest family, with at least 
600 genes encoding for E3 ligases in humans (Li et al., 2008). Substrate specificity in 
ubiquitination is attributed to E3 enzymes, who are able to interact with both the 
ubiquitin-charged E2s and the substrates to which ubiquitin is going to be transferred 
(Metzger et al., 2014). Typically, one E3 ligase is able to modify several substrates, as 
well as to bind different E2s. Consequently, the same protein can be ubiquitinated by 
different E2/E3 combinations, leading to different ubiquitination patterns according to 
the E2/E3 pair that is involved (Metzger et al., 2014). Based on conserved structural 
domains that participate in E2/E3 interaction and the mechanism by which ubiquitin is 
transferred from the E2 to the substrates, two main families of E3 ligases are usually 
distinguished: the Really Interesting New Gene (RING) family and the Homologous to 
the E6-AP Carboxyl Terminus (HECT) family (Berndsen and Wolberger, 2014).  
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Figure 2. RING and HECT type families of ubiquitin E3 ligases.  
A. Sequence of the canonical RING finger domain. It is characterized by several cysteine (C1-C7) and 
histidine (H1) residues, which are buried within the domain’s core and are bound to two molecules of 
Zn2+. The interaction with Zn2+ helps in maintaining the overall structure. X refers to any amino-acid, while 
the subscript numbers indicate the amount of amino-acids in the region. Taken from Deshaies and 
Joazeiro, 2009. B. Mechanism of RING-type E3 ligase mediated ubiquitin conjugation. RING E3s bind both 
the E2~ubiquitin and the substrate to be ubiquitinated, and put them close enough to allow the direct 
conjugation of ubiquitin from the E2. In the representation the SCF E3 complex is shown. Cul1 acts as the 
main pillar of the complex where the RING Rbx1 protein and an F-box protein, the latter through the 
adaptor Skp1, are bound. The ubiquitin-loaded E2 interact with Rbx1, while the substrate does with the F-
box protein. Modified from Bassermann et al., 2014. C. Mechanism of HECT-type E3 ligase mediated 
ubiquitin conjugation. HECT-domain has an N-lobe and a C-lobe. The E2~ubiquitin binds to the E3 
through the N-lobe and transferred the ubiquitin to the catalytic cysteine of the E3, located on the C-lobe. 
The C-lobe~ubiquitin thioester then rotates to allow the ubiquitin conjugation to the substrates, which is 
bound to the N-terminal domain of the E3. Modified from Berndsen and Wolberger, 2014. 
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RING-type E3 ligases are characterized by an E2-binding motif, called RING domain, 
composed of a series of specifically spaced cysteine and histidine residues that adopt a 
cross-brace structure with two Zn2+ ions (Figure 2A) (Metzger et al., 2014). A related 
domain is the U-box domain, which adopts a similar structure as the RING motif but 
does not contain Zn2+ ions (Morreale and Walden, 2016). Unlike E1 and E2s, RING-type 
E3s do not form a catalytic intermediate with ubiquitin. Instead, they function as 
scaffolding proteins that bring together the E2 and the substrate, so as to facilitate the 
direct conjugation of ubiquitin from the E2 to the target protein (Figure 1 and Figure 
2B) (Deshaies and Joazeiro, 2009; Metzger et al., 2014). Members of this family can 
operate either as monomers, dimers or as part of multi-subunit complexes, such as the 
Skp1-Cul1-F-box (SCF) or the anaphase-promoting complex/cyclosome (APC/C) E3 
ligases (Metzger et al., 2014; Morreale and Walden, 2016). In the case of SCF the RING-
box protein 1 (Rbx1) and the S-phase kinase associate protein 1 (Skp1) are organized 
around the scaffold Cullin 1 (Cul1) protein (Figure 2B). Rbx1 provides the E2 binding 
capacity while Skp1 serves as an adaptor that binds interchangeable F-box proteins, the 
substrate-binding subunits (Bassermann et al., 2014). APC/C, which control cell cycle 
progression by targeting several proteins for degradation, contains at least 12 subunits 
(Manchado et al., 2010).  
 
HECT-type E3 ligases are characterized by a C-terminal region of about 350 amino-
acids, which is homologous to the C-terminal part of its founding member, the human 
E6-Asociated Protein (E6AP)/UBE3A (Huibregtse et al., 1995). This domain adopts a 
bilobal structure, in which the N-terminal lobe provides the E2-binding area and the C-
terminal one a catalytic cysteine residue that associates with ubiquitin via a thioester 
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linkage (Figure 2C) (Scheffner and Kumar, 2014). Alike RING-type E3 ligases, HECT-
type enzymes first accept the ubiquitin from the E2 to form a thioester intermediate and 
then directly perform the conjugation of ubiquitin to the substrate (Figure 1 and Figure 
2C) (Huibregtse et al., 1995; Scheffner and Kumar, 2014). The binding of the proteins to 
be ubiquitin-modified is performed through the N-terminal extension of the enzymes, 
which is additionally used to further classified them into three subfamilies: 
NEDD4/NEDD4-like E3s, if carrying tryptophan-tryptophan domains, HERC E3s, if 
Chromosome Condensation 1-like domains are presence, and other HECT type, if neither 
of this motifs are found (Scheffner and Kumar, 2014).    
 
There are some E3 ligases that combine features with the RING- and HECT-type 
families. Similar to HECT-type, these enzymes have the ability to generate a thioester 
intermediate with ubiquitin and like RING-type family members, they contain RING 
binding domains (Morreale and Walden, 2016). They are known as RING between RING 
(RBR) E3 ligases, because two RING domains (RING1 and RING2) are separated by a 
conserved sequence called the in-between RING (IBR) domain (Eisenhaber et al., 2007). 
While the RING1 serves as the E2 binding platform, the RING2 contains a catalytic 
cysteine that mediates ubiquitination in a HECT E3 ligase fashion (Berndsen and 
Wolberger, 2014). On the other hand, the IBR is involved in the arrangement of the 
RING1 and RING2 in order to facilitate the ubiquitination of the target proteins (Beasley 
et al., 2007). Among the E3 ligases comprising this group, Parkin, the enzyme involved in 
Parkinson’s disease is found (Shimura et al., 2000; Berndsen and Wolberger, 2014).  
 
 
Introduction 
- 41 - 
 
1.1.5. Deubiquitinating enzymes (DUBs) 
 
As it happens with other post-translational modification, such as phosphorylation, 
ubiquitination is also a reversible process. The enzymes counteracting the action of 
ubiquitin ligases, and hence responsible for removing ubiquitin moieties from target 
proteins, are called deubiquitinases or deubiquitinating enzymes (DUBs). DUBs are 
cysteine- and metallo-proteases, encoded in the human genome by about 80 genes, that 
brake away the isopeptide and peptide bond formed between the ubiquitin and the 
target proteins (Nijman et al., 2005). They are classified into five categories according to 
sequence and structural similarities of their catalytic domain: ubiquitin C-terminal 
hydrolases (UCHs), ubiquitin-specific proteases (USPs), ovarian tumour proteases 
(OTUs), Machado-Joseph disease (MJD) proteases, also known as Josephins, and 
JAB1/MPN/MOV34 (JAMMs) (Amerik and Hochstrasser, 2004). USP is the largest 
subfamily of DUBs and together with the other cysteine-proteases (UCHs, OTUs and 
Josephins) account for more than 80 % of all the DUBs. On the contrary, JAMMs are zinc 
dependent metallo-proteases (Amerik and Hochstrasser, 2004; Komander et al., 2009a).  
 
At a first glance it might appear that DUBs are exclusively involved in the stabilization 
of ubiquitinated proteins by preventing their proteasomal degradation. However, the 
ability of DUB enzymes to discriminate between ubiquitin chains of different topology, 
together with their capacity to cleave the ubiquitin linkages either from the most 
proximal part (i.e., from the ubiquitin that is attached to the substrate) or within the 
ubiquitin chains, have demonstrated that their physiological roles are much wider 
(Komander et al., 2009a). For instance, it has been shown that DUBs are responsible for 
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the generation of free ubiquitin (Kimura and Tanaka, 2010), for the maintenance of 
appropriate ubiquitin levels by recycling the ubiquitin molecules from the proteins that 
are degraded by the proteasome (Yao and Cohen, 2002), for promoting chromosomal 
condensation during the metaphase by histone deubiquitination (Mueller et al., 1985) 
and even for controlling the release of neurotransmitters by removing ubiquitin from 
proteins on the pre-synaptic region (Rinetti and Schweizer, 2010).  
 
1.1.6. Ubiquitin receptors 
 
The coordinated action of E2s, E3s and DUBs can accomplish different type of 
ubiquitin modifications on the target proteins, ranging from the attachment of a single 
ubiquitin molecule to the conjugation of mixed and branched poly-ubiquitin chains (see 
Introduction section 1.2 in: Roles of protein ubiquitination). Consequently, the particular 
signal that each modification triggers needs to be faithfully decoded by the cell. In this 
process, proteins containing ubiquitin-binding domains (UBDs), known as ubiquitin-
receptors, are of special relevance. These proteins interact non-covalently with ubiquitin 
through their UBDs and translate the ubiquitinated target signal into biochemical 
cascades in the cells (Dikic et al., 2009).  
 
UBDs are structurally diverse and are found in proteins exerting a wide range of 
biological functions. The first UBDs to be described were the ubiquitin-interacting 
motifs (UIMs) of the human regulatory particle non-ATPase 10 (PSMD4/RPN10) 
proteasomal subunit (Young et al., 1998). Shortly after, it was shown that the ubiquitin-
associated (UBA) domains of the yeast DNA-damage inducible protein 1 (Dd1) and the 
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radiation sensitivity abnormal 23 (Rad23) protein, also present in many members of the 
UPS (Hofmann and Bucher, 1996), interact with ubiquitin (Bertolaet et al., 2001). Since 
then, more than twenty families of UBD have been described in the literature, which 
based on their structure are classified into five subfamilies: α-helices structures (where 
UIM and UBA are found), zinc fingers, pleckstrin homology fold, ubiquitin conjugating-
like structures and others structures (Husnjak and Dikic, 2012).  
 
There are some UBDs that selectively interact with specific poly-ubiquitin chains 
(Raasi et al., 2005; Trempe et al., 2005; Sims and Cohen, 2009). An example of those is 
one of the UBA domains found on Rad23, which shows a stronger preference for K48-
linked chains (Raasi et al., 2005). In contrast, there are other UBDs that promiscuously 
bind any type of ubiquitin chain (Raasi et al., 2005; Zhang et al., 2008). These differences 
in the specificity of each UBD towards particular ubiquitin modifications is believed to 
be dictated by the structure of the domain as well as by its localization within the 
protein (Sims and Cohen, 2009). The exact mechanism by which UBDs recognize various 
ubiquitin signals and how they are later decoded into specific cellular responses is still 
not well understood.  
 
1.1.7. Proteasome 
 
Protein degradation is the best characterized role of ubiquitination. This is typically 
achieved by tagging proteins with a K48-linked poly-ubiquitin chain (Swatek and 
Komander, 2016). This type of ubiquitin modification triggers the recognition and 
subsequent transport of the modified proteins to the proteasome, an ATP-dependent 
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multicatalytic enzyme complex (Matthews et al., 1989). Found both in the cytoplasm and 
the nucleus of eukaryotic cells (Peters et al., 1994; Wójcik and DeMartino, 2003), the 
proteasome is in charge of the degradation of all the ubiquitinated proteins that are 
brought to it. It is composed of two subunits (Figure 3A), the 19S regulatory particle 
(RP) and the 20S core particle (CP), which are involved in the recognition and 
degradation of the ubiquitinated substrates, respectively (Finley et al., 2016). 
 
The RP flanks both ends of the CP and is subdivided into two sub-complexes (Figure 
3B), the base and the lid (Lander et al., 2012). The lid consists on nine non-ATPase 
proteins. Of those, the best characterized one is the regulatory particle non-ATPase 11 
(Rpn11), a DUB metallo-protease that removes ubiquitin from substrates favouring their 
translocation to the 20S CP (Verma et al., 2002). The remaining subunits are thought to 
play a scaffolding role to hold Rpn11 on place and regulate its activity (Dambacher et al., 
2016). Mammalian proteasomes contain two additional associated DUBs, Usp14 and 
Uch-L5 (Maiti et al., 2011).  
 
The base is formed by six ATPase (Rpt1-6) and four non-ATPase proteins: Rpn1, 
Rpn2, Rpn10 and Rpn13 (Figure 3B) (Lander et al., 2012). The Rpts form a 
heterohexameric ring that is predicted to produce a mechanical force on the proteins, at 
the expense of ATP hydrolysis, so they are unfolded and translocated into the CP of the 
proteasome (Tomko et al., 2010). Rpn10 and Rpn13 are ubiquitin receptors involved in 
the recognition of poly-ubiquitinated proteins (Deveraux et al., 1994; Husnjak et al., 
2008), while Rpn1 and Rpn2 perform a similar task by binding ubiquitin-like domains 
usually found in ubiquitin receptors (Rosenzweig et al., 2012).  
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Figure 3. The structure of the 26S proteasome. 
A. Cryoelectron microscopy of the yeast proteasome. The 20S core particle (CP) and the two 19S 
regulatory particles (RP) are indicated. Each 19S RP appears rotated relative to each other by 180º. The 
name of each subunit is given. Taken from Finley et al., 2016. B. The 19S RP of yeast. On the left a 3D 
reconstruction of the subunits that composed the 19S lid is shown. On the right a cryoelectron microscopy 
image of the 19S RP, where only the subunits that formed the 19S base are coloured, is provided. Modified 
from Lander et al., 2012. C.  The 20S CP of yeast. Lateral (left) and top (right) views of the CP are 
represented. In both drawings the gate through which proteins are translocated into the CP is indicated. 
Taken from Finley et al., 2016. 
 
Once proteins are deubiquitinated and unfolded in the RP, they are translocated into 
the CP (Finley et al., 2016). This barrel-shape structure is composed of 28 subunits that 
are assembled into four stacked heteroheptameric rings (Figure 3C) (Groll et al., 1997). 
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The two outer rings are composed of α-type subunits, while the two inner rings of β-
type subunits (Löwe et al., 1995; Finley et al., 2016). Three of the β subunits (β1, β2 and 
β5) are proteolytically active and process hydrophobic, basic and acidic residues, 
respectively (Finley et al., 2016). Their proteolytic sites face toward the interior of the 
CP (Groll et al., 1997). Substrates entering this chamber are rapidly degraded (Finley et 
al., 2016). 
  
1.2. Roles of protein ubiquitination 
 
The extensive research performed during the past 35 years has revealed that, in 
addition to protein degradation, ubiquitination is involved in a wide range of biological 
processes (Popovic et al., 2014; Swatek and Komander, 2016). This is achieved by the 
ability of ubiquitin to be further modified, either at its N-terminus or in one of its seven 
lysine residues (K6, K11, K27, K29, K33, K48, K63) once the first ubiquitin has been 
conjugated (Figure 4A) (Swatek and Komander, 2016). Depending on the lysine of the 
previously attached ubiquitin that is used for the chain formation, diverse 
conformations can be generated (Figure 4B). Chains built up through the lysine at 
position 48 (K48-linked chains), for instance, produce a compact conformation (Eddins 
et al., 2007). In contrast, those linked through the lysine at position 63 (K63-linked 
chains), or through the N-terminus of ubiquitin, present a more open conformation 
(Komander et al., 2009b). Moreover, the lysines used throughout the poly-ubiquitin 
chain may be the same (homogenous chains), may be alternated (mixed chains) or even 
multiple lysines of the same ubiquitin may be modified at the same time (branched 
chains). Consequently, the number of distinct conformations that can be produced are 
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huge (Figure 4B), each of which will have a different readout by the cell (Swatek and 
Komander, 2016).  
 
 
 
Figure 4. Type of ubiquitin modifications. 
A. The protein sequence of ubiquitin. The seven lysine (K) residues found along its sequence, as well as 
the initial methionine (M), can be used as targets for ubiquitin attachment so poly-ubiquitin chains are 
built up. M and K are coloured. B. Illustration of the different ubiquitin modification that can be 
performed. Some of the cellular functions in which they are involved are indicated. K48-, K63- and Met1-
linked chain are represented with a distinct chain shape (compact, open and linear, respectively) to 
summarize the diverse ubiquitin chain conformation that can be generated. Modified from Swatek and 
Komander, 2016. 
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The simplest conformation consists on the attachment of a single ubiquitin molecule 
to the substrate (Figure 4B), designated as mono-ubiquitination (Hicke, 2001). Protein 
mono-ubiquitination is an abundant event, accounting for more than 50 % of all the 
cellular ubiquitin pool (Kaiser et al., 2011). This type of modification is known to be 
involved in many essential cellular roles, such as the regulation of transcriptional 
activity (Pham and Sauer, 2000), the internalization of plasma membrane proteins 
(Terrell et al., 1998) and the control of protein activity (van Delft et al., 1997; Di Fiore et 
al., 2003). Proteins can also be mono-ubiquitinated at multiple lysines (Figure 4B), 
which has been shown to induce the endocytosis and transport of the ubiquitinated 
proteins to the lysosome (Haglund et al., 2003). In this case the term multimono-
ubiquitination is used. 
 
Regarding poly-ubiquitin chains (Figure 4B) homogenous ones are the best 
characterized. Among them, the linkage more abundantly found within the cells is that 
formed through the K48 of ubiquitin, followed by K63-linked chains (Kaiser et al., 2011; 
Swatek and Komander, 2016). K48-linked chains have been classically associated with 
proteasomal degradation (Thrower et al., 2000), but a non-degradative role has also 
been reported (Flick et al., 2006). In contrast, ubiquitin chains form through the K63, 
have been mainly related to non-degradative roles (Chen and Sun, 2009), such as 
activation of protein kinases (Deng et al., 2000; Newton et al., 2008) and recruitment of 
DNA-damage response elements (Hoege et al., 2002; Zhao et al., 2007; Bennett and 
Harper, 2008). However, an involvement on lysosomal degradation of membrane 
proteins has also been described for K63-linked chains (Huang et al., 2013).  
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The remaining ubiquitin chain types are considered to be atypical due to their lower 
abundance, but they have also been associated with important biological processes. K6-
linked chains have been involved in mitochondrial homeostasis by controlling Parkin 
activity (Durcan et al., 2014). K11-linked chains serves as a proteasomal degradation 
signal during cell division (Wickliffe et al., 2011). K27-linked chains have been proposed 
to be involved in the recruitment of proteins during the DNA damage response (Swatek 
and Komander, 2016). K29-linked chains on Rpn13 have been reported under 
proteasomal stress, suggesting that this chain type may control the proteasomal 
degradation by preventing the recognition of poly-ubiquitinated proteins (Besche et al., 
2014). K33-linked chains have been implicated in protein trafficking (Yuan et al., 2014) 
and DNA-damage response (Elia et al., 2015). And linear N-terminus ubiquitin chains 
are implicated in inflammation and immune response (Gerlach et al., 2011).  
 
Taking into account the different roles that distinct ubiquitin arrangements can 
trigger and the complexity that mixed and branched ubiquitin chains (Figure 4B) might 
add to the system (Swatek and Komander, 2016), it is not a surprise to find that failures 
in this pathway are involved in many human diseases, including cancer (Popovic et al., 
2014) and neuronal diseases (Kishino et al., 1997; Shimura et al., 2000; Bertram et al., 
2005; Ding and Shen, 2008). 
 
1.3. Ubiquitination and nervous system 
 
Evidence of the involvement of the UPS in the nervous system came first from the 
discovery that ubiquitin was present in the neurofibrillary tangles of various 
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neurodegenerative diseases (Mori et al., 1987; Lennox et al., 1988). Henceforth a variety 
of failures at different levels of the UPS cascade have been linked to several 
neurodevelopmental disorders: mutations in the E1 are associated with X-linked 
Infantile Spinal Muscular Atrophy (Ramser et al., 2008); the E2-25K E2 enzyme has been 
implicated in the pathogenesis of Huntington’s disease (Wilson et al., 2009) and 
Alzheimer’s disease (Song and Jung, 2004); the UBE2H enzyme is associated with autism 
(Vourc’h et al., 2003); loss of the ligase activity of Parkin and UBE3A E3 ligases  are 
linked to autosomal recessive juvenile parkinsonism and Angelman syndrome, 
respectively (Kishino et al., 1997; Shimura et al., 2000); down-regulation of the UCHL1 
DUB enzyme has also been linked with Parkinson’s and Alzheimer’s disease (Leroy et al., 
1998; Choi et al., 2004); variants of the Ubiquilin-1 ubiquitin receptor protein are 
associated with a higher risk of developing Alzheimer’s disease (Bertram et al., 2005); 
and disruption of the Rpt2 subunit of the proteasome has been reported to be enough to 
trigger neurodegeneration (Bedford et al., 2008). Such studies have highlighted the 
relevance of the UPS in neurons. 
 
Nowadays, it is well known that the correct performance of the ubiquitination 
machinery is essential for the appropriate establishment of neuronal networks, as it 
regulates the length and the number of axons, dendrites and dendritic spines (Hamilton 
and Zito, 2013). An accurate balance between the action of E3 ligases and DUBs 
activities is mandatory for a correct axonal growth. For instance, disruption of Highwire 
E3 ligase, or overexpression of the Fat facets DUB, leads to a synaptic overgrowth in 
Drosophila neuromuscular junctions (DiAntonio et al., 2001). Similarly, mutations in 
Highwire results in axon guidance defects during the development of the axonal lobes in 
Introduction 
- 51 - 
 
Drosophila mushroom body (Shin and DiAntonio, 2011). In addition to orchestrating 
neuronal connections during development, ubiquitination is also imperative for 
neurogenesis to successfully take place, as deficiency of the Fbw7 F-box protein, a 
substrate recognition component of a SCF-type E3 ligase, is sufficient to impair neuronal 
differentiation in mice (Hoeck et al., 2010).  
 
This post-translational modification is not only restricted to development, but is also 
involved in regulating neuronal function once connections have been established (Yi and 
Ehlers, 2007). Ca2+-dependent depolarization at the pre-synaptic zone stimulates the 
exocytic release of neurotransmitters (Pang and Südhof, 2010) and induces a fast 
decrease of the total levels of the ubiquitinated proteins in rat-brains (Chen et al., 2003). 
Increased neurotransmitter release has also been observed upon proteasome inhibition 
in cultures hippocampal neurons (Rinetti and Schweizer, 2010). The alterations 
produced on synaptic transmission by the UPS are typically attributed to an acute 
control of the synaptic protein turnover, as reported for the vesicle priming-proteins 
DUNC13 (Speese et al., 2003) and Rab3-interacting molecule 1 (RIM1) factor (Yao et al., 
2007). But the fast deubiquitination of pre-synaptic ubiquitin-modified proteins seems 
also to contribute to it (Chen et al., 2003; Rinetti and Schweizer, 2010).  
 
By contrast, at the post-synaptic side ubiquitination is mainly involved in regulating 
the composition of the proteins that form the post-synaptic density and the abundance 
of membrane receptors (Yi and Ehlers, 2007). The stimulation of synaptic activity 
induces a two-fold increase in protein ubiquitination on post-synaptic density fractions 
isolated from rat cortical neurons (Ehlers, 2003). On the other hand, neurotransmitter 
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receptors, such as the α-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid 
receptors (AMPARs) have been reported to be ubiquitinated by the neural precursor cell 
expressed, developmentally down-regulated 4 (Nedd4) E3 ligase, which facilitates their 
endocytosis from the plasma membrane surface (Lin et al., 2011). 
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2. Angelman syndrome 
 
Angelman syndrome (AS; OMIM #105830) is a rare neurodevelopmental disorder 
with a prevalence of approximately 1/15.000 individuals (Margolis et al., 2015). The 
first reference to it dates back to 1965, when Dr. Harry Angelman classified three 
unrelated children with similar physical abnormalities within the same syndrome 
(Angelman, 1965). AS is characterized by a severe intellectual and developmental delay, 
movement or balance disorders, speech impairment and a happy demeanour (Figure 5) 
that includes episodes of frequent laughter and easy excitability (Williams et al., 2010). 
Very frequently (>80 % of the cases) these symptoms are accompanied by seizures, 
sleep disturbances and microcephaly (Williams et al., 2010; Bird, 2014).  
 
The syndrome is commonly diagnosed when children are 1-2 years old, as clinical 
symptoms are usually manifested after the first year of age (Margolis et al., 2015). 
 
 
 
Figure 5. Pictures of children with Angelman syndrome.  
 Six patients with a genetically confirmed diagnosis of AS. A happy expression is commonly observed in 
affected individuals. Taken from Williams et al., 2010. 
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Affected people’s lifespan is not reduced and both development and fertility are normal. 
However, independent living is not possible for adults with AS, so they require the 
presence of a caregiver along their life (Bird, 2014). Currently there is not specific 
treatment for AS, but drugs to mitigate seizures and sleeping problems are usually 
administered in combination with physical therapies to improve the motor deficits 
(Margolis et al., 2015). 
 
2.1. Genetic causes of Angelman syndrome 
 
In 1987 two unrelated females, with clinical feature consistent with AS, were found to 
carry a deletion on the 15q11-q13 chromosomal region (Magenis et al., 1987). This 
chromosomal deletion had been previously found on patients diagnosed with Prader-
Willi syndrome (PWS), a complex genetic disorder characterized by infantile hypotonia, 
obesity and behavioural issues (Kalsner and Chamberlain, 2015). How the same deletion 
could result in different syndromes was soon elucidated. The parental origin of the 
deletion was discovered to have a great influence in the development of each syndrome. 
Whereas deletions inherited on the paternal chromosome lead to PWS, those inherited 
on the maternal chromosome result on AS. These findings suggested that genes within 
the 15q11-q13 locus were subjected to genomic imprinting (Knoll et al., 1989; Magenis 
et al., 1990). Currently, it is known that some of the genes within this chromosomal 
region are either maternally, paternally or biallelically expressed (Figure 6A) (Margolis 
et al., 2015). 
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Figure 6. Genetic mechanisms that produce Angelman syndrome. 
A. Maternal deletions of the 15q11-q13 chromosomal regions are the most frequent genetic mechanism 
that lead to AS. Genes on this region are either biallelically expressed (white), paternally expressed (blue) 
or maternally expressed (red). The most common breakpoints involved in the deletions (BP1, BP2 and 
BP3), where low copy repeats are found, are indicated. B.  Inheriting both chromosomes 15 from the 
father, known as paternal uniparental disomy, results in the loss of maternally expressed genes as both 
chromosomes present equal imprinting pattern. C. Aberrant methylation patterns or microdeletion on a 
chromosomal region designated as imprinting centre (IC), results in imprinting defects that produce 
silencing of maternally expressed genes. The deleted region shared by all affected individuals has been 
shown to be 880 bp long, which is designated as the shortest region of deletion overlap (SRO). D. 
Mutations on the UBE3A gene that disrupt the encoded protein have been found in AS patients. Thus the 
loss of function of this gene is considered the underlying molecular mechanism of AS. Modified from 
Williams et al., 2010. 
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Deletions on the long arm of the maternal chromosome 15 are typically a result of 
non-allelic homologous recombination due to the presence of low copy repeats in the 
15q11-q13 area (LaSalle et al., 2015). They span about 5-7 Mb and are usually produced 
through three breakpoints (BP1, BP2 and BP3 in Figure 6A). According to the 
breakpoints that are involved two classes of deletions are distinguished. Class I are 
those produced through BP1 and BP3, while in class II BP2 and BP3 are implicated 
(Sahoo et al., 2007). This type of genetic defect, however, accounts for about ~70-80 % 
of all the AS cases (Margolis et al., 2015). Additionally, ~3-5 % (Figure 6B) of the cases 
have been reported to be arisen from paternal uniparental disomy (UPD), i.e., if both 
chromosomes 15 are of paternal origin (Nicholls et al., 1992; Margolis et al., 2015). The 
presence of two paternal chromosomes 15 results in the loss of function of maternally 
expressed genes. Another ~3-5 % are due to imprinting defects on the maternal 
chromosome (Figure 6C), which are derived either from microdeletions in a region of 
the chromosome 15 designated as imprinting centre (Buiting et al., 1995) or from 
epigenetic mutations that lead to abnormal DNA methylation patterns (Buiting et al., 
2003). Similar to UPD cases, imprinting defects result in silencing of maternally 
expressed genes. The phenotype produced by UPD or imprinting defects has 
nevertheless been reported to be less severe than that one brought about by deletions 
(Williams et al., 2010; Bird, 2014). This suggests that biallelically expressed genes 
within the 15q11-q13 locus can affect the severity of the disease (LaSalle et al., 2015) 
 
The underlying molecular cause behind the mentioned chromosomal and epigenetic 
anomalies was discovered to be the loss of function of the UBE3A protein (Figure 6D). 
Mutations leading to truncated forms of UBE3A were reported to be enough to develop 
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the syndrome (Kishino et al., 1997; Matsuura et al., 1997). Additionally, this gene, 
located on the 15q11-q13 critical region, was confirmed to be paternally imprinted in 
the brain (Rougeulle et al., 1997). Therefore, either deletions, UPD or imprinting defects 
on the maternal chromosome would also lead to the loss of UBE3A function, further 
supporting a central role of this gene in the aetiology of AS. During the last years 
different mutations on UBE3A, most of them nonsense and frameshift mutations, have 
been found in AS patients, accounting for ~10-20 % of the AS cases (Sadikovic et al., 
2014; Margolis et al., 2015).      
  
2.2. UBE3A E3 ligase protein 
 
UBE3A is an ubiquitin E3 ligase enzyme of approximately 100 kDa (Scheffner et al., 
1993). According to in vitro studies it catalyses the preferential attachment of K48-
linked chains, thus presumably targets its substrates for proteasomal degradation 
(Wang and Pickart, 2005). It was first discovered by its ability to form a complex with 
the E6 oncoprotein of the human papillomavirus types 16 and 18 and promote p53 
ubiquitin-dependent degradation (Huibregtse et al., 1991; Scheffner et al., 1993). This is 
why it was first named as E6-Associated Protein (E6-AP) (Huibregtse et al., 1991). The 
discovery that this enzyme could form a thioester intermediate with ubiquitin through a 
cysteine residue located at its C-terminal part (Scheffner et al., 1995), as well as that this 
region of over 350 amino-acid was conserved among different proteins (Huibregtse et 
al., 1995; Scheffner et al., 1995), led to the characterization of the HECT (Homologous to 
the E6-AP Carboxyl Terminus) domain (Figure 2C) and the functionally related HECT-
type E3 ligase family (see Introduction section 1.1.4: Ubiquitin-ligase enzymes). 
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In humans, the UBE3A gene encodes at least three different isoforms that differ in 
their amino-terminal part due to alternative splicing of the first 8 exons (Yamamoto et 
al., 1997; LaSalle et al., 2015). Three isoforms have also been described in mice, but only 
the isoform 2 (equivalent to human isoform 3) has been reported to have the capability 
to rescue the dendritic phenotype found in an AS mouse model (Miao et al., 2013). In 
Drosophila only one isoform has been described (Wu et al., 2008). The physiological 
functional differences of the alternative isoforms are still not well understood. Neither it 
is their significance toward AS. However, transcripts corresponding to the human 
isoform 3 have been found in a variety of organism, suggesting that this isoform might 
be of higher relevance (LaSalle et al., 2015).    
 
In neurons, while the paternal UBE3A allele is silenced (Rougeulle et al., 1997) the 
maternal copy is expressed, both in the nucleus and the cytoplasm (Dindot et al., 2008). 
Interestingly, the paternal imprinting is found restricted to the brain since biallelical 
expression of UBE3A is detected in other tissues (Rougeulle et al., 1997; Vu and 
Hoffman, 1997). This suggests that the levels of this enzyme have to be tightly controlled 
in the brain so its function is properly accomplished. In fact, while absence of UBE3A is 
the base of AS, extra doses of this protein in the brain are associated with autism 
spectrum disorders (ASDs) (Smith et al., 2011; Urraca et al., 2013; Noor et al., 2015; Yi et 
al., 2015). Despite a secondary function as a coactivator for nuclear hormone receptors 
has also been described for UBE3A, mutations affecting its ubiquitin-ligase activity, but 
that leave intact the coactivator function, have been reported on AS patients (Nawaz et 
al., 1999). Consequently, the ligase activity is thought to be responsible of the AS 
phenotype. Similarly, the ligase activity has also been associated with ASDs (Yi et al., 
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2015). Thus, identifying the ubiquitin substrates of UBE3A in neurons is required for the 
better understanding of the pathophysiology of both AS and ASD.  
 
2.3. UBE3A ubiquitin substrates 
 
Since AS was linked to UBE3A mutations (Kishino et al., 1997; Matsuura et al., 1997) 
many attempts have been performed in order to identify the substrates of this enzyme. 
The first one to be reported as a UBE3A target was p53. An increase in the total levels of 
p53 in UBE3A deficient mice brains was reported, suggesting it was due to the failure of 
the ubiquitin dependent degradation of p53 (Jiang et al., 1998). Over the following year 
several proteins were proposed as UBE3A substrates. The multicopy maintenance 
protein (Mcm) 7 subunit, a protein involved in DNA replication, and the proapoptotic 
Bak protein were shown to interact with UBE3A in HeLa and HEK293 cells, respectively 
(Kühne and Banks, 1998; Thomas and Banks, 1998). A reduction of the total protein 
level in the presence of UBE3A was described for Blk, a membrane-bound non-receptor 
tyrosine kinase, in COS-7 cells (Oda et al., 1999). The yeast Rad23 human homologue 
(HHR23A) was shown to be ubiquitinated by UBE3A in vitro (Kumar et al., 1999). And 
even UBE3A was described to be itself auto-ubiquitinated in vitro as a self-regulatory 
mechanism (Nuber et al., 1998). 
 
The arrival of mass spectrometry-based strategies allowed the identification of 
additional proteins as potential UBE3A ubiquitin substrates. The Rho-guanine-
nucleotide exchange factor (RhoGEF) Pebble (Pbl) and the Na+/K+ ATPase (Atpα) were 
proposed as UBE3A targets in Drosophila melanogaster heads (Reiter et al., 2006; Jensen 
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et al., 2013). Similarly, the activity-regulated cytoskeleton-associated (Arc) protein and 
the RhoGEF Ephexin 5 were proposed as UBE3A candidates in mice brain (Greer et al., 
2010; Margolis et al., 2010). And Annexin A1 was suggested as being regulated by 
UBE3A in human carcinoma cells (Shimoji et al., 2009).  
 
Several other proteins have been described as UBE3A substrates in the literature, 
including the amplified in breast cancer 1 (AIB1) protein (Mani et al., 2006), p27 
(Mishra et al., 2009a) and Ring1B (Zaaroor-Regev et al., 2010). The biochemical 
validation of the in vivo ubiquitination of  all these UBE3A potential substrates in a 
neuronal context, however, has still remained a challenge. Evidence of the direct 
ubiquitination of some UBE3A putative substrates (AIB1,  Bak, Blk, Mcm7, p53, Pbl) 
remains absent, as changes in their total protein levels in the presence/absence of 
UBE3A or interaction with UBE3A have only been reported (Jiang et al., 1998; Kühne 
and Banks, 1998; Oda et al., 1999; Mani et al., 2006; Reiter et al., 2006; Margolis et al., 
2010). The direct ubiquitination by UBE3A of other putative substrates (Arc, HHR23A, 
Na+/K+ ATPase, p27, Ring1B, UBE3A) has only been validated in vitro (Nuber et al., 
1998; Kumar et al., 1999; Greer et al., 2010; Mishra et al., 2009a; Zaaroor-Regev et al., 
2010; Jensen et al., 2013). Or in the case of Annexin A1 and Ephexin 5 using non-
denaturing immunoprecipitation approaches, which leaves the possibility to the 
detected signal been due to co-purifying proteins (Shimoji et al., 2009; Margolis et al., 
2010). 
  
The lack of in vivo evidence of the direct ubiquitination of the potential substrates by 
UBE3A has, as a consequence, produced controversial results. Arc ubiquitination, for 
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instance, was recently shown not be controlled by UBE3A in cells (Kühnle et al., 2013) 
and additionally suggested that it could rather be regulated by a different E3 ligase 
enzyme (Mabb et al., 2014). Similarly, the Na+/K+ ATPase was found to be upregulated in 
AS mouse model, but was reported not to be a substrate of UBE3A since no interaction 
between Na+/K+ ATPase and UBE3A could be detected from mice brain hippocampal 
homogenates (Kaphzan et al., 2011). The fact that proteins that might not be directly 
ubiquitinated by UBE3A are also affected in AS or ASD patients, suggests an indirect 
effect produced by the misregulation of upstream proteins (the “true” UBE3A 
substrates) in the affected pathways (Sell and Margolis, 2015). The relevance that these 
indirect substrates has in the phenotype of these two syndromes should not be 
undervalued, but it should be kept in mind that identifying the direct UBE3A ubiquitin 
substrates is indispensable in order to properly understand the pathophysiology of AS.  
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3. Methodology to study ubiquitination 
 
Isolation and identification of ubiquitinated proteins under physiological conditions 
from in vivo tissues is a challenging task, as the ubiquitin modified proteins are generally 
found at very low levels within the cells. Besides, the fast kinetics at which some of the 
proteins conjugated with ubiquitin are degraded (Choi et al., 2013), the action of the 
deubiquitinating enzymes (Stegmeier et al., 2007) or the fact that proteins might be 
modified with ubiquitin only in well-defined temporal windows (Clute and Pines, 1999), 
make even more difficult their analysis. The identification of the proteins that are 
ubiquitinated in a given tissue is, however, mandatory in order to better understand the 
role that ubiquitination plays in vivo. In recent years, mass spectrometry (MS) based 
ubiquitin proteomics have proven to be a good strategy for this purpose, and thus, it has 
become a routinely used technique for the large-scale identification of ubiquitinated 
proteins. 
 
3.1. Mass spectrometry 
 
In proteomics a mass spectrometer is used to measure the mass-to-charge ratio 
(m/z) of previously ionized peptides and make a record of their abundance (Steen and 
Mann, 2004). In a typical MS-based proteomics experiment, proteins extracted from 
cells or tissues are subjected to trypsin digestion. Afterwards, the resulting peptides are 
separated by chromatography and loaded into the mass spectrometer, where they are 
ionized and separated according to their m/z ratio. The molecular weights of the 
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peptides relative to their charge are then measured and used to identify the proteins 
they correspond to.  
 
A mass spectrometer is typically composed of four main components: an ion source, a 
mass analyser, a fragmentation chamber and an ion collection/detection system (Yates 
et al., 2009). The ion source converts the molecules to be analysed, such as the peptides 
generated by trypsin digestion, into charged ions. The mass analyser is responsible for 
separating the produced ions according to their m/z ratio. The fragmentation chamber 
is where ionized peptides (precursor ions) are further chopped into fragment ions, so 
information of their amino-acid sequence can be obtained. And the ion collection/ 
detection system records the number of ions at each m/z values (Finehout and Lee, 
2004; Steen and Mann, 2004; Yates et al., 2009). 
 
The Electrospray Ionization (ESI) and the Matrix Assisted Laser Desorption/ 
Ionization (MALDI) are the most used ionization techniques in proteomics (Karas and 
Hillenkamp, 1988; Fenn et al., 1989). In the case of ESI, ions are produced from samples 
found in solution by applying high voltage, resulting in a spray of highly charged 
droplets that are then desolvated. By contrast, samples are co-crystalized within an 
organic matrix and then irradiated with laser pulses in MALDI, resulting in ions in the 
gas phase (Yates et al., 2009). 
 
The peptides that have been transformed into ions are then separated according to 
their m/z ratio by the application of an electrical or magnetic field in the mass analyser. 
Four types of mass analysers are commonly used in proteomics: Quadrupole, Ion-Traps, 
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Time-Of-Flight and Fourier-Transform Ion Cyclotron Resonance, which vary in their 
physical principles and analytical performance (Yates et al., 2009). For instance, the 
amount of time required for an ion to travel a known distance is measured in Time-Of-
Flight analysers, but different voltages are applied in Quadrupole and Ion-Traps, so ions 
with a particular m/z ratio are only allowed to pass through the analyser. In addition, 
they have different sensitivities, resolution and scanning rates, thus, according to the 
researcher requirements the use of some might be more suitable than others (Domon 
and Aebersold, 2006; Yates et al., 2009).  
 
After determining the m/z of the peptides a second stage of MS can be applied. This is 
known as tandem MS and is abbreviated as MS/MS. At this stage selected ions 
(precursors) are further broken into pieces in a fragmentation chamber in order to 
obtain additional information about the composition of the peptide sequence (Steen and 
Mann, 2004). The precursor and corresponding fragment ions are then loaded into 
specific software suits that determine the identity of the proteins present in the sample 
by comparing the experimental MS data with the theoretical mass of the proteins 
defined in a database. As the sequence of each protein is unique, so are the peptides that 
can be generated from each protein by proteolytic cleavage. Thus, knowing the mass of 
each peptide their sequence can be determined and ultimately the proteins they come 
from identified. 
 
The number of ions of a given m/z ratio are also recorded by the detector/collection 
system and translated into a measurable electric current. This value, usually designated 
as intensity, correlates with the peptide abundance and thus can be employed for
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Figure 7. LFQ quantification method used by MaxQuant software. 
 A. Occurrence matrix of peptide species (P1-P7) in six MS samples (A-F). Peptide presence is indicated by 
a plus symbol. MaxQuant employs the intensities occurring in both samples to calculate peptide ratios. For 
instance, to calculate the ratio between sample B and C only P2, P3 and P6 will be taken into account. B. 
Matrix of protein ratios between samples. Median of the peptide ratios is calculated in order to provide a 
protein ratio (r) between samples. Only if a minimum number of two peptide ratio are available the 
protein ratio is considered valid. Valid and invalid protein ratios are shown in green and red respectively. 
C. System of equations that need to be solved to obtain the protein abundance profiles (I). If a sample has 
no valid ratio with any other sample, like sample F, the intensity is set to 0. An example of how ID would be 
calculated is shown. D. The protein abundance profile obtained after solving the equations from C. The 
absolute profile scale is adapted to match the summed-up raw peptide intensities. Modified from Cox et 
al., 2014. 
 
quantification purposes. However, distinct peptides have different physico-chemical 
properties that influence their MS behaviour, and hence their intensity. For this reason, 
peptides intensities have to be first normalized in order to appropriately estimate the 
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protein abundance. One of the most commonly used protein quantification strategy at 
present that employ peptide intensities is the so called Label Free Quantification (LFQ). 
Among the softwares available, MaxQuant has been used during this Thesis project to 
process the raw MS files and calculate the LFQ intensity (Luber et al., 2010; Cox et al., 
2014). Using a specific algorithm that normalizes the data across different mass 
spectrometric runs (Figure 7) the LFQ data provides accurate quantification of the 
protein abundance within the samples (Cox et al., 2014). 
 
3.2. Historically used strategies to enrich ubiquitinated material 
 
Despite the great potential of MS analysis, the low stoichiometry at which 
ubiquitinated proteins are found within the cells makes it necessary to carry out an 
enrichment of the ubiquitinated material prior the MS analysis (Mayor and Peng, 2012). 
So far several methods have been developed with that purpose with the help of 
ubiquitin-specific antibodies (Matsumoto et al., 2005; Vasilescu et al., 2005; Xu et al., 
2010), ubiquitin-binding domains (UBDs) (Bennett et al., 2007; Lopitz-Otsoa et al., 
2012) or epitope-tagged versions of ubiquitin (Greer et al., 2010; Peng et al., 2003). 
Employment of ubiquitin antibodies, UBDs or certain types of epitope-tags, such as HA, 
however, requires the purification to be performed under native conditions. Affinity 
pulldowns that cannot withstand denaturing conditions usually result in the co-
purification of proteins that are probably not ubiquitin conjugates, but interacting 
proteins (Tirard et al., 2012). Additionally, non-denaturing conditions are favourable to 
any protease or DUB activity, so a reduction in the yield of purified material might also 
occur.  
Introduction 
- 70 - 
 
The proteolytic digestion with trypsin that usually precedes the MS analysis  
produces peptides that contain either an arginine or a lysine residue at their C-terminal 
(Olsen et al., 2004). Modification with ubiquitin, however, prevents tryptic digestion 
after the modified lysines, and additionally, it leaves the last two glycine residues of 
ubiquitin still covalently attached to the lysine (Figure 8). This signature peptide, 
commonly known as di-gly signature, produces a mass shift on the peptides of 114.1 Da 
that is detectable by MS (Peng et al., 2003). In recent years, this di-gly signature has 
been exploited for the development of specific antibodies that allow the isolation and 
enrichment of di-gly containing peptides (Xu et al., 2010). Ubiquitin-remnant di-gly 
specific antibodies have been used so far for the isolation and identification of 
thousands of putative ubiquitination sites in a number of systems (Xu et al., 2010; Kim et 
al., 2011; Wagner et al., 2011; Na et al., 2012; Wagner et al., 2012; Sarraf et al., 2013). It 
should be noted, however, that a di-gly remnant is also left by other ubiquitin-like 
proteins, such as Nedd8 or ISG15. Under physiological circumstances Nedd8 and ISG15 
modifications are found at lower levels than ubiquitination, but their concentration 
dramatically increases if the proteasome is blocked, a strategy commonly used in 
ubiquitome studies (Leidecker et al., 2012).  Besides, the use of di-gly specific antibodies 
requires the proteins to be trypsin digested, preventing any immunoblotting on the 
purified material to validate and further characterize their ubiquitination. 
 
Alternatively, enrichment of ubiquitinated proteins can be carried out under 
denaturing condition, so interacting proteins are discarded and the material is further 
protected from the activity of proteases. Classically, poly-histidine tagging has been used 
for that purpose (Hitchcock et al., 2003; Peng et al., 2003; Mayor et al., 2007; Xu et al., 
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2009). However, one concern using this approach would be the presence of too many 
endogenous histidine-rich proteins in mammals, which would also be trapped in the 
nickel affinity beads, resulting in excessive background. 
 
 
 
Figure 8. The di-gly signature left on ubiquitinated proteins after trypsin digestion. 
Trypsin digests proteins after arginine and lysine residues. When an ubiquitin molecule is attached, 
however, the modified lysine is protected from the proteolytic activity of the enzyme and the last two 
glycines of ubiquitin are left covalently attached to it, resulting in a small increase of the peptide’s 
molecular weight (114.1 Da). Red arrow denotes the trypsin cleavage on the last arginine residue of 
ubiquitin. Taken from Peng et al., 2003. 
 
3.3. In vivo biotinylation of ubiquitin: the bioUb strategy 
 
Biotin-dependent carboxylases are a type of enzymes, widely distributed in nature, 
that are involved in the metabolism of fatty-acids, amino-acids and carbohydrates. They 
contain a biotin carboxyl carrier protein (BCCP) component where a covalently linked 
biotin molecule serves as an acceptor-donor of CO2 molecules (Tong, 2013). The 
attachment of biotin to BCCP is mediated through the ε-amino group of a lysine residue 
and is catalysed by the so called biotin holoenzyme synthetase enzymes (Kwon and 
Beckett, 2000). This biotinylation reaction is highly specific and only few proteins are 
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found to be modified with biotin in vivo (Chandler and Ballard, 1985). Interestingly, the 
minimal peptide that can be efficiently biotinylated by the E.coli biotin holoenzyme 
synthetase enzyme (BirA) was described to be 14 amino-acid long (Beckett et al., 1999). 
This finding provided a powerful tool for the generation of fusion proteins that can be 
easily purified or detected thanks to their biotin tag. 
 
Based on this, the laboratory of Dr. Ugo Mayor developed a strategy for the in vivo 
isolation of ubiquitin conjugates (Franco et al., 2011). This approach has so far allowed 
the purification and enrichment of hundreds of ubiquitin conjugates from flies (Franco 
et al., 2011; Ramirez et al., 2015), mice (Lectez et al., 2014) and human cell lines (Min et 
al., 2014). The system relies on the in vivo expression of the E. coli BirA enzyme as a 
fusion protein with multiple copies of ubiquitin, each of which bear a 16 amino-acid long 
biotinylatable motif at their N-terminal part (Figure 9A). Six modified ubiquitins and 
BirA are produced as a precursor polypeptide. As it happens with the endogenous 
ubiquitin genes (Kimura and Tanaka, 2010), the precursor is digested by the 
endogenous DUBs, so individual ubiquitin molecules and BirA are released (Figure 9B). 
BirA then recognizes the biotinylatable motif at the N-terminus of the ubiquitin moieties 
and conjugates a biotin molecule on them (Figure 9C). That way, a pool of biotinylated 
ubiquitin is generated within the cells, which is employed by the UPS machinery 
together with the endogenous ubiquitin (Figure 9D). Having the cellular proteins 
conjugated with biotinylated ubiquitin allows the use of avidin-beads for their isolation 
and enrichment (Figure 9E). Thanks to the strong affinity (Kd~10-15 M) of the avidin-
biotin interaction (Marttila et al., 2000), very stringent washes can be applied to the 
biotinylated material that is bound to avidin resins (Franco et al., 2011). Therefore, all 
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Figure 9. The in vivo biotinylation of ubiquitin: the bioUb strategy. 
A. The construct is expressed as a poly-ubiquitin chain fused to BirA. The sequence added at the N-
terminal part of each ubiquitin molecule is shown. The target sequence for biotinylation is underlined, 
with the lysine where the biotin is attached highlighted in red. A five amino-acid linker (italicised) was 
additionally introduced to improve the accessibility of the ubiquitin conjugates to the avidin resin. B. 
Endogenous DUBs process the fusion ubiquitin-BirA polypeptide. The same way endogenous ubiquitin 
precursors are digested, DUB enzymes cut after the last glycine of each ubiquitin, generating free 
biotinylatable ubiquitin moieties and the BirA enzyme. C. BirA catalyses the conjugation of biotin to the 
target sequences. The BirA enzyme recognizes the short motif incorporated at the N-terminus of each 
ubiquitin and attaches a biotin molecule to it. Thus, a pool of biotinylated ubiquitin is generated. D. The 
biotinylated ubiquitin is then conjugated to the cellular proteins. Endogenous ubiquitin will compete with 
the ectopic biotinylated ubiquitin. However, the conjugation of one biotinylated ubiquitin should be 
enough for their isolation. E. Avidin beads are used to purify the ubiquitinated material. The strong 
interaction of avidin-biotin allows the use of very stringent washes, so interacting proteins are discarded. 
Modified from Franco et al., 2011. 
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interacting proteins are removed and only ubiquitinated material and a few 
endogenously biotinylated carboxylases are purified. The isolated material can then be 
subjected to MS or Western blot analysis (Franco et al., 2011; Lectez et al., 2014; Min et 
al., 2014; Ramirez et al., 2015). 
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4. Drosophila melanogaster 
 
At the beginning of the 20th century Williams E. Castle initiated studies on Drosophila 
melanogaster in his laboratory at Harvard University (Cambridge, USA) (Castle, 1906; 
Roberts, 2006). Since then, many studies performed with the fruit fly have helped in the 
understanding of basic biological processes conserved from invertebrates to humans. 
Probably, the most famous are those carried out by Tomas H. Morgan that led to the 
discovery of the sex-linked inheritance (Morgan, 1910) and to the confirmation of the 
chromosomal theory of inheritance (Doncaster, 1916; Roberts, 2006). He was awarded 
the Nobel Prize in Physiology and Medicine in 1933 for these works. Additional 
outstanding breakthroughs have been achieved using Drosophila during the past 110 
years, also worthy of Nobel Prizes, such as the discovery of the mutagenic activity of the 
X-rays by Hermann J. Muller (Muller, 1927), the characterization of essential genes that 
control early embryonic development by Edward B. Lewis, Christiane Nüsslein-Volhard 
and Eric F. Wieschaus (Lewis, 1978; Nüsslein-Volhard and Wieschaus, 1980), or the 
identification of the Toll receptor as a key component required for the immune system 
activation by Jules Hoffmann (Lemaitre et al., 1996). 
 
Three of the essential features for which Drosophila has gained such a success as a 
model organism are 1) its fast generation time, 2) ease of culture and 3) low 
maintenance cost. Besides, it contains a smaller genome distributed into one X/Y pair of 
sex-chromosomes and three pairs of autosomes (Adams et al., 2000). This greatly 
simplifies the genetics and the understanding of the biological functions of Drosophila 
genes, as the gene redundancy found in higher organisms is reduced. Significantly, about 
75 % of human genes involved in disease have an homologue in the fly (Reiter et al., 
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2001). Thus, Drosophila provides a simpler in vivo system in which to study the role of 
those genes (Pandey and Nichols, 2011). In fact, many human diseases have been 
modelled in flies with that purpose (Sang and Jackson, 2005; Jackson, 2008; Pandey and 
Nichols, 2011).  
 
The tools and resources that have been developed over the past century for working 
with Drosophila, such as the tissue- and time-specific expression systems (see 
Introduction section 4.2: GAL4/UAS binary system), the different mutant lines or the 
balancer chromosomes (Bier, 2005; Matthews et al., 2005), have turned this small 
arthropod into an invaluable animal model for research that has little to envy to its 
mammalian colleagues.  
 
4.1. Life cycle of Drosophila melanogaster 
 
Drosophila is a holometabolous insect that undergoes complete metamorphosis. Their 
life cycle is divided into four main stages according to morphology: egg, larva, pupa and 
adult fly (Figure 10). The time that is required for an egg to develop into an adult fly 
varies with temperature, being shorter at higher temperatures. Fly embryogenesis takes 
place during the first 24 h following fertilization at 25 ºC. During this first day the main 
endodermal-, mesodermal- and ectodermal-derived larval tissues and organs are 
developed. Subsequently, a tiny-worm like animal hatches, known as the first instar 
larva (L1). L1 larva feeds for 24 h and moults into a bigger second instar larva (L2), who 
equally moults into the third instar larva (L3) after feeding for about another 24 h. The 
main external difference between L1, L2 and L3 larvae is their size, being L3 the biggest 
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and L1 the smallest. The L3 larval stage (about 2-3 days) is followed by the pupal stage. 
Shortly before pupation, larva stops feeding and finds a dry place suitable for pupation. 
The larva then becomes motionless and gradually acquires its pupal shape. Throughout 
the subsequent ~4-5 days metamorphosis occurs, and most of the larval structures are 
lysed or modified, leading to adult organ development. 10-11 days after the initial 
fertilization, the adult fly emerges from the pupa. 
 
 
 
Figure 10. Drosophila melanogaster life cycle. 
The four main stages during the Drosophila life cycle and the time that each stage last at 25 ºC is shown. 
The egg, larva, pupa and adult figures were taken from the interactive fly web page (Brody, 1999). 
 
4.2. GAL4/UAS binary system 
 
The GAL4 is a yeast transcription factor that promotes the expression of genes 
required for the catabolism of galactose (Traven et al., 2006). It recognizes specific DNA 
sites -known as upstream activating sequence (UAS)- that have the 5’-CGG-N11-CCG-3’ 
consensus sequence, where N11 correspond to any 11 bases (Marmorstein et al., 1992). 
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Upon galactose induction, GAL4 binds as a dimer to the UAS and activates nearby gene’s 
transcription by recruiting co-activators and the general transcription machinery 
(Traven et al., 2006). Interestingly, the expression of GAL4 in Drosophila tissues was also 
demonstrated to induce the transcription of a reporter gene, which had been placed 
downstream a 17-mer sequence closely-related to UAS (Fischer et al., 1988).  
 
Cahir J. O’Kane and Walter J. Gehring showed that the cell/tissue expression pattern 
of randomly inserted genes in the Drosophila genome, was affected by the 
transcriptional regulatory elements adjacent to their insertion sites (O’Kane and 
Gehring, 1987; Wilson et al., 1989). Based on this and on the ability of GAL4 to activate 
transcription in Drosophila (Fischer et al., 1988), Andrea H. Brand and Norbert Perrimon 
developed what is known as the GAL4/UAS system (Brand and Perrimon, 1993). They 
designed a vector (pUAST) in which genes could be inserted behind five tandemly 
arrayed UAS sites, so their transcription was subjected to the presence of the GAL4 
protein (Figure 11). On the other hand, they generated two vectors that allow the 
expression of GAL4 either under the control of characterized Drosophila promoters or 
under endogenous genomic enhancers (Figure 11). In both cases, a tissue-specific GAL4 
expression pattern is achieved (Brand and Perrimon, 1993). This binary system in 
which each vector (i.e., GAL4 and UAS vectors) is found in separated Drosophila lines 
(Figure 11), has been a revolutionary breakthrough as it allows for a huge number of 
combinations for the expression of any gene/protein of interest (including those that 
might cause lethality) in a tissue- and time-specific manner. 
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Figure 11. GAL4/UAS binary system. 
The GAL4/UAS system consists of two elements: The yeast GAL4 protein and the upstream activating 
sequence (UAS) that can be placed before any gene of interest. GAL4 can be expressed in Drosophila in a 
tissue and time specific manner, either under the control of genomic enhancers located nearby its 
insertion site or under known promoters placed upstream the GAL4. On the other hand, the addition of 
the UAS next to a gene of interest (gene X) allows its expression to be dependent on the presence of GAL4. 
Thus, crossing flies that carry any UAS-gene X construct to flies with a given tissue GAL4 distribution will 
produce a progeny that expresses the gene X with the same pattern as the GAL4. Taken from St Johnston, 
2002.     
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The main interest of the laboratory where this Thesis project was carried out is the 
understanding of the role that ubiquitination plays in the nervous system. The low levels 
at which proteins modified with ubiquitin are found within the cells, however, make the 
study of this post-translational modification a difficult task to perform. Dr. Mayor’s 
laboratory developed recently the bioUb strategy, a novel approach based on the in vivo 
biotinylation of ubiquitin, that allows the efficient isolation and subsequent MS 
identification of the most abundant ubiquitin conjugates during the Drosophila embryo 
nervous system development (Franco et al., 2011). We then hypothesized that this 
strategy could also be expanded and applied for the identification of ubiquitin-modified 
proteins from other Drosophila tissues. Particularly, we hypothesized that this strategy 
could be used to monitor changes in the ubiquitination profiles caused by the blockade 
of the proteasomal degradation or to determine the specific substrates of an E3 ligase 
involved in disease. 
 
The main objectives of this Thesis project have been the following: 
 
1. To expand the bioUb strategy to the Drosophila adult brain in order to identify 
those proteins that are being ubiquitinated in the context of a mature neuron. 
2. To identify the Drosophila neuronal ubiquitin proteome that is accumulated upon 
inhibition of proteasomal degradation. 
3. To identify the direct substrates of Ube3a, the fly homologue of the Angelman 
syndrome-causing UBE3A E3 ligase in Drosophila neurons.  
4. To develop new strategies to further study and characterize the ubiquitination of 
the proteins isolated and identified by the bioUb strategy. 
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1. Drosophila melanogaster 
 
1.1. Fly husbandry procedures 
 
All Drosophila fly lines were grown and mated, unless otherwise indicated, at 25 ºC in 
12 hours light-dark cycles in wheat flour and yeast medium, which contained 1 % of 
agar (Industrias Roko), 5.5 % of dextrose (VWR Chemicals), 3.5 % of wheat flour 
(Carrefour) and 5 % of yeast (Ynsadiet) in distilled H2O. To prevent mould and bacterial 
growth 0.25 % of Nipagin (Lemmel), 0.4 % of propionic acid (Sigma) and 0.02 % of 
benzalkonium chloride (Sigma) were added to the food mixture when it had cooled 
down below 60 ºC and before aliquoting into the plastic bottles (Scientific Laboratory 
Supplies) and vials (Genesee Scientific). 
 
1.2. Fly strains employed 
 
The yeast GAL4/UAS binary system (Brand and Perrimon, 1993) was employed to 
drive the expression of the different transgenes used in this work. Flies expressing GAL4 
under the following promoters were used: the eye-specific Glass Multimer Reporter-
GAL4 (GMRGAL4; Hay et al., 1994), the pan-neuronal embryonic lethal abnormal vision-
GAL4 (elavGAL4; Luo et al., 1994), the heat shock inducible-GAL4 (HsGAL4; Brand et al., 
1994), the tubulin-GAL4 (TubGAL4; Lee and Luo, 1999) and the vesicular glutamate 
transporter-GAL4 (OK371GAL4; Mahr and Aberle, 2006). In addition, flies expressing a 
temperature sensitive version of the GAL4-repressing protein, GAL80, under the control 
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of the tubulin promoter (TubGAL80ts; McGuire et al., 2003), were also used to avoid the 
lethality caused by TubGAL4-driven expression. Tissue expression patterns of GAL4 and 
GAL80 proteins with the mentioned promoters are shown in Table 1. GMRGAL4 (BL 
1104), elavGAL4 (BL 8765), HsGAL4 (BL 2077), TubGAL4 (BL 5138) and TubGAL80ts (BL 7017) 
flies were supplied by the Bloomington Drosophila Stock Center (BDSC, Bloomington, IN, 
USA). The OK371GAL4 line was kindly provided by Cahir O’Kane (University of Cambridge, 
UK).  
 
Table 1. Drosophila GAL4 and GAL80 lines used. 
Genotype GAL4- or GAL80-driver Expression Abbreviation 
w*; GMR-GAL4 Glass Multimer Reporter-GAL4 eye GMRGAL4 
elav-GAL4/CyO embryonic lethal abnormal vision-GAL4 nervous system elavGAL4 
Hsp70-GAL4 Heat shock inducible-GAL4 ubiquitous HsGAL4 
yw; TubP-GAL4 α-Tubulin-GAL4 ubiquitous TubGAL4 
VGlutOK371-GAL4 Vesicular glutamate transporter-GAL4 glutamatergic neurons OK371GAL4 
w*; TubP-GAL80ts α-Tubulin-GAL80 temperature sensitive ubiquitous TubGAL80ts 
Fly genotypes, names of the GAL4- and GAL80-drivers, tissue where GAL4 and GAL80 proteins are 
expressed and abbreviation with which each line is designated, are shown. All drivers are inserted on the 
second chromosome with the exception of TubGAL4 and TubGAL80ts that are on the third one. 
 
Drosophila transgenic lines carrying an insert preceded by an upstream activating 
sequence (UAS), so as to be expressed only in the presence of GAL4, are listed in Table 
2. Flies expressing a precursor protein composed of six biotinylatable ubiquitin 
moieties, fused to the E. coli biotin ligase (BirA) enzyme were used (UAS(bioUb)6-BirA) for 
studying the ubiquitinated proteome in Drosophila tissues. As control, flies that express 
only the E. coli BirA enzyme (UASBirA) were used. Both flies were previously generated 
by Professor Ugo Mayor (Franco et al., 2011). Flies overexpressing the C-terminal half of 
the regulatory particle non-ATPase 10 protein (UASRpn10-∆NTH), kindly provided by Dr. 
Zoltan Lipinszki (Lipinszki et al., 2009), were employed for the analysis of proteins that 
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accumulate upon proteasome blockade. An Ube3a gain of function (UASUbe3aA3) fly line 
was utilized to identify the substrates regulated by Ube3a E3 ligase. As a control, flies 
with the w; If/CyO; Ube3a15B/TM6 genotype were used, which bear a deletion on the 
Ube3a gene (designated as Ube3a15B allele) that results in no protein production.  These 
two fly lines were a gift from Professor Janice Fischer (Wu et al., 2008). Additionally, 
UASGFPCL1 flies expressing Green Fluorescence Protein (GFP) fused to a degradation 
signal that leads to its fast degradation (Pandey et al., 2007), OregonR flies (BL 2376) as 
wild type strain, as well as Sco/CyO (BL 2555) and w1118; Bl/CyO; TM2/TM6B (BL 3704) 
balancer flies to set up stable lines, were used. Wild type and balancer flies were 
obtained from the BDSC. 
 
Table 2. Drosophila UAS lines used. 
Genotype Description Abbreviation 
yw; UAST-BirA Express E. coli BirA enzyme UASBirA 
yw; UAST-(bioUb)6-BirA Express biotinylated ubiquitin and BirA UAS(bioUb)6-BirA 
yw; UAST-GFP-(bioUb)6-BirA Express GFP,  biotinylated ubiquitin and BirA UASGFP(bioUb)6-BirA 
w1118; If/CyO; UAST-Rpn10-∆NTH Express C-terminal half of the Rpn10 protein UASRpn10-∆NTH 
w; If/CyO; UAST-Ube3aA3/TM6B Express Ube3a E3 ligase UASUbe3aA3 
UAST-CL1-GFP Express GFP protein carrying a degradation signal UASGFPCL1 
Fly genotypes, description and abbreviation with which each line is designated are shown. UASBirA and 
UAS(bioUb)6-BirA flies carry the insert on the second chromosome. In the case of UASBirA, flies carrying the 
insert on the third chromosome were used too. UASGFP(bioUb)6-BirA, UASRpn10-∆NTH, UASUbe3aA3 and 
UASGFPCL1 have the constructs inserted on the third chromosome. 
 
1.3. Fly crosses performed 
 
Generation of elavGAL4,UAS(bioUb)6-BirA/CyO stable line, for the analysis of the 
ubiquitinated material in the Drosophila embryo nervous system development, has been 
previously described (Franco et al., 2011). For the analysis of the ubiquitinated material 
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in the fly photoreceptor cells the GMRGAL4,UAS(bioUb)6-BirA/CyO stable line was generated. 
GMRGAL4 homozygous flies were first mated to homozygous UAS(bioUb)6-BirA ones.  
GMRGAL4/UAS(bioUb)6-BirA heterozygous females obtained in the offspring were further 
crossed to Sco/CyO balancer males, so as to get flies where a recombination event has 
occurred. Afterwards, GMRGAL4,UAS(bioUb)6-BirA/CyO recombinants were stabilized by 
crossing one more time to Sco/CyO flies and selecting those in the offspring carrying 
both constructs over the CyO chromosome. As a control for embryonic samples the 
elavGAL4,UASBirA/CyO line was used (Franco et al., 2011). In the case of adult samples, the 
recombination of GMRGAL4-driver with the UASBirA construct could not be achieved and 
hence, flies carrying the UASBirA transgene on the third chromosome (GMRGAL4/CyO; 
UASBirA/TM6B) were used instead.  
 
Flies with the elavGAL4,UAS(bioUb)6-BirA/CyO; UASRpn10-∆NTH/TM6B and GMRGAL4, 
UAS(bioUb)6- BirA/CyO; UASRpn10-∆NTH/TM6B genotypes were employed for the analysis 
of the proteins that accumulate upon proteasome blockade in the embryo nervous 
system and in the adult eye, respectively. They were generated by crossing two times 
elavGAL4, UAS(bioUb)6-BirA/CyO and GMRGAL4,UAS(bioUb)6-BirA/CyO flies to If/CyO; TM2/TM6B 
ones, in order to obtain the elavGAL4,UAS(bioUb)6-BirA/CyO; TM2/TM6B and GMRGAL4, 
UAS(bioUb)6-BirA/CyO; TM2/TM6B double balanced lines, which were then crossed to 
If/CyO; UASRpn10-∆NTH/TM6B flies.  
 
The identification of Ube3a E3 ligase substrates was carried out with 
elavGAL4,UAS(bioUb)6-BirA/CyO; UASUbe3aA3/TM6B and elavGAL4,UAS(bioUb)6-BirA/CyO; 
Ube3a15B/TM6B flies in embryo, and with GMRGAL4,UAS(bioUb)6-BirA/CyO; UASUbe3aA3/ 
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TM6B and  GMRGAL4,UAS(bioUb)6-BirA/CyO; Ube3a15B/TM6B in adult. These Drosophila lines 
were generated by crossing If/CyO; UASUbe3aA3/TM6B and If/CyO; Ube3a15B/TM6B 
animals to elavGAL4,UAS(bioUb)6-BirA/CyO; TM2/TM6B and GMRGAL4, UAS(bioUb)6-BirA/CyO; 
TM2/TM6B  double balanced flies. 
 
Analysis of the in vivo interaction between Ube3a and Rpn10 was performed with 
flies carrying simultaneously the UASUbe3aA3 and UASRpn10-∆NTH constructs on the same 
chromosome (If/CyO; UASUbe3aA3,UASRpn10-∆NTH/TM6B). This line was obtained by 
recombining If/CyO; UASUbe3aA3/TM6B with If/CyO; UASRpn10-∆NTH/TM6B following the 
same procedure described for elavGAL4,UAS(bioUb)6-BirA/CyO and GMRGAL4,UAS(bioUb)6-
BirA/CyO lines (see above). If/CyO; UASUbe3aA3,UASRpn10-∆NTH/TM6B flies were then 
mated to elavGAL4,UAS(bioUb)6-BirA/CyO; TM2/TM6B and to GMRGAL4,UAS(bioUb)6/CyO; 
TM2/TM6B lines in order to analyse their isolated ubiquitinated material. The eye 
phenotype was evaluated after crossing If/CyO; UASUbe3aA3,UASRpn10-∆NTH/TM6B with 
GMRGAL4 flies. Flies carrying each construct independently were also crossed to GMRGAL4. 
Flies expressing at the same time Ube3aA3 and GFPCL1, under the control of GMRGAL4, 
were additionally created to discard the possibility of the eye phenotype being rescued 
due to lower ratio of GAL4 protein for each UAS site. 
 
1.4. Fly sample collection  
 
Embryo sample collection was performed at 25 ºC by enclosing flies in ventilated fly 
cages with Petri dishes containing an apple juice-rich agar layer, made of 2.5 % of agar 
(Industrias Roko), 2.5 % of dextrose (VWR Chemicals), 25 % of apple juice (Carrefour), 
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0.25 % of Nipagin (Lemmel) and distilled H2O, partially covered with yeast paste 
(Levital). Flies were then let to lay eggs over a 12 hour period, after which the Petri 
dishes were substituted. The 0-12 hours old embryo laid were then allowed to further 
age for 9 extra hours at 25 ºC, so the embryos were 9-21 hours old (stage 13 to stage 17) 
at the time of extract preparation. The embryos were washed with 1X Phosphate 
Buffered Saline (PBS) from Fisher Scientific, containing 0.1 % Triton X-100 (Sigma), 
dechorionated with 50 % bleach solution for 3 minutes, immediately washed with PBS-
Triton (0.1%), collected into tubes and flash frozen in liquid nitrogen before been stored 
at -80 ºC.  
 
Drosophila heads were collected from flies grown at 25 ºC in wheat flour and yeast 
medium. Two to five days old adult flies were flash frozen in liquid nitrogen. Heads were 
then severed by shaking the frozen flies and separated from the remaining body parts 
using a pair of sieves with a nominal cut-off of 710 and 425 μm. Heads were stored at -
80 ºC until needed.  
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2. Molecular Biology 
 
2.1. Oligonucleotides 
 
Primers were designed to have between 18-30 nucleotides complementary to the 
target template and to finish with G or C bases at 3’ end, in order to enhance primer 
annealing. New restriction sites and tags were included at their 5’ ends. Primers 
developed for the generation of point mutations were between 25-45 bases in length, 
have a Tm ≥ 78 ºC and contained the desired mutation in the middle of the sequence, as 
suggested by the manufacturer’s instructions (Stratagene). Oligonucleotides for the 
generation of pAc5-GFP vectors and GFP-tagged proteins were prepared jointly with Dr. 
So Young Lee. All primers, listed in Table 3, were synthesized by Invitrogen.  
 
Table 3. List of primers used. 
Primer name Primer sequence 
pAc5 GFP vectors 
N-GFP-F GCAGGGTACCATGAGTAAAGGAGAAGAACTTTTCACTGG 
N-GFP-R GCAGTCTAGACTAGCTAGCGCGGCCGCGAATTCCTCGAGTTTGTATAGTTCATCCATGCCATGTG 
C-GFP-F GCAGGGTACCCTCGAGGAATTCGCGGCCGCGCTAGCATGAGTAAAGGAGAAGAACTTTTCACTGG 
C-GFP-R GCAGTCTAGATTATTTGTATAGTTCATCCATGCC 
Flag-tagged ubiquitin 
Ub KpnI Flag-F GCAGGTACCATGGATTACAAGGATGATGACGATAAGATGCAGATCTTCGTGAAGAC 
Ub EcoRI-R GCCGAATTCCTAACCACCACGGAGACG 
HA-tagged Ube3a 
Ube3a XhoI HA-F GCCCTCGAGATGTACCCCTACGATGTGCCCGATTACGCCATGAACGGTGGC 
Ube3a XbaI-R GCCTCTAGACTACAGCATGCCGAAGCC 
Site directed mutagenesis 
Ube3a-C941S-F TTGCCTACCTCGCACACCTCCTTCAACGTTCTCC 
Ube3a-C941S-R GGAGAACGTTGAAGGAGGTGTGCGAGGTAGGCAA 
nSyb-K71R-F CGCACGAACGTGGAGAGGGTGCTGGAGCGCGAC 
nSyb-K71R-R GTCGCGCTCCAGCACCCTCTCCACGTTCGTGCG 
nSyb-K78R-F CTGGAGCGCGACAGCAGGCTGTCGGAGCTGGACG 
nSyb-K78R-R CGTCCAGCTCCGACAGCCTGCTGTCGCGCTCCAG 
GFP-tagged proteins 
CG12082 XhoI-F GCCCTCGAGATGGAGGAACTACGCAAGC   
CG12082 NheI-R GACGCTAGCCTGTTCGCGCATATACAGATCAG 
(Continued) 
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Table 3. (Continued) 
Primer name Primer sequence 
Rad23 XhoI-Fw GCCCTCGAGATGATTATTACAATTAAAAATCTTC 
Rad23 NheI-Rv GACGCTAGCATCATCGAAGCTAGACGATAGC 
P47 XhoI-Fw GCCCTCGAGATGGCCGCGCGCGGCGATTTG 
P47 NheI-Rv GACGCTAGCCTTGAGGCGCTGCATGAGTGC   
TER94 XhoI-Fw GCCCTCGAGATGGCAGATTCCAAGGGTG 
TER94 NheI-Rv GACGCTAGCACTGTAAAGATCATCGTCGC   
CG8209 XhoI-Fw GCCCTCGAGATGAGTGAAGTGCAGACATTGATGG 
CG8209 NheI-Rv GACGCTAGCTGCGGGCGTCTTGGTCATGG 
Rpn13 XhoI-Fw GCCCTCGAGATGTTTGGAAGACAAAGTGG 
Rpn13 NheI-Rv GACGCTAGCCTTTTGCTTCTCCTCCTGTT 
rngo XhoI-Fw GCCCTCGAGATGAAAATCACAGTGACGACC 
rngo NheI-R GACGCTAGCGCTGAGTTCGCTCCCCGAGG 
Rpn10 XhoI-F GCCCTCGAGATGGTTCTGGAGAGTACTATGATATGC 
Rpn10 NheI-R GACGCTAGCTTTTTTTTGCGAGTCCTTGCC 
Rpn10 CH XhoI-F GACCTCGAGATGTTCGAATTCGGTGTAGATCCC 
Rpn10 NH NheI-R GACGCTAGCGACGTTGCCGCCCAGG 
Tbp-1 XhoI-F GCCCTCGAGATGGCTCAGACTCTGGAGG 
Tbp-1 NheI-R GACGCTAGCAGCGTAGTAGTTAAGATTAGCC 
Uch-L5 XhoI-F GCCCTCGAGATGGGCGACGGTGCTGG 
Uch-L5 NotI-R GATAGCGGCCGCTGTCGGTATCCTTTTTGCGCTGC 
CG15118 XhoI-F GCCCTCGAGATGAGGAGCGTCGAGGAGATC 
CG15118 NheI-R GACGCTAGCGTGCTCTTGCAGACTAAGC 
Hsp83 XhoI-F GCCCTCGAGATGCCAGAAGAAGCAGAGACC 
Hsp83 NheI-R GACGCTAGCATCGACCTCCTCCATGTGG     
Hsp26 XhoI-F GCCCTCGAGATGTCGCTATCTACTCTGCTTTCG 
Hsp26 NheI-R GACGCTAGCCTTGTCCTTGCCGTTGGGTGC 
Hsp27 XhoI-F GCCCTCGAGATGTCAATTATACCACTGCTGC 
Hsp27 NheI-R GACGCTAGCCTTGCTAGTCTCCATTTTCTCG 
HIP XhoI-F GCCCTCGAGATGGCTTTCACAATGCAAACC 
HIP NheI-R GACGCTAGCGTCCAAACCGTCATCGACGAAG 
Hsc70Cb EcoRI-F GCCGAATTCATGTCCGTGATTGGCATCG 
Hsc70Cb NotI-R GATAGCGGCCGCTCTCCACTTCCATGGAGGGATCG 
CG7033 XhoI-F GCCCTCGAGATGGAGATGTCCTTGAATCCCGTGC 
CG7033 NheI-R GACGCTAGCGCAGTAGCCCCTGTCGGGAACG 
Nrt EcoRI-F GCCGAATTCATGGGCGAACTCGAGGAGAAGG 
Nrt NheI-R GACGCTAGCATCGACGCGCGCATACCG 
Fax XhoI-F GCCCTCGAGATGGCAAGCGAAGTGGC 
Fax NheI-R GACGCTAGCCTTTGTTTCCTCCTTCTCTTTG 
Akap200 XhoI-F GCCCTCGAGATGGGTAAAGCTCAGAGCAAGC 
Akap200 NheI-R GACGCTAGCTTCGCATGTAACGGGCAGTTG 
Flo-1 XhoI-F GCCCTCGAGATGACTTGGGGATTTGTAACCTGC  
Flo-1 NheI-R GACGCTAGCGCCAGCATGCACAGACCG 
ArgK EcoRI-F GCCGAATTCATGTTCGCTTTGTGGTATTTAACTTTTGC 
ArgK NheI-R GACGCTAGCCAGGCTCTTCTCGAGCTTGATC 
Fas-2 EcoRI-F GCCGAATTCATGGGTGAATTGCCGCCAAATTC  
Fas-2 NheI-R GACGCTAGCAGCAGTGTGCGTCGTCGG 
Fas-3 NotI-F GATAGCGGCCGCTATGTCACGGATCGTTTTTATATGTC 
Fas-3 NheI-R GACGCTAGCGTACAAGTTCAGCATAGACGAGTTG 
Flo-2 XhoI-F GCCCTCGAGATGCCTTCACACACATGCACACC 
Flo-2 NheI-R GACGCTAGCCGCCTTGGCCCCCGGTATC 
Src42A XhoI-F GCCCTCGAGATGGGTAACTGCCTCACCAC 
Src42A NheI-R GACGCTAGCGTAGGCCTGCGCCTCTTTG 
β-Tub56D XhoI-F GCCCTCGAGATGAGGGAAATCGTTCACATCC 
β-Tub56D NheI-R GACGCTAGCGTTCTCGTCGACCTCAGCC 
(Continued) 
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Table 3. (Continued) 
Primer name Primer sequence 
α-Tub67C EcoRI-F GCCGAATTCATGCGCGAAGTAGTCTCCATCC 
α-Tub67C NheI-R GACGCTAGCGAACTCATCGAAGTCCTCGTCG 
α-Tub84D EcoRI-F GCCGAATTCATGCGCGAATGTATCTCTATCC 
α-Tub84D NheI-R GACGCTAGCGTACTCCTCAGCACCCTCGC 
Hsc70-4 EcoRI-F GCCGAATTCATGTCTAAAGCTCCTGCTGTTGG 
Hsc70-4 NheI-R GACGCTAGCGTCGACCTCCTCGATGGTGG 
Esp15 NotI-F GATAGCGGCCGCTATGAATGTGGACTTTGCGAGG 
Esp15 XbaI-R GCCTCTAGAGTTGTCCAGTACGCTGCG 
Df31 XhoI-F GCCCTCGAGATGGCTGATGTGGCTGAGC 
Df31 NotI-R GATAGCGGCCGCTGGCGGCCACTTCGCTAGC 
CG8223 XhoI-F GCCCTCGAGATGTCTGCTGAAGCCGAAGC 
CG8223 NheI-R GACGCTAGCGACGGCGGCACGCTTGG 
RpS7 NotI-F GATAGCGGCCGCTATGGCTATCGGCTCCAAGAT 
RpS7 NheI-R GACGCTAGCGACATTCAGGTAGTTGTCGG 
Rm62 XhoI-F GCCCTCGAGATGATGATGATGGCACCACACG  
Rm62 NheI-R GACGCTAGCGTCGAAGCGCGAGTGTCTGC 
pAbp XhoI-F GCCCTCGAGATGGCTTCTCTATACGTCGGTGATCTCC 
pAbp NotI-R GATAGCGGCCGCTGTTGGCGGGCTCGGTGACG 
elF-4a XhoI-F GCCCTCGAGATGGATGACCGAAATGAGATACC  
elF-4a  NheI-R GACGCTAGCAATCAAATCGGCAATATTAGCAGG 
Hrb27C XhoI-F GCCCTCGAGATGGAGGAAGACGAGAGGG 
Hrb27C NheI-R GACGCTAGCGACAGCCTGCGAGGTTGC 
Atp-α XhoI-F GCCCTCGAGATGCCGGCCAAAGTTAATAAAAAGG 
Atp-α NheI-R GACGCTAGCGTTCTTAACTATTAACTGGGATGG 
Eno XhoI-F GCCCTCGAGATGTCTTGGACCGCTTCAG 
Eno NheI-R GACGCTAGCCTGCGGCTTCCTGAACGAC 
dUTPase XhoI-F GCCCTCGAGATGCCATCAACCGATTTCGC 
dUTPase NheI-R GACGCTAGCCGTAGCAACAGGAGCCGGAGC 
CG1910 NotI-F GATAGCGGCCGCTATGTCGGAGGCAACTGTGG 
CG1910 NheI-R GACGCTAGCGTTACACACTTTGGGCGCAGC 
RpS10b XhoI-F GCCCTCGAGATGTTTATGCCAAAGGCCCATCG 
RpS10b NheI-R GACGCTAGCGTTGCGCGATCCGCGTCC 
14-3-3-ε NotI-F GATAGCGGCCGCTATGACTGAGCGCGAGAACAATG 
14-3-3-ε NheI-R GACGCTAGCCGACACGTCCTGATCCTCAAC 
Cyp1 XhoI-F GCCCTCGAGATGGTCTCTTTTTGTGCAACTC  
Cyp1 NheI-R GACGCTAGCAAGAGAACCAGAGTTAGCCAC 
14-3-3-τ XhoI-F GCCCTCGAGATGTCGACAGTCGATAAGGAAGAGC 
14-3-3-τ NheI-R GACGCTAGCGTTGTCGCCGCCCTCCTG 
hts XhoI-F GCCCTCGAGATGACTGAAGTTGAGCAACCG 
hts NheI-R GACGCTAGCGGCCTCGGCCTTCTTCTTC 
rin EcoRI-F GCCGAATTCATGGTCATGGATGCGACC 
rin NheI-R   GACGCTAGCGCGACGTCCGTAGTTGCC 
nSyb XhoI-F GCCCTCGAGATGGCGGACGCTGCACCAGCTGG 
nSyb NheI-R GCCGCTAGCCACGCCGCCGTGATCGCC 
Viral (bioUb)6-BirA and BirA vectors 
bioUb BamHI-F GCCGGATCCATGGGTTTGAATGACATATTTGAAGC 
BirA EcoRI-R GCCGAATTCCTATTATTTTTCTGCACTACG 
BirA BamHI-F GCCGGATCCATGAAGGATAACACCGTGC 
doubled-stranded RNA (dsRNA) 
E1-S AATACGACTCACTATAGGGGCATTGGGGAAGTTCTTCAG 
E1-R AATACGACTCACTATAGGGTGACTCGAAATGGTTTATTGTC 
Primer names and sequences are shown. Names consist on the gene name, followed by the enzyme site 
that this primer generates for their insertion into pAc5 or pBABE vectors. Forward or reverse orientation 
of the primers is indicated with an F or R letter at the end of the primer name, respectively. 
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2.2. DNA plasmids used 
 
The pAc5 expression vector from Invitrogen, that contains the promoter from the 
Drosophila actin 5C gene, was used for the generation of all the constructs used in 
Drosophila BG2 cells. This plasmid was further modified by introducing between KpnI 
and XbaI sites the GFP protein followed by XhoI, EcoRI, NotI and NheI enzymes sites, 
which were introduced during the GFP amplification process using the N-GFP-F and N-
GFP-R primers (Table 3). The modified vector (pAc5-N-GFP) allows the insertion of the 
protein of interest in the newly synthesized multicloning site, so as to generate N-
terminally GFP-tagged proteins. Equally, using the C-GFP-F and C-GFP-R primers, GFP 
protein preceded by the same XhoI, EcoRI, NotI and NheI sites was inserted into the pAc5 
vector (pAc5-C-GFP), to allow the generation of C-terminal GFP-tagged proteins, as 
described in Material and Methods section 2.3: Cloning procedures. These three vectors 
(i.e., pAc5, pAc5-N-GFP and pAc5-C-GFP) were used to generate the different plasmids 
carrying either N-terminal and C-terminal GFP-tagged proteins, as well as the Flag-
tagged ubiquitin and the HA-tagged Ube3a enzyme. 
 
Generation of viral vectors containing the (bioUb)6-BirA transgene, or the BirA gene 
alone, was performed using the hygromycin-resistant retroviral pBABE vector 
(Addgene; #1765), which is based on the Moloney murine leukaemia virus. This vector 
expresses inserted genes from the promoter within the long terminal repeat and a 
hygromycin drug-resistance gene from the simian vaculating virus 40 promoter 
(Morgenstern and Land, 1990).  
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2.3. Cloning procedures 
 
PCR reactions were carried out in a GS1 Thermal Cycler (G-Storm). Generally, about 5 
ng of template DNA were incubated with 200 µM of each dNTP, 1.5 mM of MgCl2, 0.5 µM 
of each primer and 0.02 U/µL of Phusion High-Fidelity DNA polymerase enzyme in 1X 
Phusion HF buffer. All reagents were obtained from Thermo Scientific. A typical reaction 
consisted on an initial denaturation step of 30 seconds at 98 ºC, followed by 25 cycles of 
10 seconds of denaturation at 98 ºC, 20 seconds of annealing at a convenient 
temperature and 15 second of extension per kilobase of amplicon length at 72 ºC. 
Afterwards, a final extension of 5 minutes at 72 ºC was applied. Annealing temperature 
for each primer pair was calculated with the Thermo Fisher Scientific Tm calculator tool.  
 
All Drosophila genes were amplified from a Berkeley Drosophila Genome Project 
cDNA library. Flag-tagged ubiquitin was amplified using the Ub KpnI Flag-F and Ub 
EcoRI-Rv primers (Table 3) and inserted between the KpnI and EcoRI sites of the pAc5 
vector (Invitrogen) to generate the Flag-Ub-pAc5 plasmid. Ube3a XhoI HA-F and Ube3a 
XbaI-R primers were employed to introduce an HA-tagged version of the wild type 
Ube3a gene into XhoI and XbaI sites of the pAc5 plasmid (HA-Ube3aWT-pAc5). All the 
GFP-tagged proteins generated were amplified using the primers described in Table 3, 
and inserted in the newly generated N-terminal or C-terminal GFP pAc5 vectors. Each 
gene was introduced using specific combinations of enzymes sites, which are indicated 
in the name of each primer (Table 3). This work was done jointly with Dr. So Young Lee 
(Lee et al., 2014).  
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Generation of retroviral vectors with the (bioUb)6-BirA transgene was performed by 
re-amplifying the whole construct from the initial pUAST plasmid employed to produce 
the UAS(bioUb)6-BirA transgenic flies (Franco et al., 2011). The bioUb BamHI-F and BirA 
EcoRI-R primers were utilized for that purpose. BirA gene alone was amplified from the 
same vector using BirA BamHI-R and BirA EcoRI-R primers. Both transgenes were then 
inserted into the BamHI and EcoRI sites of pBABE-hygro vector and sent to the Viral 
Vector Core of the University of Tennessee Health Science Center (UTHSC, Memphis, TN, 
USA) for viral production. 
 
Digestion of DNA molecules was performed at 37 ºC for a two-hour period with each 
of the restriction enzymes (Fermentas), followed by additional 20 minutes at the 
inactivation temperature recommended for each enzyme, typically 65 ºC or 80 ºC. 
Afterwards, ligation of the digested PCR fragments and vectors was performed 
overnight, at 18 ºC, in the presence of a T4 DNA ligase (England biolabs). Next day, about 
1.5 µL of the ligation mixtures were used to transform 20 µL of XL-1 blue competent 
cells (Agilent Technologies) according to manufacturer’s instruction, and let them grow 
overnight, at 37 ºC, in LB agar (Conda-Pronadisa) plates with appropriate antibiotic. The 
presence of plasmids in the grown transformants was further checked by PCR. Positive 
colonies were then incubated overnight with regular mixing at 37 ºC in LB broth (Conda-
Pronadisa) with appropriate antibiotic (Sigma). Plasmids were purified from the 
overnight grown cultures using the QIAGEN miniprep kit. Correct plasmid sequence was 
confirmed by sequencing by STAB VIDA (Portugal). 
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2.4. Site directed mutagenesis 
 
Point mutations were introduced by inverse PCR on double-stranded DNA plasmids 
using oligonucleotides, each complementary to opposite strand of the vectors, with the 
desired mutation (Table 3). For each reaction 50 ng of template DNA were incubated 
with 2 % v/v of an optimized dNTP mix solution (Stratagene), 0.25 µM of each primer 
and 0.05 U/µL of Pfu Turbo DNA Polymerase in 1X reaction buffer (10 mM KCl, 10 mM 
(NH4)2-SO4, 20 mM Tris-HCL (pH 8.8), 2 mM MgSO4, 0.1 % Triton X-100 and 0.1 mg/mL 
nuclease-free bovine serum albumin). Sample reactions were then subjected to the 
following thermal cycles: 1 minute of denaturation at 95 ºC, 18 cycles of 50 seconds of 
denaturation at 95 ºC, 50 seconds of annealing at 60 ºC and 10 minutes of extension at 
68 ºC, and a final extension cycle of 7 minutes at 68 ºC. Parental DNA templates were 
then digested by DpnI enzyme and plasmids containing the desired mutations were used 
to transform XL1-blue super-competent cells. All mutagenesis procedure was carried 
out using the QuickChange Site-Directed Mutagenesis Kit (Stratagene). 
 
The nSyb lysine to arginine mutants carrying either the lysine 71 or lysine 78 
mutated to arginine (K71R and K78R) and a double mutant carrying both (DM: 
K71R/K78R) were generated on the pAc5-nSyb-C-terminal GFP vector with the nSyb-
K71R-F, nSyb-K71R-R, nSyb-K78R-F and nSyb-K78R-R primers (Table 3). Generation of a 
ligase death version of the HA-tagged Ube3aWT protein (HA-Ube3aLD) was performed on 
the HA-Ube3aWT-pAc5 plasmid by mutating the catalytic cysteine of this E3 ligase, at 
position 941, to a serine using Ube3a-C941S-F and Ube3a-C941S-R primers (Table 3). 
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Plasmid purification and sequence confirmation was performed as described in Material 
and Methods section 2.3: Cloning procedures. 
 
2.5. RNA interference experiments 
 
A fragment of Uba1 of approximately 500 bp, containing the T7 promoter sequence 
on both ends, was generated using the E1-S and E1-R primers (Table 3). 
Oligonucleotides to generate this template were selected by searching the Drosophila 
RNAi Screening Center (DRSC, Boston, MA, USA) database (www.flyrnai.org). The Uba1-
T7-tailed DNA was then used as template in an in vitro transcription reaction in order to 
synthesize a double-stranded RNA (dsRNA). The in vitro transcription was carried out 
using the MEGAscript kit (Ambion). The produced T7-tailed dsRNA was then purified 
with the RNeasy kit (QIAGEN) and the amount and quality of the produced RNA 
determined by spectrophotometric analysis and agarose gel electrophoresis.  
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3. Cell culture 
 
3.1. BG2 cell culture procedures 
 
BG2 cells are neuronal-like cells derived from the Drosophila larval central nervous 
system, which, despite being proliferative, contain acetylcholine neurotransmitter and 
positively react with antibodies against specific neuronal markers (Ui et al., 1994). We 
used them with the purpose of studying protein ubiquitination and screening for Ube3a 
substrates in the context of a neuron. The cells, obtained from the DRSC, were cultured 
at 25 ºC in Shields and Sang M3 Insect Medium (Sigma) supplemented with 10 % fetal 
bovine serum (FBS; Invitrogen), 100 U/mL of penicillin (Invitrogen), 100 µg/mL of 
streptomycin (Invitrogen), 20 µg/mL of insulin (Sigma) and 50 % conditioned medium 
(medium removed from cultured cells, centrifuged 5 min at 364 g, or 1250 rpm, in a 
Allegra X-12R centrifuge, Beckman Coulter).  
 
3.2. Dental Pulp Stem Cell (DPSC) procedures 
 
DPSCs are neural crest-derived cells that can be easily obtained from teeth (Graziano 
et al., 2008). They have the ability to differentiate into numerous tissues, including 
neurons (Kanafi et al., 2014). For this work teeth from three control subjects (TP023, 
TP024 and TP037) were obtained through the Department of Paediatric Dentistry at the 
UTHSC. Teeth from three AS deletion (TP055, TP059 and TP078) and three Dup15q 
patients (TP041, TP058 and TP044) were posted to Dr. Reiter’s lab (UTHSC) by parents 
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of the children with these conditions. In all cases, according to UTHSC Institutional 
Review Board policy, an informed consent was obtained from parents or legal guardian 
of each participant. Exfoliated or extracted teeth were immediately placed in Dulbecco's 
Modified Eagle Medium: Nutrient Mixture F-12, 1:1 (DMEM/F12, 1:1) containing HEPES 
(Fisher Scientific) for their transportation, to which 100 U/mL of penicillin (Invitrogen) 
and 100 µg/mL of streptomycin (Invitrogen) were also added. Upon arrival, teeth were 
broken, dental pulp extracted with the help of tweezers, chopped into small pieces and 
further digested in a solution containing 0.9 mg/mL of Collagenase type I and 1.6 
mg/mL of Dispase II for 1 hour at 37 ºC. Digested pulp was then cultured under standard 
condition (37 ºC, 5 % CO2) with DMEM/F12 (1:1), supplemented with 10 % FBS (Fisher 
Scientific), 10 % of newborn calf serum (NCS; Fisher Scientific), 100 U/mL of penicillin 
(Invitrogen) and 100 µg/mL of streptomycin (Invitrogen).  
 
3.3. Cell transfection and transduction assays 
 
The calcium phosphate method (Kingston et al., 2003) was employed for BG2 cell 
transfection. Typically, 1 mL of BG2 cells at 1 x 106 cell/mL concentration was seeded 
per well on 12-well plates. Next day, 10 µL of 2.5 M CaCl2 were mixed with 2 µg of GFP-
tagged genes construct and 0.4 µg of Flag-tagged ubiquitin constructs in 100 µL of H2O. 
This DNA mix solution (100 µL) was then added drop-wise to 100 µL of 2X HEPES buffer 
saline (50 mM HEPES, 1.5 mM NaH2PO4, 280 mM NaCl at pH 7.1), incubated for 40 min 
at room temperature and the 200 µL applied into the cell culture. After 18 hours, cells 
were washed twice with 1X PBS, 1 mL of supplemented M3 insect medium was added 
and incubated at 25 ºC for further 48 hours. Afterwards, cells were washed three times 
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with 1X PBS and stored at -20 ºC until required. To check the effect of HA-tagged 
Ube3aWT and HA-tagged Ube3aLD, 0.2 µg of HA-Ube3a plasmids were additionally added 
to the CaCl2-DNA mixture and 1 µg of GFP-tagged protein and Flag-tagged ubiquitin used 
instead. 
 
Effectene transfection reagent (QIAGEN) was used for dsRNA treatment of BG2 cells. 
1 mL of cells at 5 x 105 cells/mL was seeded on 12 well-plates containing 800 ng of 
dsRNA against E1 and incubated 5 days at 25 ºC. After this period, 2 µg of GFP-tagged 
constructs and 0.8 µg of Flag-tagged ubiquitin plasmid were mixed with 230 µL of EC 
buffer and 20 µL of Enhancer. The solution was incubated for 2 min at room 
temperature and then 15 µL of Effectene were added and further incubated for 8 min at 
room temperature. The DNA mix solution was co-transfected to dsRNA pre-treated cells. 
Seventy-two hours later cells were washed three times with 1X PBS and store at -20 ºC 
until further use. 
 
Generation of stable DPSC-lines expressing BirA protein alone or the whole bio(Ub)6-
BirA construct was carried out on previously human telomerase reverse transcriptase 
(hTERT)-immortalized DPSCs (Wilson et al., 2015).  About 1 x 104 of hTERT-DPSCs were 
seeded on 12-well plates and left to attach overnight. Next day, the medium was 
removed and 500 µL of DMEM/F12 medium containing 6 µL of polybrene (6 mg/mL) 
and virus, at a multiplicity of infection of 20, were added with no antibiotics. Two hours 
later the total volume of each well was increased to 1 mL with DMEM/F12. The 
following morning, the medium with the virus was washed away with 1X PBS, replaced 
with fresh supplemented DMEM/F12 media and cells were left to grow, at 37 ºC and 5 % 
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CO2, for further 72 hours. After this period infected cells were selected with 15 µg/mL of 
hygromicin for 7-10 days. 
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4. Biotin pulldown of ubiquitinated material 
 
4.1. Extract preparation  
 
About 1 g of whole dechorionated embryos (stages 13-17) or 0.35 g of heads of 2-5 
days old flies were homogenized under denaturing condition in 2.9 mL of lysis buffer 
using a tissue grinder (Jencons). The lysis buffer contained 8 M Urea, 1 % of Sodium 
Dodecyl Sulfate (SDS), 50 mM of N-ethylmaleimide (NEM) and a 1X protease inhibitor 
mixture (Roche Applied Science) diluted in PBS from Fisher Scientific. Urea, SDS and 
NEM were obtained from Sigma.  
 
DPSCs extracts were prepared from about 1 x 107 cells that were pelleted at 364 g 
(1250 rpm) for 5 minutes using an Allegra X-12R centrifuge (Beckman Coulter) and 
resuspended in lysis buffer (8 M Urea, 1 % SDS, 50 mM NEM and protease inhibitor 
mixture). Cells were then left in a rotator (Stuart) at 4 ºC for extra 20 min. DPSC growing 
medium was additionally supplemented with 50 µM of biotin (Sigma) for biotin 
pulldown experiments. 
 
4.2. Purification of biotinylated proteins  
 
Fly or DPSC lysates were centrifuged for 5 minutes at 16100 g (13200 rpm), at 4 ºC, in 
a 5415-R centrifuge (Eppendorf). Supernatants were applied to PD10 desalting columns 
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(GE Healthcare), which were previously equilibrated with 25 mL of binding buffer 
containing 3 M Urea (Sigma), 1 M NaCl (Sigma), 0.25 % SDS (Sigma) and 50 mM NEM 
(Sigma) diluted in PBS. Afterwards, adult, embryo or DPSC PD10-eluates, except 50 µL 
that were kept for monitoring the inputs by SDS-PAGE, were incubated in a roller 
(Stuart) with 300 µL, 200 µL or 150 µL of NeutrAvidin agarose beads suspension 
(Thermo Scientific), respectively, for 1 hour at room temperature and 2 additional hours 
at 4 ºC. Non-bounded material (flow through) was recovered by spinning down beads at 
233 g (1000 rpm) for 2 minutes in an Allegra X-12R centrifuge (Beckman Coulter). 
Beads were then subjected to stringent washes with six different washing buffers (WB). 
Number of washes and the order in which they were applied were as follows: two times 
with WB1 (8 M Urea, 0.25 % SDS), three times with WB2 (6 M Guanidine-HCl), 1 time 
with WB3 (6.4 M Urea, 1 M NaCl, 0.2 % SDS), three times with WB4 (4 M Urea, 1 M NaCl, 
10 % Isopropanol, 10 % Ethanol, 0.2 % SDS), 1 time with WB1, 1 time with WB5 (8 M 
Urea, 1 % SDS) and three times with WB6 (2 % SDS). All buffers were prepared in PBS 
(Fisher Scientific). Guanidine-HCl, Isopropanol and Ethanol were provided by Sigma, 
Panreac and Merck, respectively. Each wash consisted on 5 minutes of incubation in a 
roller (Stuart) and 2 minutes of centrifugation at 233 g (1000 rpm) in an Allegra X-12R 
centrifuge (Beckman Coulter). Elution of beads-bounded material was performed by 
heating beads in a dry bath (Fisher Scientific) at 95 ºC in 4X Laemmli buffer (250 mM 
Tris-HCl pH 7.5, 40 % Glycerol, 4 % SDS, 0.2 % Bromophenol blue) and 100 mM 
Dithiothreitol (DTT). The volume of elution buffer employed was half of the NeutrAvidin 
agarose beads suspension used. Boiled samples were applied to 0.8 µm pore size 
centrifugal filters (Sartorius) and centrifuged for 2 minutes at 16160 g (14799 rpm) in a 
Microfuge-16 centrifuge (Beckman Coulter) to separate beads from the eluted material. 
Samples were then analysed by Western blot or sent to mass spectrometric analysis. 
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5. GFP pulldown 
 
5.1. Extract preparation  
 
About 1 x 106 transfected-BG2 cells were harvested with 300 µL of 50 mM Tris-HCl 
pH 7.5, 150 mM NaCl (Sigma), 1 mM EDTA (Gibco), 0.5 % Triton (Sigma), 1X Protease 
Inhibitor cocktail (Roche Applied Science) and 50 mM NEM (Sigma) containing lysis 
buffer and incubated for 20 minutes at room temperature with regular mixing in an 
orbital shaker (Stuart). Lysates were then centrifuged at 16100 g (13100 rpm) for 15 
minutes in a cooled (4 ºC) 5415-R centrifuge (Eppendorf) and supernatants kept for the 
purification process. 
 
5.2. Purification of GFP-tagged proteins 
 
275 µL of BG2 cell lysates (25 µL were kept for monitoring the inputs by SDS-PAGE 
and Western blot) were mixed with 15 µL of GFP-Trap-A agarose beads suspension 
(Chromotek GmbH), which were previously washed twice with a dilution buffer 
containing 10 mM Tris-HCl pH 7.5, 150 mM NaCl (Sigma), 0.5 mM EDTA (Gibco), 1X 
Protease Inhibitor cocktail (Roche Applied Science) and 50 mM NEM (Sigma). The 
mixture was incubated for 2 hours at room temperature with gentle rolling in a rotator 
(Stuart) and then centrifuged for 2 minutes at 2700 g (6049 rpm) in a Microfuge-16 
centrifuge (Beckman Coulter) to separated beads from the unbound material. 25 µL of 
the unbounded fraction were also kept to monitor the flow through fraction by Western 
Materials and Methods 
- 110 - 
 
blot. GFP beads were subsequently washed once with dilution buffer, three times with a 
washing buffer composed of 8 M Urea (Sigma) and 1 % SDS (Sigma) in PBS (Fisher 
Scientific) and once with 1 % SDS in PBS. Beads-bound GFP proteins were eluted by 
heating at 95 ºC, for 10 minutes, with 4X Laemmli buffer (250 mM Tris-HCl pH 7.5, 40 % 
Glycerol, 4 % SDS, 0.2 % Bromophenol blue) and 100 mM DTT in a dry bath (Fisher 
Scientific) and then eluted suspension separated from the beads by centrifuging for 2 
minutes at 16160 g (14799 rpm) in a Microfuge-16 centrifuge (Beckman Coulter).  
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6. Immunoblotting and silver staining 
 
Protein samples subjected to immunoblot analysis or silver staining were first 
separated by SDS-PAGE using either 4-15 % gradient gels from Bio-RAD or 4-12 % 
gradient gels from Invitrogen. Proteins were then transferred to PVDF membrane using 
the iBlot system (Invitrogen) if Western blot analysis was to be performed. On the 
contrary, gels were fixed for 1 h at room temperature with a 40 % methanol and 10 % 
acetic acid containing solution in order to stain proteins with silver.  
 
6.1. Western blotting 
 
The amount of material loaded for Western blot analysis varied according to the 
tissue and the antibody employed. In the case of the material obtained from fly biotin 
pulldown experiments, between 0.001% and 0.2% of the input samples and 5–10% of 
the elution samples were loaded. When material purified from cells was used instead, 
either from the biotin or the GFP pulldown approach, between 10-20 % of inputs and 
10-40 % of the elutions were loaded. Immunoblots with adult flies whole extracts were 
typically performed with six heads of 1-day-old flies, which were cut and homogenated 
in 60 µL of 4X Laemmli buffer (and 100 mM DTT) and boiled for 5 minutes in a dry bath 
(Fisher Scientific). After centrifugation of the non-soluble fraction, at 16160 g (14799 
rpm) in Microfuge-16 centrifuge (Beckman Coulter), 10 µL were loaded, equating 
roughly to one fly head being loaded per lane. In the case of embryo whole extracts same 
lysis procedure was carried out with about 50 µL of embryo that were crashed in 100 µL 
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of 4X Laemmli buffer and 10 µL of the recovered supernatant loaded. Estimating the 
presence of about 50 embryos per 1 µL (Markow et al., 2009), approximately 500 
embryos were loaded per lane. 
 
PVDF membranes were blocked with a blocking solution containing 5 % of fat-free 
milk powder and 0.1 % of Tween 20 detergent (AMRESCO) in PBS. Both primary and 
secondary antibodies were prepared in blocking solution containing 2.5 % of fat-free 
milk powder and 0.1 % of Tween 20 in PBS. In the case of biotin antibody, milk was 
substituted with 0.5 % of casein (Roche Applied Science) to avoid cross-reactivity 
between the antibody and the biotin present in the milk. Typically primary antibodies 
were incubated overnight at 4 ºC and secondary antibodies for 1 h at room temperature. 
Washes to remove excess of antibody were performed with 1X PBS containing 0.1 % 
Tween 20. Membranes were developed by chemiluminescence using the enhance 
chemiluminescence kit from Amersham (GE Healthcare). Dual-colour Western blots 
were prepared by assigning independent colour channels to two independent Western 
blots developed in the same membrane. 
 
The following antibodies were used for immunoblot analysis: goat anti-biotin-
horseradish peroxidase (HRP) conjugated antibody (Cell Signalling) at 1:200 for 
Drosophila embryo and human DPSCs samples, and at 1:1000 for Drosophila adult 
samples; chicken polyclonal anti-BirA antibody (Sigma) at 1:1000; mouse monoclonal 
anti-GFP antibody (Roche Applied Science) at 1:1000; rabbit polyclonal anti-GFP 
antibody (Santa Cruz Biotechnology) at 1:1000; mouse monoclonal anti-Flag M2-HRP 
conjugated antibody (Sigma) at 1:1000; mouse monoclonal anti-Syx1A antibody 
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(Developmental Studies of Hybridoma Bank; DSHB) at 1:50; rabbit polyclonal anti-Eps-
15 antibody (Koh et al., 2007) at 1:150; rabbit polyclonal anti-Fax antibody, a gift from 
Eric Liebl (Deninson University, OH, USA) at 1:1000; mouse monoclonal anti-Atpα 
antibody (DSHB) at 1:50; rabbit polyclonal anti-Parkin antibody, a gift from Alex 
Whitworth (University of Sheffield, UK), at 1:3000; rabbit polyclonal anti-TBPH 
antibody (Feiguin et al., 2009) at 1:50; rabbit polyclonal anti-Ube3a antibody (Lu et al., 
2009) at 1:1000; rabbit polyclonal anti-Tan antibody (Wagner et al., 2007) at 1:100; 
mouse monoclonal anti-Rpn10 antibody (Lipinszki et al., 2009) at 1:100; rabbit 
polyclonal anti-Rngo antibody (Morawe et al., 2011) at 1:500; rabbit polyclonal anti-
Ref(2)P antibody (Pircs et al., 2012) at 1:500; rabbit polyclonal anti-E2-14K (to detect 
its Drosophila homologue UbcE2H) from Boston Biochem at 1:300; mouse monoclonal 
anti-FK1 antibody (Enzo Life Sciences) at 1:1000; mouse monoclonal anti-Nrt (DSHB) at 
1:20; guinea pig polyclonal anti-Lqf (Chen et al., 2002) at 1:200, mouse monoclonal anti-
FK2-HRP conjugated antibody (Ubiquigent) at 1:1000; mouse monoclonal anti-HA 
antibody (Sigma) at 1:1000; rabbit polyclonal anti-Uba1 antibody (Abcam); mouse 
monoclonal anti-β-Tubulin antibody (DSHB) at 1:500 and HRP-labelled secondary 
antibodies, typically at 1:4000, from Jackson ImmuoResearch Laboratories. 
 
6.2. Silver staining 
 
About 10 % of the elution samples were typically used for silver staining analysis. 
Stainings were performed using the SilverQuest kit from Invitrogen according to 
manufacturer’s instructions. Briefly, gels were fixed in a 40 % Ethanol and 10 % Acetic 
acid solution for 1 hour at room temperature. Then, they were incubated with a 
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sensitizing solution to improved protein reactivity toward silver ions, and thus enhance 
the protein staining. After removing excessive of sensitizing solution with H2O, gels were 
incubated with a staining solution, in order to bind silver ions to the proteins, and 
subsequently wash with H2O to remove excess of silver from gels surfaces. Silver ions 
were then reduced to metallic silver until proteins were detected, which typically needs 
about 5-6 minutes.  
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7. Mass spectrometry data collection and analysis 
 
The identification of ubiquitinated proteins isolated from embryo and adult 
Drosophila samples was performed by MS analysis. Eluted fraction from biotin pulldown 
experiment were trypsin digested and extracted peptides run into a mass spectrometer 
as described in Material and Methods section 7.2: Mass spectrometric analysis. Mass 
spectra were then analysed using the MaxQuant software (Cox and Mann, 2008), with 
which protein identification and quantification of protein abundance were obtained. 
 
7.1. Analysed samples 
 
MS analysis performed and the samples that were analysed are listed in Table 4. The 
identification of ubiquitinated material from adult heads samples was performed from 
three independent pulldown experiments. To identify ubiquitin-modified proteins 
during the embryo nervous system development four independent pulldowns were 
analysed by MS. Each pulldown consisted on the experimental sample expressing the 
UAS(bioUb)6-BirA construct and its corresponding control expressing only the BirA 
enzyme. Analysis of the proteins accumulating when C-terminal half of Rpn10 is 
expressed, in embryo and adult flies, was carried out from three independent biological 
replicas. The identification of Ube3a substrates was carried out from one MS analysis, 
each with embryo and adult samples, in which Ube3a loss of function or gain of function 
flies (Ube3a15B vs. Ube3aA3) were compared.  
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Table 4. Mass spectrometric analysis performed. 
MSC number Tissue BirA bioUb Rpn 15B A3 
MSC05753-55 eye + + +   
MSC07038-42 eye + + +   
MSC08962-85 eye + + + + + 
MSC03818-19 embryo NS + +    
MSC04306-07 embryo NS + +    
MSC08200-06 embryo NS + + ++ + + 
MSC08209-13 embryo NS + + +   
Mass spectrometric analysis numbers, assigned by the mass spectrometric core facility at the Max 
Delbrück Center for Molecular Medicine, the tissue from which proteins were extracted and the samples 
that were analysed (indicated with +) are shown. (++) indicates two samples of the same genotype. BirA: 
UASBirA; bioUb: UAS(bioUb)6-BirA; Rpn: UAS(bioUb)6-BirA; UASRpn10-ΔNTH; 15B: UAS(bioUb)6-BirA; Ube3a15B; A3: 
UAS(bioUb)6-BirA; UASUbe3aA3. 
 
7.2. Mass spectrometric analysis 
 
All MS analyses were performed in the lab of Dr. Gunnar Dittmar, at the mass 
spectrometric core facility of the Max Delbrück Center for Molecular Medicine (MDC, 
Berlin, Germany). Eluted samples from biotin pulldowns were run on a SDS-PAGE for 
approximately 4 mm in the separating gel, which was afterwards cut in two slices to 
remove the avidin band. Proteins were converted to peptides using an in-gel digestion 
protocol (Shevchenko et al., 2006; Kanashova et al., 2015) and then separated on a 15 
cm reverse phase column (packed in house, with 3 µm Reprosil beads, Dr. Maisch 
GmbH) using a 5 to 50% acetonitrile gradient (Proxeon nano nLC). Peptide ionization 
was performed on a proxeon ion source and sprayed directly into the mass 
spectrometer (Q-Exactive or Velos-Orbitrap, Thermo Scientific). MaxQuant software 
package (version 1.3.0.5), with top 10 MS/MS peaks per 100 Da and 1% FDR for both 
peptides and proteins (Cox and Mann, 2008), was used for the analysis of recorded 
spectra. Searches were performed using the Andromeda search engine against the 
Uniprot Drosophila melanogaster database. Cysteine carbamidomethylation was 
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selected as a fixed modification and methionine oxidation, protein N-terminal 
acetylation and di-glycine addition on the ε-amino group of lysines as variable 
modifications. Two missed trypsin (full specificity) cleavages were allowed. Mass 
tolerance of precursor ions was set to 6 ppm and for fragment ions to 20 ppm. The 
identified ubiquitination sites were checked using in house programmed software tools. 
Label Free Quantification was also performed with MaxQuant.  
 
7.3. Data analysis 
 
Label Free Quantification (LFQ) ratios were calculated for proteins identified among 
BirA and bioUb samples, so as to discriminate between those purified because of being 
conjugated to ubiquitin and those unspecifically purified. Only proteins whose LFQ 
bioUb/BirA ratio was bigger than 4 (or 2 in log2 scale) were considered to be 
ubiquitinated. In those situations were LFQ value was not available, raw intensities were 
used instead. However, as raw intensity is not a proper quantifiable measurement, 
proteins were only considered to be ubiquitin conjugates if their intensity was at least 
ten-fold bigger in bioUb samples than in BirA. Proteins for which no intensity was 
recorded were discarded from further analysis. Classification of proteins found to be 
more ubiquitinated upon expression of C-terminal half of Rpn10 or Ube3a was only 
performed with LFQ ratios. Vulcano plots, generated with Prism (GraphPad Software), 
were used to depict the LFQ fold changes found between proteins identified in two 
conditions. Box plots and frequency histograms were also produced with Prism. 
Proportional Venn diagrams were done with eulerAPE v3 (Micallef and Rodgers, 2014). 
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8. Microscopy techniques 
 
8.1. BG2 cell confocal imaging 
 
Drosophila BG2 cells were grown over a coverslip glass and transfected with GFP-
tagged genes using the calcium phosphate method (see Material and Methods section 
3.3: Cell transfection and transduction assays). After 72 hours of growth cells were 
washed with 1X PBS (Fisher Scientific) and fixed with 4 % Paraformaldehyde for 30 
minutes on ice. Cells were subsequently washed three times with 1X PBS-0.1 % Triton 
(Sigma) and the nuclei stained with DAPI (Sigma) for 10 minutes. After staining, cells 
were further subjected to three more washes with 1X PBS, one wash with H2O and then 
the coverslips were mounted into slides with Vectashield Mounting Medium (Vector 
Labs). Samples were analysed in a Leica DM IRE2 confocal microscope using LCS-Leica 
confocal software.  
 
8.2. Drosophila eye imaging 
 
Five days old fly eye pictures were taken from CO2 anesthetized flies in a Leica M80 
microscope, incorporated with a Leica EC3 camera, and the Leica Acquire software.  
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9. Bioinformatic and statistical analysis 
 
9.1. Bioinformatic analysis 
 
Two different bioinformatic tools were employed for the gene ontology analysis: GO 
Term Mapper, which bins submitted gene lists into high-level and broader GO parent 
terms (http://go.princeton.edu/cgi-bin/GOTermMapper), also known as GO Slim 
(Harris et al., 2004), and g:Cocoa, a tool integrated in the g:Profiler web server 
(http://biit.cs.ut.ee/gprofiler) that allows to perform comparative analysis of multiple 
gene list, providing an hierarchically sorted list of enriched GO terms. In the latter, the 
statistical enrichment is calculated using the Fisher’s one tailed test, combined with a 
custom multiple correction algorithm (Reimand et al., 2011).  
 
The relative mRNA levels in the Drosophila eye and during the embryonic 
development for the MS-identified ubiquitin carrier enzymes were obtained from 
Flybase (www.flybase.org).  
 
9.2. Statistical analysis 
 
Statistical analysis between Drosophila nSyb mutants was performed by quantifying 
their ubiquitination levels, relative to the total GFP protein purified, using Image J 
(Schneider et al., 2012). A t-test was then applied to every pair of nSyb variants. 
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Similarly, Rpn10 total levels in the presence of wild type or ligase dead Ube3a was 
assessed with Image J. Their levels were normalized to those detected in control 
samples and statistical differences determined using a t-test. Normal distribution was 
assessed by the Kolmogorov-Smirnov test and equality of variance with F test. All 
statistics were performed with Prism (GraphPad Software).     
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1. Expansion of the bioUb strategy from embryonic to adult neurons 
 
An in vivo biotinylation of ubiquitin (bioUb) strategy has been successfully applied in 
Drosophila melanogaster embryos of stage 13-17 in order to identify those proteins that 
are ubiquitinated during the development of the nervous system (Franco et al., 2011). 
This report provided for the first time an in vivo empirical overview of the involvement 
of the ubiquitination machinery in synaptogenesis and showed that non-proteolytic 
roles of ubiquitination during the nervous system development are more abundant than 
generally believed. The post-translational modification of proteins with ubiquitin, 
however, is not restricted to development, but it has been shown to play important roles 
in synaptic plasticity in adult organisms (Hegde, 2010). We therefore decided to apply 
the bioUb strategy on adult flies, aiming to discover the proteins that are ubiquitinated in 
mature neurons of the fruit fly, which could greatly contribute to understand the role of 
protein ubiquitination in brain function.  
 
1.1. Drosophila eye for studying ubiquitination from mature neurons 
 
Flies expressing the UAS(bioUb)6-BirA (bioUb) or the UASBirA (BirA) constructs under the 
control of the pan-neuronal elav-GAL4 (elavGAL4) driver (Luo et al., 1994) were 
previously used to identify proteins ubiquitinated during the development of the 
nervous system (Franco et al., 2011). When tested the expression of bioUb in the adult 
heads of those elavGAL4 flies (Figure 12A), we noticed that this promoter is not suitable 
to perform the same approach in Drosophila adult brain, as the bioUb transgene 
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Figure 12. Expression of bioUb under the control of distinct GAL4 drivers.  
Anti-biotin immunoblots were performed to analyse the expression of the UAS(bioUb)6-BirA construct in 
Drosophila adult heads using various GAL4 drivers. Flies were raised at 25 ºC, unless mentioned otherwise. 
A. The pan-neuronal elavGAL4 (lane 1), the glutamatergic neuron-specific OK371GAL4 (lanes 2-4), the eye-
specific GMRGAL4 (lane 5) and the temperature-sensitive TubGAL4,GAL80ts (lane 8) drivers were used to 
express bioUb. A modified version of the construct, carrying GFP attached (UASGFP(bioUb)6-BirA), was 
employed in the case of OK371GAL4 too (lane 4). Co-expression with UASRpn10-∆NTH was further tested 
using the elavGAL4 (lane 6) and OK371GAL4 (lanes 7) drivers to accumulate more ubiquitinated material. 
GMRGAL4 provided the highest expression. B. Expression of bioUb was additionally tested using the HsGAL4 
driver and different heat shock treatments (lanes 3, 5-13). Among the different conditions assessed, the 
highest expression was obtained when flies were born and kept at 29 ºC (lane 3). However, this condition 
did not reach the expression levels achieved with the GMRGAL4 driver (lane 1). Six heads (three males and 
three females) were collected for each condition, but only a volume equivalent to 1 head loaded per lane. 
Endogenously biotinylated proteins are indicated with arrowheads. Taken from Ramirez et al., 2015. 
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does not reach the expression required for MS-based proteomic studies (Figure 12A, 
lane 1). Alternatively, the expression of bioUb was tested under the control of different 
GAL4 drivers, including the glutamatergic neuron-specific OK371-GAL4 (OK371GAL4; 
Mahr and Aberle, 2006), the eye-specific glass multimer reporter-GAL4 (GMRGAL4; Hay et 
al., 1994), the heat shock-GAL4 (HsGAL4; Brand et al., 1994) and tubulin-GAL4 (TubGAL4; 
Lee and Luo, 1999) (Figure 12A and Figure 12B). The latter was further combined 
with the temperature-sensitive tubulin-GAL80 (TubGAL80ts; McGuire et al., 2003) because 
expression of bioUb with TubGAL4 alone resulted in embryonic lethality (data not shown). 
In an attempt to enrich those proteins conjugated with the biotinylated ubiquitin, 
OK371GAL4 and elavGAL4 drivers were additionally combined with the expression of the C-
terminal half of the proteasome regulatory particle non-ATPase 10 (Rpn10) protein 
(UASRpn10-∆NTH), whose overexpression has been reported to cause accumulation of 
ubiquitinated material (Lipinszki et al., 2009; Lee et al., 2014). This approach, however, 
did not improve the overall biotinylation yield (Figure 12A, lanes 6-7).  
 
Among the panel of drivers tested GMRGAL4 (Figure 12A, lane 5; Figure 12B, lane 1) 
and HsGAL4 (Figure 12B) provided an expression of the transgene high enough to ensure 
the isolation, and subsequent MS-based analysis, of the ubiquitinated proteins from the 
adult fly neurons. The GMRGAL4 driver, despite being reported to control the expression 
of a reporter gene on a number of different cell types (Li et al., 2012), drives the 
expression of the target genes mostly in Drosophila photoreceptors cells, a mature and 
specialized type of neurons. In addition, it has been widely used to investigate and 
model neurodegenerative disorders (Jackson, 2008). For these reasons, and because 
none of the temperature conditions tested with HsGAL4 reached comparable expression 
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levels (Figure 12B), the study of the ubiquitinated proteome in Drosophila mature 
neurons was conducted with the GMRGAL4 driver (Ramirez et al., 2015). 
 
A pre-requisite for the bioUb strategy to work is that the UAS(bioUb)6-BirA precursor 
has to be fully digested by endogenous DUBs. In the embryo this is successfully 
accomplished when the construct is expressed under the control of the elavGAL4 driver 
(Franco et al., 2011). Equally, this is also achieved in the Drosophila eye when the 
expression of the transgene is modulated by the GMRGAL4 driver. Western blot detection
 
 
 
Figure 13. Biotinylated ubiquitin is conjugated to proteins in the fly eye. 
A. Western blot-based detection of BirA, on Drosophila head whole extracts, confirmed the full digestion of 
the bioUb precursor by endogenous DUBs. No undigested forms of the precursor were found above the 
expected molecular size of BirA (35 kDa). B. Anti-biotin Western blot on the same whole extracts 
confirmed the biotinylation and conjugation of the GMRGAL4–driven expressed ubiquitin. A protein known 
to be endogenously biotinylated (CG1516) appeared in all the samples (arrowhead), but the expected 
smear corresponding to biotinylated ubiquitin conjugates was only present in the bioUb sample. WT: 
Oregon R; BirA: GMRGAL4/CyO;UASBirA/TM6B; bioUb: GMRGAL4,UAS(bioUb)6-BirA/CyO. Taken from Ramirez et al., 
2015. 
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of BirA revealed a single band of about 37 kDa corresponding to the expected size of the 
E. coli BirA enzyme in the BirA and bioUb samples, but not in the wild type (WT), which 
indicates that the UAS(bioUb)6-BirA construct is being fully digested (Figure 13A). In 
addition, anti-biotin Western blot showed that the expression of BirA alone did not 
cause promiscuous biotinylation of endogenous proteins in the fly eye. A single band 
corresponding to the most abundant endogenously biotinylated protein (CG1516) was 
detected in WT and BirA extracts. By contrast, the typical smear corresponding to 
ubiquitin modified proteins was found in the bioUb sample (Figure 13B). 
 
1.2. Identification of the ubiquitin landscape in Drosophila adult eye 
 
BirA and bioUb extracts from 2-5 days old adult heads were prepared under 
denaturing conditions, incubated with NeutrAvidin agarose beads and subjected to 
biotin pulldown, as described in the Material and Methods section (see also Ramirez et 
al., 2015), in order to purify the ubiquitinated material from photoreceptors cells of 
Drosophila melanogaster. Immunoblot with anti-biotin, as well as silver staining of the 
purified material, suggested that the purification worked successfully (Figure 14). 
Three biologically independent pulldown experiments were therefore performed, with 
their corresponding BirA controls (Figure A1 in appendix II), and subjected to LC-
MS/MS analysis. After subtraction of proteins known to be common contaminants in MS 
analysis (Keller et al., 2008), in our case mostly trypsin and keratin, and discarding 
detections for which no intensity was recorded, a total of 407 and 150 proteins were 
identified among the three bioUb and BirA samples, respectively (Table A1 in appendix 
I). Of those, 108 were detected in both BirA and bioUb samples. In order to discern 
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between true ubiquitinated proteins or background/unspecific proteins, Label Free 
Quantification (LFQ) ratio between bioUb and BirA samples was calculated for each 
replica (bioUb/BirA LFQ ratio). Proteins displaying a bioUb/BirA LFQ ratio higher than 
four (bioUb/BirA LFQ intensity > 4) in each of the replicates were considered putative
 
 
Figure 14. Biotinylated material is efficiently isolated from fly eye. 
A. Representative anti-biotin Western blot performed to monitor the purification process from the 
Drosophila eye. Various dilutions of the input, flow-through (FT) and elution, as indicated, were loaded. 
The estimated recovery yield for all pulldowns was in the range of 20-40 %. B. Representative silver 
staining of the purified material. Equal amounts of BirA and bioUb samples were analysed by SDS-PAGE, 
and stained with silver. Common bands between the two samples are expected to be composed mainly of 
endogenously biotinylated material, while the thick bands at around 40 kDa and below correspond to 
trimer, dimer and monomer forms of NeutrAvidin. The main high molecular weight smear observed in the 
experimental (bioUb) but not in the control (BirA) samples corresponds to the isolated ubiquitinated 
material. BirA: GMRGAL4/CyO;UASBirA/TM6B; bioUb: GMRGAL4,UAS(bioUb)6-BirA/CyO. Taken from Ramirez et al., 
2015. 
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ubiquitinated proteins. In the absence of LFQ values, raw intensities were used instead 
to separate ubiquitinated material from background. In this case the ratio threshold was 
increased up to ten (raw intensity bioUb/BirA > 10), with the intention of being more 
conservative. With this approach a total of 369 proteins were classified as ubiquitin 
conjugates, while 80 (38 of which were also identified among the bioUb samples) were 
assigned as experimental background (Figure 15A, Table A1 in appendix I).  
 
The Drosophila Acetyl-CoA carboxylase (ACC), the pyruvate carboxylase (CG1516) 
and the biotin carboxylase (CG2118) were the only proteins classified as background 
that were consistently found in all the BirA replica analysed (Figure 15A). These three 
enzymes are known to be covalently modified with biotin (Chandler and Ballard, 1986), 
which acts as a co-factor so they can performed their function within the cells 
(Chapman-Smith and Cronan, 1999). The remaining background proteins were, 
however, mainly identified in one biological replica (MSC5753-55), and showed 
relatively lower MS intensities (Figure 15B and C). In regards to the proteins 
categorized as ubiquitin conjugates, 56 % of the identifications came only from one 
biological replica, while the remaining 44 % were detected in at least two independent 
experiments (Figure 15A). This variability positively correlates with the LFQ intensity 
recorded for each protein, being those with higher LFQ values the ones detected in more 
experiments, and vice-versa (Figure 15B and C). 
 
Proteins detected in all bioUb replicates, and hence more confidentially considered as 
true ubiquitinated proteins in Drosophila photoreceptor cells, are listed in Table 5. 
Among them, members of the ubiquitin-proteasome pathway, such as the E1 (Uba1), an 
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Figure 15. Analysis of the proteins identified by MS in the fly eye. 
A. Venn diagrams showing the overlap existing between the proteins classified as background (black 
circle) and bioUb conjugates (green), as well as the overlap between the identified proteins in the several 
pulldown experiments performed. In each independent analysis every protein displaying a bioUb/BirA LFQ 
intensity ratio higher than four, or ten if using raw intensity, were considered as ubiquitin conjugates. In 
those situations where a protein was considered background in one biological replica but conjugate in 
another one was only considered a true ubiquitin conjugate if the number of times classified as so were 
higher than those classified as background, or if we had evidence of its ubiquitination. Each colour 
represents one independent pulldown experiment. For each pulldown experiment the number assigned 
by the MS core facility at the MDC Institute is provided. B. Frequency histograms indicating the number of 
proteins (Y axis) found among different range of LFQ intensity (X axis), represented in log2 scale, for both 
the protein classified as background and ubiquitin conjugates. In green, blue and white are represented 
those proteins found among 3, 2 or 1 independent pulldowns, respectively. In the lowest range of each 
group and coloured with pink are depicted the proteins for which LFQ was not available. C. Box plots 
indicating the positive correlation between the LFQ intensity recorded for the identified proteins among 
different replicates (Y axis) and the number of independent replicates (X axis) on which those proteins 
appeared.  
 
E2 (CG7656) and an E3 (Nedd4) enzyme, as well as two proteins involved in the 
recruitment of proteins to the proteasome: Rad23 and TER94 (Zhang et al., 2013), were 
found. In addition, Smt3, the Drosophila homologue of the ubiquitin-like SUMO protein 
(Talamillo et al., 2013) was detected, suggesting the presence of mix Smt3-ubiquitin 
chains. Ubiquitin was found in all the bioUb pulldowns performed too, with at least 9 
peptides. More interestingly, proteins with a role in the maintenance of the neuron 
homeostasis and in signalling and communication between neurons, such as trans-
membrane ion transport proteins or those involved in endocytic/exocytic processes 
were found. This suggests a role of ubiquitination in the regulation of these pathways in  
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Table 5. List of proteins consistently found in all three bioUb experiments. 
Protein name a MSC05753-55 MSC07038-42 MSC8962-85 PEP Score 
Ubiquitin-proteasome pathway   
 Ub/bioUb 294.98 8.42 181.64 0 
 Uba1 - - 70.01 0 
 Rad23 - - - 10-276 
 CG7656 - - - 10-274 
 Nedd4 - - 7.15 10-142 
 TER94 82.14 - 21.87 10-039 
 Smt3 - - 36.38 10-039 
Trans-membrane ion transport   
 Atpα 6.94 - 68.25 0 
 Calx - - 222.95 10-239 
 Nrv2 57.59 - - 10-157 
 Vha68-2 12.29 - - 10-121 
 Vha55 13.49 - - 10–020 
Exocytosis/Endocytosis  
 AnxB10 - - 7.53 10-260 
 Eps-15 - - - 10-196 
 Ltd - 247.26 - 10-160 
 Syx7 - - - 10-079 
 Scamp - - - 10-051 
 Pi4KIIα - 4.43 - 10-051 
 Gga - - - 10-039 
 Lap - - 16.98 10-030 
 Snap24 - - 30.44 10-019 
Cytoskeletal/Structural proteins   
 C11.1 - - 5.82 0 
 Tm1 0.41 - - 10-156 
 CG3921 - - - 10-017 
Protein folding  
 Hsc70-1 - - - 10-103 
 Hop - - 1.03 10-034 
 Droj2 - - - 10-014 
Metabolic enzymes  
 Wat - - - 0 
 Ald 0.96 - - 10-148 
 Pdh - - - 10-128 
 CG17121 - - 10.55 10-088 
 Sktl - - - 10-044 
Signal transduction  
 Fax 323.25 - - 0 
 Uif - - - 10-023 
 Gαq - - - 10-021 
Transcription  
 Df31 - - - 10-025 
 CtBP - - - 10-018 
 Wbp2 - - - 10-012 
Other function  
 CG3529 - - - 10-185 
 CG1648 - 0.52 - 10-170 
 CG7675 - - - 10-101 
 CG1561 - 105.16 15.05 10-060 
 CG12025 - - 7.97 10-025 
 Mad1 - - 0.81 10-004 
The bioUb/BirA LFQ ratios on independent MS experiments are shown. The number assigned by the MS 
core facility at the MDC Institute is provided. Raw intensity-based ratios are coloured in grey. Absence of 
ratio (-) denotes that the protein was not identified in BirA sample. The lowest Posterior Error 
Probabilities (PEP Score) identified among replicates are reported. All PEP Scores, peptides and 
intensities are shown in Table A1 in Appendix I. 
a Protein names given following Flybase (www.flybase.org) nomenclature. 
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the fly eye. Some other proteins with a more common role inside the cells (structural 
proteins, metabolic enzymes and transcription) were also identified, as well as five 
proteins of a yet unknown function. 
 
1.3. Ubiquitination sites identified in Drosophila photoreceptor cells 
 
Trypsin digestion of ubiquitin conjugates produces a characteristic feature on the 
modified peptides known as di-gly signature (Peng et al., 2003). While ubiquitinated 
lysines remain protected from the action of trypsin, the attached ubiquitins are fully 
digested leaving their last two glycines still covalently attached to the target lysine (thus 
the name di-gly). As this fragments are identifiable by MS (Peng et al., 2003) they can be 
used in order to detect ubiquitination sites. The bioUb strategy does not particularly 
enrich for peptides carrying this signature, however, we did still find a total 21 di-gly 
remnants among the three independent replicates (Table 6). Some of those sites found 
in Drosophila eye seem to be conserved across mammalian homologues and had been 
previously identified in mouse and rat tissues, as well as in human cell lines, such as the 
K421 of Hsc70-1 (Kim et al., 2011; Wagner et al., 2012), the K85 of Pdh (Wagner et al., 
2012), the K214 of Scramb2 (Wagner et al., 2012) and the K71 and K78 of nSyb 
(Danielsen et al., 2011; Na et al., 2012; Wagner et al., 2011, Wagner et al., 2012), 
validating the use of Drosophila as a model system even for the identification of specific 
ubiquitination sites. 
 
Ubiquitin has seven lysine residues along its sequence (K6, K11, K27, K29, K33, K48 
and K63) that may themselves also be modified with another ubiquitin moiety, allowing 
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the formation of poly-ubiquitin chains. According to the position of the lysine in the 
receptor ubiquitin where the next ubiquitin is attached, chains of different topology may 
be formed, which can be homogenous if the same residue is modified along the chain 
(i.e., K48 linked chains) or mixed/branched if the linkages alternate (Komander and 
Rape, 2012). Among the ubiquitination sites identified in this analysis four of the seven 
lysines found in the ubiquitin molecule were detected (Table 6), indicating the presence 
of poly-ubiquitin chains of different topology in our pulldowns. Raw intensities of the 
ubiquitin di-gly peptides measured by MS, despite not being fully quantifiable, were 
further used in order to provide a view of the relative abundance of each type of 
ubiquitin chain linkage. As shown in Figure 16, the most abundant ubiquitin linkage
 
Table 6. Ubiquitination sites identified by MS in the fly eye. 
Protein name a  Peptide Sequence Position of di-glycine PEP Score 
C11.1 R ↓ GK (G-G) VM*VPGAETIYAR ↓ C K587 10-003 
CG10550 R ↓ DLFESLGK (G-G) QR ↓ E K214 10-003 
CG44252 R ↓ K (G-G) NLNIGDIFESNVAR ↓ R K137 10-011 
Fax K ↓ SEAPPAQK (G-G) FNVHK ↓ T K93 10-006 
 K ↓ SEAPPAQK (G-G) FNVHK (G-G) ↓ T K93(0.987) K98(0.013) 10-003 
Hsc70-1 R ↓ ITITNDK (G-G) GR ↓ L K421 10-005 
Nrv2 M ↓ (ac)SK (G-G) PVPM*SPSFVDEDLHNLR ↓ K K3 10-034 
nSyb R ↓ TNVEK (G-G) VLER ↓ D K71 10-006 
 R ↓ DSK (G-G) LSELDDR ↓ A K78 10-007 
Pdh K ↓ NAVVTGGAGGIGLQVSK (G-G) QLLAAGAAK(G-G) ↓ V K40(0.993) K49(0.007) 10-010 
 K ↓ K (G-G) GVEATYEEIAK ↓ T K85 10-009 
 R ↓ LNK (G-G) QSAADVSR ↓ C K232 10-003 
Scramb2 K ↓ LELLTGFETK (G-G) NR ↓ F K82 10-004 
 K ↓ VLSANNEEIGK (G-G) ISK ↓ Q K214 10-009 
Spn-F R ↓ INIIQEK (G-G) IK ↓ A K300 10-003 
Syd R ↓ ISELEDELK (G-G) K (G-G) AK ↓ E K430 K431 10-003 
Ub/bioUb K ↓ TLTGK (G-G) TITLEVEPSDTIENVK ↓ A K11 10-191 
 K ↓ IQDK (G-G) EGIPPDQQR ↓ L K33 10-006 
 R ↓ LIFAGK (G-G) QLEDGRTLSDYNIQK ↓ E K48 10-044 
 R ↓ TLSDYNIQK (G-G) ESTLHLVLR ↓ L K63 10-032 
 R ↓ TLSDYNIQK (G-G) ESTLHLVLRLR ↓ G K63 10-300 
Peptides sequences, positions of di-gly (G-G) with each probability in brackets (when different from 1) 
and Posterior Error Probabilities (PEP Score) are reported. Oxidized methionine is indicated by an 
asterisk (*) and acetylation by (ac). Downward arrow (↓) indicates the site of trypsin digestion. All 
peptides and intensities are shown in table A1 in Appendix I. Modified from Ramirez et al., 2015. 
a Protein names given following Flybase (www.flybase.org) nomenclature.  
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detected in the pulldowns was that formed along K48, followed by K63 and K11. These 
results are in accordance with previous reports (Peng et al., 2003; Danielsen et al., 2011; 
Ziv et al., 2011). Additionally, despite its low abundance, a di-gly site at K33, whose 
modification is yet poorly understood (Komander and Rape, 2012), was also detected.  
 
 
 
Figure 16. Relative abundance of distinct ubiquitin linkages in the fly eye.  
A. Relative average abundance of the different ubiquitin linkages found among three replicates. B. Relative 
abundance of the ubiquitin linkages in each independent replicate. Each colour represents one 
independent MS replica. The number assigned by the MS core facility is provided. The relative abundance 
in (A) and (B) is given as percentage (%) of the sum of all intensities for each ubiquitin site.  
 
1.4. In vivo validation of protein ubiquitination by Western blot 
 
The bioUb strategy allows samples to be subjected to very stringent washing 
conditions during the pulldown process, so just those proteins that are ubiquitinated are 
enriched and purified. Eluted material can then be analysed by MS, or it can be subjected 
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to Western blot analysis in order to confirm that the purified proteins are indeed 
ubiquitinated in vivo, and further characterize whether they are mono- or poly-
ubiquitinated (Franco et al., 2011; Lectez et al., 2014; Ramirez et al., 2015).  Attachment 
of one ubiquitin results in an increase in the protein molecular mass of about ~10 kDa. 
The size of a given ubiquitinated protein detected in the eluted fraction, therefore, 
should be higher than the band identified in the input sample, where ubiquitin 
conjugates will remain undetected due to their low stoichiometry.  
 
Some of the proteins identified in all the three independent experiments (Table 5) 
were validated by immunoblotting. The Epidermal growth factor receptor pathway 
substrate clone 15 (Eps-15) and Failed axon connections (Fax) proteins had been 
previously identified to be mono-ubiquitinated and di-ubiquitinated during the nervous 
system development of Drosophila melanogaster embryo, respectively (Franco et al., 
2011). Equally, in the fly eye the same ubiquitination pattern for both proteins was 
observed (Figure 17).  Similarly, the alpha subunit of the Na+/K+ ATPase (Atpα) was 
also detected to be di-ubiquitinated in photoreceptor cells (Figure 17). The di-ubiquitin 
band seen for both Fax and Atpα might correspond to a chain of two ubiquitins or to the 
attachment of two ubiquitins into two different lysines, however to discern between 
these two situations further experiments would be required.  
 
Western blots to putative ubiquitinated proteins identified in two or even in a single 
replica were also performed. Rings lost (Rngo), the Drosophila homologue of the yeast 
Ddi1/Vsm1 and vertebrate Ddi1/Ddi2 (Morawe et al., 2011), is an extraproteasomal 
ubiquitin receptor seen in two out of three independent bioUb replicates, but not in BirA 
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ones, that appeared poly-ubiquitinated in our samples (Figure 17). A band which a 
priori would be considered as an unmodified form of Rngo was also detected by 
immunoblot (marked with an asterisk in Figure 17). Recent studies have shown that 
cysteines can also be ubiquitinated through a thioester linkage (Wang et al., 2012; 
Lectez et al., 2014). As in the bioUb pulldown protocol DDT is used during the elution 
 
  
 
Figure 17. Western blot validation of ubiquitin conjugates identified in the fly eye. 
Western blots with specific antibodies to some of the proteins identified in the adult pulldown revealed 
the expected increase of their molecular weight in the bioUb elution sample relative to the inputs. 
Covalent attachment of ubiquitin should increase the protein’s molecular weight by about 10 kDa for 
each ubiquitin attached. Therefore, the molecular mass shift shown in the Western blots (arrows) reflects 
their ubiquitinated status. In the case of Rngo a band of the same size as in the input was also detected 
(*). Endogenously biotinylated CG1516 protein, non-specifically identified by anti-Fax antibody, is 
marked with an arrowhead. BirA: GMRGAL4/CyO;UASBirA/TM6B; bioUb: GMRGAL4,UAS(bioUb)6-BirA/CyO. Taken 
from Ramirez et al., 2015.  
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step, thioester bonds are broken away (Franco et al., 2011; Lectez et al., 2014; Min et al., 
2014), hence, this band may also correspond to a fraction of Rngo that is ubiquitinated 
at cysteine residues. Among proteins found only in one experiment the cysteine 
peptidase Tan (T), which is involved in the recycling cycle of the histamine 
neurotransmitter (Wagner et al., 2007) and the synaptic plasma membrane protein 
Syntaxin 1A (Syx1A), involved in the exocytosis of neurotransmitter (Ossig et al., 2000), 
were validated as ubiquitin conjugates by Western blot (Figure 17). Tan was found to 
be modified with up to four ubiquitin moieties, while Syx1A was found to be mono- and 
di-ubiquitinated. These results suggest that proteins identified just in one experiment 
are not necessarily false positives but ubiquitin conjugates of low abundance that may 
sometimes be below the MS detection limit. Indeed, in an ongoing collaboration with Dr. 
Fabian Feiguin (International Centre for Genetic Engineering and Biotechnology, Italy), 
the ubiquitination of the TAR DNA-binding protein-43 homologue (TBPH), a protein 
associated with amyotrophic lateral sclerosis (Feiguin et al., 2009), was also validated in 
Drosophila eye (Figure 17). TBPH has not yet been identified by MS in our experiments. 
This could be due to the amino-acid composition of this protein preventing any MS-
suitable peptides being produced during the trypsin digestion process. 
 
As mentioned above, addition of DTT in the last step of the pulldown protocol breaks 
thioester bonds between ubiquitin and cysteine residues (Franco et al., 2011; Lectez et 
al., 2014; Min et al., 2014). E1 activating, E2 conjugating and some E3 ligating enzymes 
(those classified as HECT, and also the RBR) also generate a thioester linkage in its 
active cysteine with ubiquitin before transferring it to substrates (Wijk and Timmers, 
2010; Berndsen and Wolberger, 2014). This characteristic allows us to isolate those 
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enzymes that are carrying ubiquitin (i.e., enzymes with ubiquitin attached at their active 
cysteine) and therefore detect their carrier condition by Western blot. As it happens 
with ubiquitin conjugates modified at cysteine residues, E2s and E3s enzymes carrying 
ubiquitin via a thioester linkage will not show an increase in their molecular weight in 
the elution fraction, relative to the input, due to the loss of the attached ubiquitin upon 
DTT treatment. A total of 19 ubiquitin carriers were identified across the different 
samples (Table 7), including the ubiquitin activating enzyme E1, twelve E2 conjugating 
enzymes and seven E3 ligating enzymes (Ramirez et al., 2015). Having in the past 
validated the carrier status of the Uba1 and some E2 enzymes (Ubc4, UbcE2H
 
Table 7. List of ubiquitin carriers found by MS in the fly eye. 
Protein name a MSC05753-55 MSC07038-42 MSC8962-85 PEP Score 
Ubiquitin activating enzyme    
 Uba1 - - 70.01 0 
Ubiquitin conjugating enzymes    
 CG7656 - - - 10-274 
 CG40045  - - 0 
 Crl  - - 10-035 
 CG2924 - -  10-029 
 Morgue - -  10-020 
 Ben  -  10-205 
 Ubc10  -  10-142 
 TSG101 -   10-091 
 UbcE2H  -  10-075 
 Ubc6  -  10-026 
 Ubc2  -  10-007 
 Ubc4   - 10-003 
Ubiquitin ligase enzymes    
 Nedd4 - - 7.15 10-142 
 Su(dx) - -  10-021 
 CG5604 -  - 10-019 
 Ube3a -  - 10-016 
 Park -   10-013 
 Ctrip   - 10-003 
The bioUb/BirA LFQ ratios on independent MS experiments are shown. The number assigned by the MS 
core facility at the MDC Institute is provided. Absence of ratio (-) and empty cells denote that the protein 
was not identified in BirA and bioUb sample, respectively. The lowest Posterior Error Probabilities (PEP 
Score) identified among replicates are reported. All PEP Scores, peptides and intensities are shown in 
Table A1 in Appendix I. 
a Protein names given following Flybase (www.flybase.org) nomenclature. 
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Figure 18. Confirmation of carrier activity of Parkin and Ube3a E3 ligases in the fly eye. 
A. Western blots with Parkin and Ube3a antibodies on pulldowns of bioUb flies. Both Parkin and Ube3a 
antibodies non-specifically recognized several proteins in the inputs. The appropriate band of Parkin 
appears at ~55 kDa, while the one of Ube3a does at ~130 kDa. The reducing agents used in the elution 
step breaks the thioester linkage form between these two E3s and ubiquitin, so no increase in their 
molecular weight relative to the inputs is detected in the elution (*). While a fraction of Parkin appears 
also conjugated with ubiquitin (arrow), most of it is carrying it (*). Ube3a antibody cross-reacted with one 
of the endogenously biotinylated proteins (CG1516), thus, endogenous Ube3a remained hidden in the 
elution. Endogenously biotinylated CG1516 protein, non-specifically identified by antibodies recognizing 
Parkin and Ube3a, is marked with an arrowhead. BirA: GMRGAL4/CyO;UASBirA/TM6B; bioUb: GMRGAL4, 
UAS(bioUb)6-BirA/CyO. B. Western blot with Ube3a antibody on pulldowns of bioUb flies, which additionally 
overexpressed the Ube3a E3 ligase (A3) or carry a deletion on the Ube3a gene leading to no protein 
production (15B). Ectopically expressed Ube3a is mostly purified as a carrier protein (*), although there is 
also a small fraction of it ubiquitinated (arrow). BirA and bioUb genotypes as in panel A; A3 refers to flies 
overexpressing Ube3a: GMRGAL4,UAS(bioUb)6-BirA/CyO;UASUbe3aA3/TM6B; 15B refers to flies carrying an 
Ube3a deletion: GMRGAL4,UAS(bioUb)6-BirA/CyO, Ube3a15B/TM6B. Modified from Ramirez et al., 2015. 
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and CG40045) in the nervous system of Drosophila embryo (Franco et al., 2011), we 
decided to test the Western pattern for some of the E3 ligases. Based on antibody 
availability we were able to confirm that Parkin and Ube3a, two E3 ligases involved in 
Parkinson’s disease and Angelman syndrome (AS), respectively (Kishino et al., 1997; 
Shimura et al., 2000), were carrying ubiquitin at the time the extracts were prepared 
(Figure 18) (Ramirez et al., 2015). A Western blot against Parkin showed a band at 
approximately 55 kDa in the input and elution of the bioUb sample (indicated with an 
asterisk in Figure 18A), confirming that Parkin is being mostly pulled down because it 
is active and carrying ubiquitin in the Drosophila eye. A fraction of Parkin appeared also 
ubiquitinated (indicated with arrow in Figure 18A) probably due to self-ubiquitination 
at some lysine residues (Chaugule et al., 2011). The fraction of the endogenous Ube3a 
(indicated with asterisk in Figure 18A) was close to the limit of detection due to its low 
abundance and was, in addition, hindered because the antibody cross-reacted with 
CG1516, one of the endogenously biotinylated proteins (indicated with arrowhead in 
Figure 18A). When combining the bioUb flies with an Ube3A overexpressing line (Wu et 
al., 2008), the preferential carrier status of the expressed Ube3a was clearly confirmed 
(Figure 18B). 
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2. Comparison of ubiquitinated landscapes in developing and adult 
neurons 
 
Each cell type within an organism has a distinctive proteome that characterizes them 
according to the functions in which they are involved in. Similarly, different post-
translational modifications (methylation, acetylation, phosphorylation) have also been 
shown to be cell-specific (Garcia et al., 2008; Huttlin et al., 2010), which further 
contributes to increase the complexity of the proteomes. With regards to ubiquitination, 
a recent work by Wagner and co-workers has uncovered differences in the ubiquitinated 
proteins found among a variety of mice tissues (Wagner et al., 2012). In order to test 
whether such differences are detectable not only among different type of cells but also 
during  different stages of the development, we decided to compare the ubiquitinated 
landscape between a yet developing embryonic neuron and an already developed and 
specialized one, the eye photoreceptor cell.  
 
2.1. Identification of the ubiquitin landscape of Drosophila embryo neurons 
 
Four biologically independent pulldown experiments with elavGAL4-driven BirA and 
bioUb extracts from stage 13-17 Drosophila embryos were subjected to biotin pulldown 
(Figure 19, Figure A2 in appendix II) and LC-MS/MS analysis. Proteins identified by 
MS but known to be contaminants (Keller et al., 2008) and those with no intensity were 
excluded from the MS lists, leaving a total of 67 and 262 identifications in BirA and bioUb 
samples, respectively (Table A2 in appendix I). Proteins displaying a LFQ bioUb/BirA 
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intensity ratio above 4, or in absence of LFQ values a raw bioUb/BirA intensity ratio 
above 10, were considered as ubiquitin conjugates. Consequently, following this criteria 
37 proteins were classified as background and 234 as ubiquitin conjugates (Figure 
20A). 
 
 
 
Figure 19. Biotinylated material isolated from neurons of stage 13-17 fly embryos. 
A. Representative anti-biotin Western blot performed to monitor the purification process of ubiquitinated 
proteins from fly embryos. Dilutions of the input, flow-through (FT) and eluted samples are shown. The 
estimated recovery yield for all pulldowns was in the range of 20-40 %. B. Representative silver staining 
of the purified material. Equal amounts of BirA and bioUb samples were analysed by SDS-PAGE, and 
stained with silver. The common band at ~130 kDa present in both samples corresponds to the 
endogenously biotinylated CG1516 protein. Thick bands at around 40 kDa and below correspond to 
trimer, dimer and monomer forms of NeutrAvidin. The smear observed at the high molecular weight 
range in the experimental (bioUb) but not in the control (BirA) samples corresponds to the isolated 
ubiquitinated material. BirA: elavGAL4,UASBirA/CyO; bioUb: elavGAL4,UAS(bioUb)6-BirA/CyO. Taken from Ramirez 
et al., 2015. 
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Among the identifications classified as background, the three endogenously 
biotinylated proteins (ACC, CG1516 and CG2118) were the only ones to be consistently 
detected in all the independent replicates. With regards to the proteins categorized as 
ubiquitin conjugates, 33 % were found in at least two bioUb experiments (Figure 20A). 
The LFQ intensities of most of the putative ubiquitinated proteins identified in a single 
bioUb replica were found to be in the lowest region of the overall LFQ intensity range 
detected across MS analyses (Figure 20B), which suggest that they are of lower 
abundance. In fact, while ~75 % of the proteins identified in two bioUb experiments and 
the totality of proteins found in at least three experiments have a LFQ intensity above 
106, about 80 % the identification coming from one replica showed a LFQ intensity 
lower than 106 (Figure 20C). The majority of the ubiquitinated proteins identified only 
once came from the MSC04307-06 analysis, in which a bigger depth was obtained. 
Among the 234 ubiquitin conjugates, 83 out of 108 proteins that were previously 
identified as ubiquitin conjugates in the developing nervous system of the fly embryo 
(Franco et al., 2011), were also confirmed in this new analysis. 
 
We were confident about the MS identified proteins during the embryonic nervous 
system development, as Western blot to some of them provided evidence of their 
ubiquitination (Figure 21). We were able to validate that Rad23 and Rngo proteins 
were poly-ubiquitinated during these embryo stages, while Fax, liquid facets (Lqf) and 
Neurotactin (Nrt), the latter being identified in two MS analysis, were found to be mono-
ubiquitinated. In addition, the carrier status of the E3 ligase Ube3a, upon its over- 
expression, was also confirmed. The ubiquitination of other proteins from the MS list 
such as Fasciclin 2 (Fas2), Eps-15, Arginine kinase (ArgK), the Heat shock protein 27 
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Figure 20. Analysis of the proteins identified by MS in fly embryos. 
A. Venn diagrams showing the overlap existing between the proteins classified as background (white 
circle) and bioUb conjugates (green), as well as the overlap between the identified proteins in the several 
pulldown experiments performed. In each independent analysis every protein displaying a bioUb/BirA LFQ 
intensity ratio higher than four, or ten if using raw intensity, were considered ubiquitin conjugates. In 
those situations where a protein was considered background in one biological replica but conjugate in 
another one were only considered a true ubiquitin conjugate if the number of times classified as so were 
higher than those classified as background, or if we had evidence of their ubiquitination. Each colour 
represents one independent pulldown experiment. For each pulldown experiment the number assigned 
by the MS core facility at the MDC Institute is provided. B. Frequency histograms indicating the number of 
proteins (Y axis) found among different range of LFQ intensity (X axis), represented in log2 scale, for both 
the protein classified as background and ubiquitin conjugates. In green, blue and white are represented 
those proteins found among 3 or more, 2 or 1 independent pulldown, respectively. In the lowest range of 
each group and coloured with pink are depicted the proteins for which LFQ was not available. C. Box plots 
indicating the positive correlation between the LFQ intensity recorded for the identified proteins among 
different replicates (Y axis) and the number of independent replicates (X axis) on which those proteins 
appeared. 
 
(Hsp27) or the Regulatory particle non-ATPase 10 (Rpn10), as well as the carrier status 
of the E1 (Uba1) and some E2 enzymes (Ubc4, UbcE2H, Ubc2, eff and CG40045) had 
been previously verified using this system (Franco et al., 2011). It should be noted that 
proteins not identified by neither of the MS analysis but known to be ubiquitinated 
(Franco et al., 2011) were also validated by Western blot (Figure 21), such as Syx1A or 
the Anaplastic lymphoma kinase (ALK) protein, indicating that the pulldown process 
from embryonic tissues worked properly, and hence technical issues during the 
processing of the samples for MS analysis were likely the cause of the low number of 
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identification is some of the MS analyses. A list of the proteins detected in at least three 
out of the four different experiments (Figure 20A) is shown in Table 8. 
 
 
 
Figure 21. Western blot validation of ubiquitin conjugates and carriers identified in embryos. 
Western blots with specific antibodies to some of the proteins identified in embryo pulldown revealed the 
expected increase of their molecular weight in the bioUb sample relative to the inputs (arrows). Un-
modified or cysteine-ubiquitinated forms of Rad23 and Rngo are indicated by an asterisk (*). In the case of 
Ube3a flies that overexpressed the E3 were used. The asterisk indicates the fraction of Ube3a that was 
carrying the ubiquitin on its active cysteine. BirA: elavGAL4,UASBirA/CyO; bioUb: elavGAL4,UAS(bioUb)6-BirA/CyO; 
A3 (Ube3a overexpression): elavGAL4,UAS(bioUb)6-BirA/CyO;UASUbe3aA3/TM6B; 15B (Ube3a deletion): elavGAL4, 
UAS(bioUb)6-BirA/CyO;Ube3a15B/TM6B. 
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Table 8. List of proteins consistently found among embryo bioUb experiments. 
Protein name a MSC3818-19 MSC04306-07 MSC08200-06 MSC08209-13 PEP Score 
Ubiquitin-proteasome pathway 
 Ub/bioUb  122.85 7.12 16.78 0 
 Uba1 - 637.32 - - 0 
 CG40045 - - - - 0 
 CG8209  - - - 10-269 
 Uba2 - 17.35  - 10-266 
 Ben - - - - 10-195 
 Rad23 - - - - 10-185 
 UbcE2H  - - - 10-136 
 CG7656  - - - 10-086 
 CG2924  - - - 10-026 
 CG12082  - - - 10-022 
 Rngo  - - - 10-078 
 Smt3 - 34.88  - 10-085 
 Crl - - - - 10-032 
 Ubc10 - 6.01 - - 10-087 
 p47  - - - 10-019 
Trans-membrane ion transport 
 Atpα - - -  10-099 
Endocytosis/Exocytosis 
 Eps-15  - - - 0 
 AnxB10 - - -  10-049 
 Snap24 - - - - 10-042 
 Lqf - -  - 10-015 
Metabolic enzymes 
 Eno  35.62 - - 10-237 
Cytoskeletal/Structural proteins 
 Tm1  - - - 10-135 
 CG9135  - - - 10-006 
Signal transduction 
 Akap200  - - - 0 
 Fax - - - - 0 
Transcription/Translation 
 Df31 - - - - 0 
 RpS7 - - - - 0 
 Rm62 - - - - 10-215 
 His2A 115.65 1191.78 - - 10-206 
 Rin - - - - 10-089 
Other function 
 Alt  - - - 10-065 
 Kuk  - - - 10-022 
 CG5830  - - - 10-021 
 Bacc  - - - 10-227 
 CG15435 - - - - 10-064 
The bioUb/BirA LFQ ratios on independent MS experiments are shown. The number assigned by the MS 
core facility at the MDC Institute is provided. Raw intensity-based ratios are coloured in grey. Absence of 
ratio (-) and empty cells denote that the protein was not identified in BirA and bioUb sample, respectively. 
The lowest Posterior Error Probabilities (PEP Score) identified among replicates are reported. All PEP 
Scores, peptides and intensities are shown in Table A1 in Appendix I. 
a Protein names given following Flybase (www.flybase.org) nomenclature. 
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2.2. Ubiquitination sites identified in embryo samples 
 
A number of ubiquitination sites were detected by MS among the identified proteins 
in the embryonic analysis performed (Table 9). Some of those had been previously 
reported in mammalian counterparts, such as the K74 of Ben (Wagner et al., 2011), the
 
Table 9. Ubiquitination sites identified by MS in embryos. 
Protein a Peptide sequence Position of di-glycine PEP Score 
Act42A R ↓VAPEEHPVLLTEAPLNPK (G-G) ANR ↓ E  K114 10-003 
Ben R ↓ FITK (G-G) IYHPNIDR ↓ L K74 10-005 
CG6652 R ↓ LEEK (G-G) DNDMK (G-G) LM*AR ↓ K K210 K215 10-002 
CG7768 R ↓ SDVVPK (G-G) TAENFR ↓ A K31 10-002 
CG8223 K ↓ GK (G-G) ELFSQGSR ↓ N K60 10-002 
CG12237 R ↓ K (G-G) GFAM*EK (G-G) HLLR ↓ N K226(0.92) K232(0.08) 10-002 
CG13855 K ↓ EMGK (G-G) PIEWVGYK (G-G) DSK (G-G) ↓ I K412(1) K420(0.975) K423(0.025) 10-002 
Df31 K ↓ VAAEEVDAVK (G-G) K (G-G) ↓ D K26(0.858) K27(0.142) 10-002 
 K ↓ K (G-G) DAVAAEEVAAEK ↓ A K27 10-006 
 R ↓ K (G-G) VDEAAAK (G-G) ADEAVATPEKK ↓ A K142(0.03) K149(0.97) 10-002 
 K ↓ ADEAVATPEK (G-G) K (G-G) ↓ A K159(0.978) K160(0.022) 10-002 
Eps-15 K ↓ FQSK (G-G) EPVKDK ↓ F K1221 10-006 
Fax K ↓ LDLNAHIPK (G-G) PEPETK ↓ E K365 10-004 
 K ↓ SNEQEGTEGDK (G-G) IEK (G-G) ELEK (G-G) ↓ D K392(0.008) K395(0.535) K399(0.457) 10-125 
His2A K ↓ LLSGVTIAQGGVLPNIQAVLLPK (G-G) K (G-G) ↓ A K118(0.5) K119(0.5) 10-015 
His2B K ↓ AVTK (G-G) YTSSK K118 10-009 
Hrb98DE K ↓ LFVGALK (G-G) DDHDEQSIR ↓ D K129 10-005 
Hsc70-4 R ↓ IINEPTAAAIAYGLDK (G-G) K (G-G) ↓ A K187(0.5) K188(0.5) 10-002 
 K ↓ ITITNDK (G-G) GR ↓ L K507 10-012 
Hsp26 R ↓ IIQIQQVGPAHLNVK (G-G) ANESEVK (G-G) ↓ G K189(0.988) K196(0.012) 10-004 
Nlp K ↓ QILLGAEAK (G-G) ENEFNVVEVNTPK ↓ D K44 10-004 
Rin R ↓ NNK (G-G) GDFEQR ↓ R K475 10-003 
RpS10b R ↓ RAPGGSGVDK (G-G) K (G-G) GDVGPGAGEVEFR ↓ G K137 K138 10-007 
RpS20 K ↓ DIEK (G-G) PHVGDSASVHR ↓ I K10 10-003 
 M ↓ (ac)AAAPK (G-G) DIEK (G-G) PHVGDSASVHR ↓ I K6 K10 10-003 
RpS27A K ↓ VDENGK (G-G) IHR ↓ L K113 10-005 
Ub/bioUb K ↓ TLTGK (G-G) TITLEVEPSDTIENVK ↓ A K11 10-105 
 K ↓ TITLEVEPSDTIENVK (G-G) AK (G-G) ↓ I K27(0.948) K29(0.052) 10-035 
 K ↓ AK (G-G) IQDKEGIPPDQQR ↓ L K29 10-302 
 R ↓ LIFAGK (G-G) QLEDGR ↓ T K48 10-176 
 R ↓ TLSDYNIQK (G-G) ESTLHLVLR ↓ L K63 10-068 
 R ↓ TLSDYNIQK (G-G) ESTLHLVLRLR ↓ G K63 10-111 
Peptides sequences, positions of di-gly (G-G) with each probability in brackets (when equal to 1) and 
Posterior Error Probabilities (PEP Score) are reported. Oxidized methionine is indicated by an asterisk (*) 
and acetylation by (ac). Downward arrow (↓) indicates the site of trypsin digestion. All peptides and 
intensities are shown in table A2 in Appendix I. Modified from Ramirez et al., 2015. 
a Protein names given following Flybase (www.flybase.org) nomenclature.  
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K137 and K138 of RpS10b (Danielsen et al., 2011; Wagner et al., 2012), the K6 and K10 
of RpS20 (Wagner et al., 2011, 2012) and K113 of Rps27A (Wagner et al., 2012). 
Regarding the lysines at ubiquitin, the most abundantly modified ones (i.e., K48, K63 
and K11) were also detected. In addition, di-gly sites in lysines at position 27 (K27) and 
29 (K29) were detected with a very low abundance (Figure 22).  
 
 
 
Figure 22. Relative abundance of the ubiquitin linkages in embryos.  
A. Relative abundance of the different ubiquitin linkages found among three replicates B. Relative 
abundance of the ubiquitin linkages in each independent replicate. Each colour represents one 
independent MS replica. The number assigned by the MS core facility is provided. No ubiquitination sites 
on ubiquitin were detected in the MSC3818-19 analysis. The relative abundance in (A) and (B) is given as 
percentage (%) of the sum of all the intensities for each ubiquitin site. 
 
 
 
 
Results: comparison of ubiquitinated landscapes in developing and adult neuron 
- 154 - 
 
2.3. Comparison of the embryo and adult neuron ubiquitin proteome 
 
Comparison of the ubiquitin proteome between the adult (369 proteins) and the 
embryonic datasets (234 proteins) resulted in only 103 proteins being found to be 
common between them (Figure 23). As shown in Table 10, 13 of these common 
proteins corresponded to known ubiquitin carrier enzymes (i.e., proteins transporting 
ubiquitin before it is conjugated into K residues), and hence the remaining 90 were
 
 
 
 
Figure 23. Overlap between the ubiquitinated proteins detected in embryo and adult samples. 
Venn diagrams showing the existing overlap between the ubiquitinated proteins (bioUb/BirA ratio >4 if 
LFQ intensity; > 10 if raw intensity) identified from Drosophila embryo nervous system at stages 13-17 
and the adult eye. Overlap between the complete list (Total overlap), only the ubiquitin carriers (Overlap 
between carriers) and only the ubiquitin conjugates (Overlap between conjugates) are shown. 
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proteins considered to be modified with ubiquitin at lysine residues (Figure 23). In a 
previous study, 11 active ubiquitin carriers were identified among the proteins isolated 
from the embryonic nervous system (Franco et al., 2011). Here, taking in consideration 
the analyses performed in both embryo and adult, a total of 23 ubiquitin carriers were 
identified (Figure 23 and Table 10), although not all of them were found in both stages. 
For instance, ubiquitin activating enzyme E1 (Uba1) was detected in all the different 
replica of both embryo and adult samples. Out of the 16 identified ubiquitin conjugating
 
  Table 10. Ubiquitin carrier enzymes identified in embryo and adult samples. 
  elav  GMR 
Protein name a Protein description a PEP Score n  PEP Score n 
Ubiquitin activating enzyme      
 Uba1 Ubiquitin activating enzyme 1 0 4  0 3 
Ubiquitin conjugating enzymes      
 CG40045 - 0 4  0 2 
 Ubc10 Ubiquitin conjugating enzyme 10 10-087 4  10-142 1 
 Crl Courtless 10-032 4  10-035 2 
 Ben Bendless 10-195 4  10-205 1 
 CG7656 - 10-086 3  10-274 3 
 CG2924 - 10-026 3  10-029 2 
 UbcE2H Ubc-E2H 10-136 3  10-075 1 
 Eff Effete 10-009 2    
 Ubc4 Ubiquitin conjugating enzyme 4 10-142 2  10-003 1 
 Ubc2 Ubiquitin conjugating enzyme 2 10-048 2  10-007 1 
 CG5823 - 10-003 1    
 CG8188 - 10-006 1    
 Morgue Modifier of rpr and grim, ubiquitously expressed 10-010 1  10-020 2 
 Vih Vihar 10-040 1    
 TSG101 Tumour susceptibility gene 101    10-091 1 
 Ubc6 Ubiquitin conjugating enzyme 6    10-026 1 
Ubiquitin ligase enzymes      
 Ube3a Ubiquitin protein ligase E3A 10-019 2  10-016 2 
 Ctrip Circadian trip 10-004 1  10-003 1 
 Nedd4 Nedd4    10-142 3 
 CG5604 -    10-019 2 
 Su(dx) Suppressor of deltex    10-021 2 
 Park Parkin    10-013 1 
The lowest Posterior Error Probabilities (PEP Score) identified among replicates and the number of 
identification in independent bioUb experiments are reported. All PEP Scores, peptides and intensities are 
shown in table A1 and A2 in Appendix I. 
a Protein name and protein description given according to Flybase nomenclature (www.flybase.org) 
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E2 enzymes, 10 appeared in both tissues, while the remaining 6 were detected only in 
embryo (CG5823, CG8188, Eff and Vih) or in adult (TSG1 and Ubc6) samples. Similarly, 
only two ubiquitin ligating E3 enzymes (Ctrip and Ube3a) were identified in both 
tissues, whereas the rest were only seen in the Drosophila eye. Absence of E2 and E3 
enzymes in the developing embryo nervous system, is probably explained by the low 
expression levels of some of those genes, as suggested by reported RNA levels (Figure 
A3 in appendix II) during this stages (Graveley et al., 2011), as well as by the poor 
depth obtained in the proteomic analysis. Absence of CG5823, CG8188 and Vih E2s in 
the photoreceptors cells, might also be explained by the relatively low mRNA signals of 
these genes in the Drosophila eye (Figure 24A), as reported by the FlyAtlas webserver 
(www.flyatlas.org) (Chintapalli et al., 2007).  
 
According to this transcriptomic data one would expect to detect Effete (Eff) from 
both adult and embryo samples, since this enzyme has been classified in the group of 
genes presenting very high mRNA levels in the Drosophila eye (Figure 24A) as well as 
during the embryo development (Figure 24B). Moreover, in the fly eye the mRNA levels 
of this enzyme are supposed to be at least two fold higher than those described for Uba1, 
CG7656 or Nedd4 (Figure 24A), three proteins seen in every MS analysis performed 
with adult samples (Table 10). The fraction of Eff carrying ubiquitin, or modified with it, 
however, was only detected by MS and Western blot from embryonic pulldowns (Figure 
24C). Western blot with anti-Eff antibody performed with adult samples showed a band 
of the appropriate size in the input fraction (Figure 24C), confirming that this enzyme is 
indeed expressed in the eye. In the eluted fraction no band was detected though, 
suggesting that the amount of this enzyme carrying or modified with ubiquitin is of very 
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Figure 24. Reported RNA levels for the carriers detected in Drosophila eye. 
A. mRNA signal, obtained from a GeneChip Drosophila Genome 2.0 array (Affymetrix) and reported on the 
fly atlas web server (www.flyatlas.org), for the identified E1, E2 and E3 carrier enzymes in the eye of 
Drosophila melanogaster. Dot vertical lines indicate the expression level threshold used by Flybase, where 
(L) is low expression level, (H) high expression and (VH) very high expression. A colour code indicating 
the expression level of each mRNA is also provided. Red indicates very high expression level (above VH 
threshold), orange high expression (between V and VH thresholds), green moderate expression (between 
L and V thresholds) and blue low expression (below L threshold). These publicly available data were 
obtained from Flybase (www.flybase.org) B. mRNA levels for Effete (Eff), measure as reads per kilobase of 
exon model per million mapped reads (RPKM), at different times of the embryo development. As for panel 
(A) horizontal dot lines indicate the expression level threshold used by Flybase. L: Low, H: High and VH: 
Very High. These publicly available data were obtained from Flybase (www.flybase.org). C. Western blot 
with Eff antibody in pulldown samples obtained from fly embryo and adult eye. BirA stands for: 
elavGAL4,UASBirA/CyO for embryo and GMRGAL4/CyO;UASBirA/TM6B for adult eye; bioUb stands for: elavGAL4, 
UAS(bioUb)6-BirA/CyO and GMRGAL4,UAS(bioUb)6-BirA/CyO for embryo and adult, respectively. 
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low abundance in the Drosophila eye, and therefore difficult to detect by MS and 
Western blot. 
 
Having analysed the ubiquitin carrier enzymes separately, the remaining 
identifications are expected to correspond to lysine-ubiquitinated proteins, some of 
which were validated by Western blotting to characterize the number of ubiquitin 
molecules attached (Figure 17, Figure 21 and Franco et al., 2011). The total numbers of 
ubiquitin conjugates identified in embryonic and adult samples were, respectively, 217 
and 350, with only 90 being common to both data sets (Figure 23) for each of the 
groups. A list of the top-20 ubiquitin conjugated proteins, based on the number of 
independent identification in different replicate and in PEP score, is given in Table 11. 
 
Table 11. Lis of top 20 proteins found only in adult, only in embryo or in both datasets. 
Identified only in adult  Common identified proteins  Identified only in embryo 
       adult  embryo      
Protein a  PEP Score n  Protein a  PEP Score n  PEP Score n  Protein a  PEP Score n 
C11.1  0 3  Fax  0 3  0 4  Rm62  10-215 4 
Wat  0 3  RpS7  10-189 2  0 4  Rin  10-089 4 
Calx  10-239 3  His2A  10-176 2  10-206 4  Alt  10-065 3 
CG3529  10-185 3  Rad23  10-276 3  10-185 4  Kuk  10-022 3 
Ltd  10-160 3  Snap24  10-019 3  10-042 4  CG9135  10-006 3 
Nrv2  10-157 3  Eps-15  10-196 3  0 3  Hsp26  0 2 
Pdh  10-128 3  Df31  10-025 3  0 3  His2B  0 2 
betaTub56D  10-125 3  Eno  10-203 2  10-237 3  CG8223  10-183 2 
Vha68-2  10-121 3  Tm1  10-156 3  10-135 3  NAT1  10-103 2 
CG7675  10-101 3  Atpα  0 3  10-099 3  Lig  10-082 2 
CG17121  10-088 3  Smt3  10-039 3  10-085 3  Asx  10-078 2 
CG1561  10-060 3  AnxB10  10-260 3  10-049 3  Act42A  10-069 2 
Scamp  10-051 3  CG15435  10-003 2  10-064 4  EIF-4a  10-032 2 
Pi4KIIalpha  10-051 3  Akap200  10-011 2  0 3  Fas2  10-018 2 
Sktl  10-044 3  Bacc  10-078 2  10-227 3  His1  10-018 2 
Gga  10-039 3  Rngo  10-047 2  10-078 3  HIP  10-017 2 
Hop  10-034 3  Hsc70-1  10-103 3  10-081 2  dUTPase  10-012 2 
lap  10-030 3  CtBP  10-018 3  10-007 2  CG1307  10-010 2 
CG12025  10-025 3  Argk  10-194 2  10-058 2  CG3223  10-010 2 
Uif  10-023 3  Hsc70Cb  10-125 2  10-008 2  Stai  10-008 2 
The lowest Posterior Error Probabilities (PEP Score) and number of identification in independent bioUb 
experiments are reported. All PEP Scores, peptides and intensities are shown in table A2 in Appendix I. 
a Protein name given according to Flybase nomenclature (www.flybase.org) 
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For the purpose of obtaining a functional overview of the main pathways regulated by 
ubiquitination at those two stages, a bioinformatic analysis was performed with GO 
Term mapper and g-profiler (Reimand et al., 2011).  As illustrated with the pie charts for 
the gene’s biological processes, localization and activities, significant differences exist 
between the proteins found only in embryonic and only in adult samples (Figure 25). 
Most notably, a shift was found in the “Biological processes” domain from a 
predominance of “Cell cycle + Reproduction” and “Cellular component organization and 
biogenesis” terms in the embryo to “Localization and transport” and “Cell 
communication” in the adult samples. Concomitantly, in regards to “Cellular 
compartment”, a shift was detected from a predominance of proteins with “Nuclear” 
localization in the embryonic neurons to “Plasma membrane” in the adult ones. When 
analysing the “Molecular function” domain, a significant shift was observed from 
“Structural molecule” and “Transcription factor” activities to the “Transporter activity” 
and “Molecular transducer activity” categories. Similarly, the g:profiler analysis (Figure 
26) showed the specific enrichment of terms such as “Cell cycle”, “Developmental 
process” and “Cellular component organization or biogenesis” in the analysis performed 
with the proteins found only in embryo. These biological processes did not appear 
enriched in the analysis with the proteins found only in adult, but instead “Localization”, 
“Synaptic transmission” and “Establishment of localization” did. Differently enriched 
terms in regards to the “Cellular compartment and molecular” function domains were 
also found. Terms as “Macromolecular complex”, “Cytoskeleton”, “Nucleus” and “mRNA 
binding” were enriched in the embryonic sample, while “Plasma membrane”, “Synapse”, 
“Transporter activity” and “SNAP receptor activity” terms were enriched in the adult 
sample.  
Results: comparison of ubiquitinated landscapes in developing and adult neuron 
- 160 - 
 
 
 
Figure 25. Functional interpretation of identified ubiquitin conjugates with GO Term mapper. 
Analysis of ubiquitin conjugates identified only in the embryo or in adult provided a list of broad GO terms 
(GO Slim) for the biological process (72 categories), cellular compartment (30 categories) and molecular 
function (44 categories) domains, which were additionally grouped into fewer categories to make their 
representation easier to interpret. Categories representing less than 3% in the biological processes were 
grouped as “others”. Only “extracellular matrix”, “plasma membrane”, “nucleus” and “cytoplasm” 
categories are depicted in the cellular compartment classification. Taken from Ramirez et al., 2015. 
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Figure 26. Functional interpretation of the identified ubiquitin conjugates with G:Profiler. 
Proteins found only in embryo or only in adult were analysed by G:profier for GO Term enrichment 
analysis. Summary of the enriched GO Terms in the biological process (BP), cellular compartment (CC) 
and molecular function (MF) domains are shown. Statistical enrichment of each Term is provided by the 
p-value, which is also represented by a colour according to its value (the lower the p-value the stronger 
intensity of red). The software calculates p-values using Fisher´s one tailed test combined with a custom 
multiple testing correction algorithm (Reimand et al., 2011). Taken from Ramirez et al., 2015. 
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3. Changes in the ubiquitinated landscape upon different conditions 
 
The bioUb strategy has proven to be very efficient for the isolation and enrichment of 
ubiquitinated material from cells (Min et al., 2014) and tissue lysates (Franco et al., 
2011; Lectez et al., 2014; Ramirez et al., 2015). The expression of biotinylated ubiquitin 
can be directed in vivo to any cell population, and at any stage during the development, 
with the used of specific expression systems such as the GAL4/UAS (Brand and 
Perrimon, 1993) or tetracycline-responsive promoters (Gossen and Bujard, 1992). 
Further combination of this tool with a particular treatment or a disease model could 
therefore be of great value in order to identify proteins whose ubiquitination is affected 
in response to specific perturbations. For this reason, we decided to evaluate the 
capacity of the bioUb strategy to monitor changes in protein ubiquitination upon 
inhibition of proteasomal degradation and to identify E3-specific substrates. 
  
3.1. bioUb strategy upon interference with proteasomal function 
 
Most ubiquitin proteomic studies have been performed on cell culture on which the 
proteasome had been inhibited using specific drugs (Kisselev and Goldberg, 2001), with 
the intention to lead to a significant accumulation of ubiquitinated proteins. However, 
while the amount of the provided drug is easily controlled in cell culture assays, in 
Drosophila a variability in the dosage might exist, due to differences in ingestion rates 
and even to adaptative mechanisms to prolonged exposures (Pandey and Nichols, 2011). 
Besides, proteasome inhibitor drugs may also affect other cellular proteases (Kisselev 
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and Goldberg, 2001), leading to cellular responses that are not exclusively dependent on 
the proteasome inhibition. Recently, flies overexpressing a truncated form of Rpn10 
(UASRpn10-ΔNTH), a proteasomal ubiquitin receptor, were reported to cause an 
accumulation of ubiquitinated proteins that should otherwise be degraded by the 
proteasome (Lipinszki et al., 2009). This failure on protein turnover is not a result of 
direct proteasomal inhibition, but caused by the inability of Rpn10 to transport the 
trapped proteins to the proteasome. Furthermore, Rpn10-mediated inhibition of protein 
degradation can be applied in a tissue specific manner, as its expression is controlled by 
the yeast transcription activator GAL4 protein (Lipinszki et al., 2009; Ramirez et al., 
2015). Combination of those UASRpn10-ΔNTH flies with the bioUb ones was therefore 
performed in order to analyse the Drosophila ubiquitination landscape upon a selective 
blockade of the proteasomal degradation pathway.  
 
3.1.1. Generation of flies that accumulate ubiquitinated material 
 
Flies with elavGAL4,UAS(bioUb)6-BirA /CyO; TM2/TM6B and GMRGAL4,UAS(bioUb)6-BirA/CyO; 
TM2/TM6B genotypes were crossed to those that overexpressed the C-terminal half of 
the proteasomal shuttling protein Rpn10 under the control of the GAL4 protein 
(UASRpn10-∆NTH; hereinafter Rpn10DN). Rpn10DN contains three UIMs (Figure 27A) 
that recognize and bind poly-ubiquitinated material, but lacks the von Willebrand factor 
A (VWFA) domain required for binding to the proteasome (Lipinszki et al., 2009). 
Overexpression of Rpn10DN has been shown to act in a dominant negative manner by 
binding to ubiquitinated proteins and preventing their delivery to the proteasome. This 
results in a significant accumulation of ubiquitinated material when it is either 
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ubiquitously expressed in larvae, under the control of the daughterless-GAL4 (Lipinszki 
et al., 2009), or when it is expressed in the Drosophila eye under the control of GMRGAL4 
(Lee et al., 2014).  
 
In agreement with previous reports, combination of Rpn10DN with the bioUb 
transgene resulted in an increase of high molecular- weight ubiquitinated material when 
compared to bioUb alone, as shown by anti-biotin Western blot in embryo whole extracts 
(Figure 27B). In adults, rather than an increase, a differential distribution was 
observed, with a preferential attachment of the biotinylated ubiquitin to higher 
molecular weight proteins. Western blots performed with anti-BirA antibody revealed 
that the expression level of the UAS(bioUb)6-BirA construct was similar when expressed 
alone or together with Rpn10DN transgene in embryonic samples (Figure 27B). In adult 
a slight reduction in BirA expression was observed in Rpn10DN expressing flies, which 
might indicate a deficiency of the GAL4 protein to drive the expression of both 
constructs simultaneously. Similarly, when a biotin pulldown was performed with either 
embryo or adult fly heads of the mentioned genotype, an increased or a differential 
distribution of the purified material was also observed by Western blot in the eluted 
fraction (Figure 27C). Nonetheless, silver staining of the eluted proteins confirmed the 
presence of more material in Rpn10DN expressing embryo and adult flies (Figure 27D), 
as for similar level of the endogenous biotinylated protein that run at ~130 kDa 
(CG1516) a smear of stronger signal is observed in Rpn10DN samples.  
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Figure 27. Expression of the C-terminal half of Rpn10. 
A. Schematic illustration of the main domains found in Rpn10 protein. The full length Rpn10 contains a 
von Willebrand factor A (VWFA) domain required for interaction with the proteasome as well as three 
ubiquitin-interacting motifs (UIMs) that allow Rpn10 to bind ubiquitinated proteins. The VWFA is located 
in the N-terminal part of the protein (residues 1-188) and the UIMs are found on the C-terminal region 
(residues 205-396). While the full length protein will bind and shuttle ubiquitinated proteins to the 
proteasome, the overexpressed C-terminal half will be able to bind the ubiquitinated material, but not the 
proteasome, preventing the degradation of the bound proteins B. Western blot analysis from adult head 
(GMRGAL4) and embryo (elavGAL4) whole extract expressing the UAS(bioUb)6-BirA construct alone (bioUb) or 
together with Rpn10DN (Rpn). The anti-biotin antibody revealed an increase in the amount of the material 
that is ubiquitinated with biotinylated ubiquitin when Rpn10DN is expressed in embryos, as compared to 
expression of bioUb alone. In adults, a differential distribution is observed instead, with a preferential 
attachment of the biotinylated ubiquitin to higher molecular weight proteins. This effect is observed for 
similar expression levels of the UAS(bioUb)6-BirA construct, as detected by anti-BirA antibody, indicating 
that the accumulation or the differential distribution of the bioUb conjugates is due to the overexpression 
of Rpn10DN. The expression of Rpn10DN construct was detected using an antibody to the Rpn10 protein. C. 
Anti-biotin Western blots with adult (top) and embryo (bottom) pulldown samples confirmed that the 
same effect happens in the eluted fractions upon Rpn10DN expression (Rpn). Dilutions of the input, flow 
through (FT) and elution are shown.  D. Silver staining of the material purified with the NeutrAvidin beads 
for Rpn10DN (Rpn) and bioUb samples. Equal amounts of bioUb and Rpn10DN samples were analysed for 
each pulldown using SDS-PAGE and stained with silver. Both for adult (left) and embryo (right) samples 
an accumulation of ubiquitinated material is detected on samples overexpressing the C-terminal half of 
Rpn10 (Rpn), as compared to the bioUb control samples. In B, C and D panels bioUb stands for flies 
expressing the UAS(bioUb)6-BirA construct and Rpn for flies expressing both the UAS(bioUb)6-BirA construct 
and the C-terminal half of Rpn10 (Rpn10DN) protein. Ramirez et al., 2015. 
 
 
 
Results: ubiquitinated landscape upon different conditions 
 
- 168 - 
 
3.1.2. Mass spectrometric identification of proteins accumulated upon Rpn10DN 
expression 
 
Three independent biological replicates, for both embryo and adult, overexpressing 
Rpn10DN were subjected to NeutrAvidin pulldown (Figure A4 in appendix II) and MS 
analysis, with the aim of identifying the proteins that are accumulating in Rpn10DN flies. 
Contrary to what it would have been expected, however, the MS analysis provided a 
reduced number of identification in all three Rpn10DN experiments (Figure 28). These 
results suggest that expression of Rpn10DN is interfering with the biotinylated ubiquitin 
pool, affecting the number of proteins that are purified under these conditions. Yet some 
proteins were exclusively identified in the purified material of Rpn10DN expressing flies, 
21 in the adult eye and 11 in the Drosophila embryo.  
 
The various datasets in this work were obtained from independent biological 
samples, and the experiments performed independently in different days. Consequently, 
we were not confident enough to jointly analyse all our data sets, as MS settings might 
vary from experiment to experiment. Moreover, comparison of protein abundance 
between two conditions requires a proper quantifiable value. LFQ has proven to be a 
proper measurement for that purpose (Luber et al., 2010). In some circumstances, 
however, mass spectrometric software does not obtain enough data to provide a LFQ 
value for a given identified protein, as is the case for many of the proteins seen in 
Rpn10DN (Table A1 and A2 in Appendix I). For that reason, LFQ intensity ratios 
between pairs of Rpn10DN and bioUb samples analysed on the same day were determined 
and used as selection criteria to discriminate among those proteins found more 
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Figure 28. Number of proteins identified by MS across independent Rpn10DN pulldowns.  
Venn diagrams showing the overlap existing between independent biological replicates in adult and 
embryo samples (upper), as well as the overlap existing between the proteins identified in bioUb and 
Rpn10DN samples (bottom). The variability found among independent replicate is similar to that earlier 
found for bioUb replicates. The total amount of proteins isolated from embryo and adult Rpn10DN samples, 
however, was in both cases lower than the amount of proteins identified in bioUb samples. For each 
pulldown experiment the number assigned by the MS core facility at the MDC Institute is provided. 
 
ubiquitinated upon Rpn10DN overexpression. Proteins identified in at least two 
independent Rpn10DN biological replica and whose Rpn10DN/bioUb LFQ intensity ratio 
was bigger than 4 in at least two experiments were preliminary selected as candidate 
Rpn10 substrates. Among Rpn10DN embryo samples none of the identifications 
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Figure 29. Proteins found differentially ubiquitinated in adult Rpn10DN samples.  
Vulcano plots showing the proteins that appeared differentially ubiquitinated upon Rpn10DN 
overexpression. Rpn10DN/bioUb LFQ ratios of those proteins identified in at least two independent 
Rpn10DN experiments were calculated for each MS analysis. For those proteins for which LFQ values were 
not reported, the lowest LFQ value obtained in the analysis was assigned. Those proteins with a LFQ ratio 
bigger than 2 (in log2 scale) were considered to be more ubiquitinated in Rpn10DN samples vs control 
samples, while those with a ratio lower than -2 were considered to be less ubiquitinated,. For each 
pulldown experiment the number assigned by the MS core facility at the MDC Institute is provided. 
 
completely fulfil the applied criteria (Figure A5 appendix II). However, among adult 
Rpn10DN five were found to do so (Figure 29): Raspberry (Ras), Fatty acid binding 
protein (Fabp), PHGPx, Eukaryotic initiation factor 1A (EIF-1A) and Tan (T). Besides, 
three ubiquitination sites (K56, K88 and K104) were also detected for EIF-1A protein in 
one Rpn10DN pulldown (MSC7038-42) but not in bioUb sample (Table A1 in appendix I). 
 
Those proteins whose Rpn10DN/bioUb LFQ ratio was lower than 0.25 (i.e., the LFQ 
intensity in the Rpn10DN sample was 4 times lower than that detected in bioUb sample) in 
at least two independent experiments, were considered to be less ubiquitinated upon 
Rpn10DN overexpression. Those with a ratio between 0.25 and 4 were, hence, classified 
as having no significant variation in their ubiquitination level. For instance, ubiquitin 
protein levels were deemed similar between bioUb and Rpn10DN samples, as its LFQ 
Rpn10DN/bioUb ratio was found to be between the 0.25-4 range in all the pulldown 
experiments performed from adult (average of 2.2 ± 1.5 SD) and embryo (average of 1.3 
± 0.05) samples. Similar results were found for Uba1 enzyme, whose LFQ ratio was 
between the mentioned range in two out of three adult samples (average of 0.27 ± 0.1 
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SD) and in all the embryo experiments (average of 1.2 ± 0.8 SD). Among the proteins 
found to be less ubiquitinated in at least two independent experiments Atpα, Eps-15 or 
Lqf were found. Those are known mono-ubiquitinated proteins (Figure 17, Figure 21 
and Figure 29). It has been proposed that upon an increase in protein poly-
ubiquitination caused by the blockade of the proteasome, mono-ubiquitinated 
molecules, such as histones, are deubiquitinated as a mechanism to rapidly provide the 
cell with free ubiquitin monomers, which could not be otherwise accomplished by new 
ubiquitin synthesis (Dantuma et al., 2006; Groothuis et al., 2006). We can therefore 
conclude that exactly the same is happening here to those other mono-ubiquitinated 
proteins, in this case with their less modification being driven by the ectopic 
biotinylated ubiquitin. 
 
3.1.3. In vivo validation of proteins accumulated upon Rpn10DN overexpression 
 
In order to confirm the increased ubiquitination of Ras, Fabp, PHGPx, ElF-1A and T, 
additional biotin pulldowns from both bioUb and Rpn10DN fly heads were performed. 
Unfortunately, we could not test all the proteins mentioned above as we were only able 
to obtained antibodies for T (Wagner et al., 2007) and EIF-1A. The commercially 
available mammalian EIF-1AX (AntibodyBcn), however, did not recognize the 
Drosophila protein despite an 80% homology between the fly and the mammalian 
proteins is found (data not shown). On the other side, anti-Tan Western blot did detect a 
band of the appropriate size in the input fractions of both bioUb and Rpn10DN pulldowns, 
at about 25 kDa (Wagner et al., 2007). Several bands in the eluted fraction 
corresponding to mono and poly-ubiquitinated portions of Tan were also detected, 
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which presented a stepwise increase of approximately 8 kDa (one ubiquitin) each. 
However, contrary to what would be expected from the MS data, this protein was found 
by Western blot to be less ubiquitinated when Rpn10DN was expressed (Figure 30A). An 
immunoblot with an antibody that detect poly-ubiquitin chains performed on the same 
membrane where anti-Tan was used, confirmed the presence of more poly-
ubiquitinated material on Rpn10DN sample (Figure 30B). We therefore conclude that 
Tan is not enriched upon Rpn10DN expression, despite appearing to be so as suggested 
by the MS data. This result emphasizes the importance of using orthogonal approaches 
along with MS, as the reliance on one unique technique, no matter how advance, might 
lead to obtain false positives. 
 
Western blots to the mono-ubiquitinated proteins, however, were consistent with the 
mass spectrometric observation of reduced ubiquitination upon Rpn10DN expression. 
For instance, Atpα protein was found to be less ubiquitinated in Rpn10DN expressing 
adult flies (Figure 30C). Equally, the ubiquitination of Fax was also detected by Western 
blot to be reduced in the Rpn10DN sample (Figure 30C). In the case of embryo samples, 
two antibodies, anti-Lqf and anti-Nrt, previously used to validate by Western blot the 
ubiquitination of these two proteins (Figure 21), were selected to analyse the effect of 
Rpn10DN expression on mono-ubiquitination in developing neurons. The amounts of 
both Lqf and Nrt, were found to be also reduced within the ubiquitin-enriched pulldown 
(Figure 30D). These results support the idea that biotinylated ubiquitin, as it has been 
reported for endogenous ubiquitin (Groothuis et al., 2006; Kaiser et al., 2011; Wagner et 
al., 2011), is preferentially retained by poly-ubiquitinated proteins upon Rpn10DN 
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overexpression, and hence mono- ubiquitinated proteins, become absent or present on a 
reduced scale on the biotin purification performed on tissues expressing Rpn10DN. 
 
 
 
Figure 30. Western blots on ubiquitinated material isolated from Rpn10DN samples.  
A. Western blot to Tan protein on adult bioUb and Rpn10DN samples revealed that Tan is not found more 
ubiquitinated upon Rpn10DN overexpression. B. Anti-FK1 immunoblot performed on the same membrane 
as in (A) showed an increase in the formation of poly-ubiquitin chains when Rpn10DN is expressed. C and 
D. Western blot to some mono-ubiquitinated proteins confirmed that in Rpn10DN samples the biotinylated 
ubiquitin is preferentially attached to poly-ubiquitinated proteins, in both embryos (C) and adult (D) 
samples. BirA: flies expressing only the BirA enzyme; bioUb: flies expressing the UAS(bioUb)6-BirA construct; 
Rpn: flies expressing both the UAS(bioUb)6-BirA construct and the C-terminal half of Rpn10 (Rpn10DN) 
protein. Taken from Ramirez et al., 2015. 
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3.2. bioUb strategy directed to identify substrates for specific E3 ligases 
 
Mutations on the UBE3A gene that result on the loss of function of the encoded 
protein, a HECT type E3 ubiquitin ligase, is one of the genetic mechanism leading to 
Angelman syndrome (AS) development (Kishino et al., 1997; Matsuura et al., 1997). 
Likewise, UBE3A duplication has been related with autism spectrum disorders (ASD) 
(Smith et al., 2011; Urraca et al., 2013), suggesting that the pathogenesis of these two 
diseases could be caused by the misregulation of common ubiquitin targets. The 
identification of the direct substrates regulated by this E3 ligase, however, has remained 
elusive so far as the low level at which ubiquitinated proteins are found within the cells 
make them difficult to detect. In Drosophila melanogaster the homologue of UBE3A 
(Ube3a),  has been identified as an active-ubiquitin carrier during the embryo nervous 
system development (Franco et al., 2011) and in the photoreceptor cells (Ramirez et al., 
2015), suggesting that this enzyme is physiologically regulating the ubiquitination of 
certain proteins in the fly neurons. We hence reasoned that overexpression of Ube3a 
would cause an increase in its targets ubiquitination, that could be detectable using the 
bioUb strategy. 
   
3.2.1. Generation of bioUb and Ube3a overexpressing flies 
 
Different fly models have been generated to study AS or Ube3a duplication-based 
autism cases (Reiter et al., 2006; Wu et al., 2008; Lu et al., 2009;  Valdez et al., 2015). 
Flies carrying deletions on the Ube3a gene, therefore leading to a loss of function of the 
encoded protein, have been reported to mimic characteristic of AS, such as motor
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Figure 31. Ube3a mutant and Ube3a overexpressing flies. 
A. Anti-Ube3a Western blot on Drosophila head whole extracts was used to monitor the levels of Ube3a 
protein when Ube3a is either overexpressed (A3) or mutated (15B). Equal protein loading was 
determined by anti-Syx1A immunoblot. WT: OregonR; GMR: GMRGAL4;TM2/TM6B; 15B: If/CyO; 
Ube3a15B/Ube3a15B (null mutant); A3: GMRGAL4/CyO; UASUbe3aA3/TM6B (Ube3a overexpression). B. Anti-
Ube3a Western blot performed on material eluted from adult (GMRGAL4) and embryo (elavGAL4) biotin 
pulldowns. A significantly higher amount of the E3 ligase that was carrying ubiquitin was isolated from 
flies overexpressing Ube3a (A3), as compared to Ube3a15B heterozygous mutants (15B). C and D. Anti-
biotin immunoblots on material eluted from Ube3a overexpressing (A3) and Ube3a15B heterozygous 
mutant (15B) adult heads (C) and embryo (D) samples. 15B: flies heterozygous for the Ube3a deletion and 
expressing the UAS(bioUb)6-BirA construct; A3: flies expressing both the UAS(bioUb)6-BirA construct and the 
Ube3a E3 ligase enzyme. 
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coordination issues or learning and memory defects (Wu et al., 2008). Similarly, 
overexpression of the Drosophila Ube3a has been shown to display analogous 
neurotransmission defects to those seen in mouse models of duplication 15q autism 
(Valdez et al., 2015). Ube3a loss of function (Ube3a15B) and gain of function (UASUbe3aA3) 
flies (Figure 31A), obtained from Dr. Janice Fischer (Wu et al., 2008), were crossed to 
flies expressing the bioUb construct under the control of elavGAL4 and GMRGAL4–drivers, in 
order to perform a comparison between the ubiquitinated proteome of flies lacking or 
having an extra dose of Ube3a protein. While in the absence of an E3 ligase enzyme, its 
substrates should not show any ubiquitination; upon E3 ligase overexpression will show 
a significant ubiquitination increase. Thereby, proteins identify by MS in Ube3a 
overexpressing flies, but absent in Ube3a null ones will be potential Ube3a substrates.  
 
The Drosophila Ube3a mutants (Ube3a15B) had been reported to be viable and fertile 
in homozygosis (Wu et al., 2008). When combined with the expression of bioUb it was, 
however, required to grow them in heterozygosis, as null Ube3a flies, despite viable, 
were not fertile (data not shown). Nevertheless, Western blot with anti-Ube3a antibody 
on material eluted from flies overexpressing Ube3a showed that the amount of E3 ligase 
that is active in these flies is high enough, as compared to heterozygous Ube3a15B 
animals (Figure 31B), to test our hypothesis regarding the detection by MS and 
Western blot of its substrates. With regards to bioUb, a higher expression was observed 
in both adult (Figure 31C) and embryo (Figure 31D) Ube3a15B flies, when compared to 
Ube3aA3 flies. Most probably this is due to a reduce GAL4 availability, as the amount of 
GAL4 protein needs to be split in Ube3aA3 flies in order to express both the bioUb 
construct and the Ube3a E3 ligase. Anyhow, those proteins found to be more 
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ubiquitinated in Ube3a overexpressing flies should with no doubt be true Ube3a 
substrates. 
 
3.2.2. Mass spectrometric identification of Ube3a ubiquitin substrates 
 
One biotin pulldown from adult fly heads overexpressing Ube3a under the control of 
GMRGAL4 (hereinafter A3 for Ube3aA3 allele) was compared with a pulldown from fly 
heads carrying a deletion on the Ube3a gene (hereinafter 15B for Ube3a15B allele), in 
order to identify the proteins that are regulated by this E3 ligase in the Drosophila 
photoreceptor cells. As measured by silver staining, the amount of purified material 
from A3 and 15B fly heads was similar (Figure 32A). Correspondingly, MS analysis 
provided a similar number of identification in both samples (Table A1 in appendix I). 
After subtraction of known contaminants and background identifications, a total of 108 
and 102 proteins were classified as ubiquitin conjugates in 15B and A3 flies, 
respectively, of which 91 were detected in both (Figure 32B).  
 
The LFQ ratio (A3/15B) for each protein was calculated in order to elucidate which of 
them were differentially ubiquitinated upon Ube3a overexpression. LFQ ratio threshold 
was set up to 4 to consider a protein to be more ubiquitinated and, in addition, only 
those proteins identified with at least two peptides were taken into account, to avoid the 
identification of false candidates due to their low abundance. As expected, Ube3a was 
found highly enriched in A3 flies (Figure 33), indicative of its high activity. Two more 
ubiquitin carriers were also found to be accumulated: a putative HECT type E3 ligase 
(CG5604) and the ubiquitin conjugating enzyme E2H (UbcE2H). The latter is the 
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Figure 32. Purified material from Ube3a overexpressing and Ube3a-deleted fly eye. 
A. Silver staining of the material purified in the biotin pulldown from Ube3a deletion (15B) and Ube3a 
overexpression (A3) fly eye. Equal amounts of 15B and A3 samples, as shown by the most abundant 
endogenously biotinylated proteins, were analysed for each sample using SDS-PAGE, and stain with silver. 
Thick bands at around 40 kDa and below correspond to trimer, dimer and monomer forms of 
NeutrAvidin. B. Venn diagram indicating the overlap between the proteins identified in 15B and A3 
samples. About 75 % of all the proteins identified were found in both samples. 15B: GMRGAL4,UAS(bioUb)6-
BirA/CyO;Ube3a15B/TM6B; A3: GMRGAL4,UAS(bioUb)6-BirA/CyO;UASUbe3aA3/TM6B. 
 
homologue of the human UBE2H E2 enzyme, which has been associated with autistic 
disorders (Vourc’h et al., 2003). Five more proteins related to the ubiquitin system had 
an A3/15B LFQ ratio bigger than 4 (Figure 33): The Ubiquitin carboxy-terminal 
hydrolase (Uch) deubiquitinating enzyme, which is the fly homologue of the human 
UCH-L1 (Thao et al., 2012); the extraproteasomal ubiquitin receptors Ring lost (Rngo) 
and the Regulatory particle non-ATPase 10 (Rpn10), whose human counterpart are 
DDI1/DDI2 (Morawe et al., 2011) and PSMD4 (Haracska and Udvardy, 1997), 
respectively; the Refractory to sigma P (Ref(2)P) protein, homologue of the mammalian 
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Figure 33. Proteins found differentially ubiquitinated upon Ube3a overexpression. 
Vulcano plot displaying the LFQ A3/15B ratios found for each protein in log2 scale (x axis). In the y axis the 
sum of the LFQ intensity found in A3 and 15B pulldowns is depicted (in log10 scale). For those proteins 
that did not have LFQ intensity on one of the samples the lowest LFQ intensity recorded in the MS analysis 
was given, in order to provide a ratio. Proteins whose LFQ A3/15B ratio was lower than “2” and bigger 
than “-2” (in log2 scale) were considered to be equally ubiquitinated in both conditions (grey region). 15B: 
GMRGAL4,UAS(bioUb)6-BirA/CyO;Ube3a15B/TM6B; A3: GMRGAL4,UAS(bioUb)6-BirA/CyO;UASUbe3aA3/TM6B. 
 
p62 (Nezis et al., 2008), that also binds ubiquitinated proteins and targets them for 
autophagic degradation (Lippai et al., 2014); and the protein p47 which acts as a co-
factor of TER94/p97, an ATPase involved in protein degradation (Meyer et al., 2012) 
(Figure 33). Interestingly, Uch/UCHL-1 and Ref(2)P/p62 have been associated with a 
number of neurological disorders, such as Parkinson’s, Alzheimer or Polyglutamine 
diseases (Choi et al., 2004; Saitoh et al., 2015). And Rpn10/PSMD4 has been shown to 
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regulate dendrite development in the mammalian brain (Puram et al., 2013), as well as 
to interact with Ube3a (Martínez-Noël et al., 2012; Tomaić and Banks, 2015).  
 
Another three proteins enriched in the bioUb pulldown upon Ube3a overexpression 
were the Heat shock protein cognate 1 (Hsc70-1), the Heat shock 70-kDa protein 
cognate 3 (Hsc70-3) and the Hsp70/Hsp90 organizing protein homologue (Hop). 
Chaperones such as the mammalian Hsp70 and Hsc70 had been previously reported to 
interact with Ube3a in Cos-7 cells (Mishra et al., 2009b). Finally, two metabolic enzymes: 
Aldolase (Ald) and CG7675; two cytoskeleton associated proteins: β-Spectrin (β-Spec) 
and Activity-regulated cytoskeleton associated protein 1 (Arc1); and the Innexin 3 
(Inx3) protein, involved in gap junction formation, did also present a fold change bigger 
than 4 in Ube3a expressing flies.  
 
On the other side, a number of proteins showed a noticeable lower LFQ intensity 
when Ube3a was overexpressed than when it was absent. Accordingly, they were 
considered to be less ubiquitinated upon Ube3a expression if their LFQ ratio (A3/15B) 
was lower than 0.25 (Figure 33). This group included two ubiquitin conjugating 
enzymes: CG40045 and CG7656; proteins involved in the vesicle endocytosis and 
exocytosis cycle (Lloyd et al., 2000): the synaptosomal-associated protein 24kDa 
(Snap24), Eps-15, Like-AP180 (Lap) and Scamp; three proteins required for axonal 
growth (Speicher et al., 1998; Hummel et al., 2000; Liebl et al., 2000): Fax, Futsch and 
Nrt; Three trans-membrane ion transport proteins: Atpα, the Na/Ca-exchange protein 
(Calx) and the Vacuolar H+-ATPase 68 kDa subunit 2 (Vha68-2); the calcium binding 
protein Calbindin 53E (Cbp53E); the Photoreceptor dehydrogenase (Pdh), Waterproof 
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(Wat) and Punch (Pu) metabolic enzymes and the Arrestin2 (Arr2), White (W) and 
CG6051 proteins. The reduction in ubiquitination levels detected on these proteins 
suggests that they are not direct Ube3a substrates. In fact, the ubiquitination of Eps-15 
and Pu had been previously reported not to be dependent on Ube3a ligase function 
(Ferdousy et al., 2011; Jensen et al., 2013).  
 
A similar experiment was carried out with embryos either overexpressing Ube3a 
under the control of elavGAL4-driver or carrying the Ube3a15B allele. However, the MS 
analysis performed was of very poor quality resulting in a small number of 
identifications and with very low intensities (Table A2 in appendix I), so it was 
discarded for further analysis. We would also like to note that further MS analysis were 
carried out with both adult and embryo Ube3aA3 and Ube3a15B flies, however, due to 
technical issues none of them provided good quality results (data no shown). 
 
3.2.3. In vivo validation of Ube3a substrates from Drosophila photoreceptor cells 
 
Biotin pulldowns from 15B and A3 Drosophila fly heads were performed in order to 
analyse by Western blot some of the proteins whose ubiquitination was seen to be 
affected upon Ube3a overexpression. The higher abundance of Ube3a in A3-flies-eluted 
material was confirmed by anti-Ube3a immunoblots (Figure 34). As previously shown 
(see Figure 31B), a large amount of the E3 ligase was purified from Ube3a expressing 
flies, while no band was detected from 15B ones. With regards to the other proteins 
found by MS to be more ubiquitinated, those for which antibodies were available were 
tested. The ubiquitination of Rngo was confirmed by Western blot to be Ube3a 
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dependent, since fractions of this ubiquitin receptor carrying three or more molecules of 
ubiquitin attached were found to be enhanced in A3 Drosophila line, as compared to the 
15B sample (Figure 34). Western blot to Rpn10, Ref(2)P and UbcE2H were also 
performed, but no band was detected in neither of the elutions with Rpn10 antibody 
(data not shown) nor with Ref(2)P (Figure 34). It is likely that the amounts of 
ubiquitinated Rpn10 and Ref(2)P in the Drosophila eye are so low that they escape
 
 
 
Figure 34. Validation of differentially ubiquitinated proteins upon Ube3a overexpression.  
Western blotting confirmed that Ube3a is more active in the Drosophila eye when overexpressed, as more 
of it was detected in the eluted material of A3 flies. Immunoblot performed with anti-Rngo antibody 
confirmed the increase ubiquitination detected by MS for this protein upon Ube3a overexpression. This 
result places Rngo as the first substrate shown to be more ubiquitinated in vivo by Ube3a E3. Western blot 
to UbcE2H and Ref(2)P did not reveal higher ubiquitination of these two proteins in A3 flies. Western to 
Atpα and Eps-15 confirmed that a smaller fraction of these proteins is being conjugated with biotinylated 
ubiquitin upon Ube3a overexpression. Arrow heads indicate endogenously biotinylated proteins. 15B: 
GMRGAL4,UAS(bioUb)6-BirA/CyO;Ube3a15B/TM6B; A3: GMRGAL4,UAS(bioUb)6-BirA/CyO;UASUbe3aA3/TM6B.  
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Western blot detection. Indeed, these two proteins were only identified by MS in one out 
of three pulldown experiments earlier performed with GMRGAL4,UAS(bioUb)6-BirA/CyO flies 
(see Table A1 in appendix I). In the case of UbcE2H, no increased ubiquitination was 
detected (Figure 34).  
 
Anti-Atpα and anti-Eps-15 immunoblots were also carried out to validate the 
detected reduction in their ubiquitination upon Ube3a overexpression. As shown in 
Figure 34, both proteins were found to be less ubiquitinated in A3 flies, supporting MS 
results. The reduce ubiquitination observed for these two proteins could be due to a 
cellular response produced by the overexpression of Ube3a. Likewise, it could be due to 
technical issues, such as a limited amount of available free biotinylated ubiquitin or the 
preferential attachment of the biotinylated ubiquitin to Ube3a substrates. Discerning 
between these situations would require further experiments. However, independently 
of the reason why their ubiquitination is reduced, there is no doubt to assert that Atpα 
and Eps-15 are not directly ubiquitinated by Ube3a in Drosophila photoreceptor cells, 
and hence that they are not direct substrates of this E3 ligase in vivo. 
 
On the other hand, the observation that Rngo ubiquitination is enhanced upon Ube3a 
overexpression does suggest that it is a direct in vivo target of Ube3a in the fly eye. To 
our knowledge, Rngo is therefore the first Ube3a substrate to be validated in vivo in the 
context of a whole organism. In addition, despite the ubiquitination of Ube3a is thought 
to be a degradation signal, a decrease in the total levels of Rngo upon Ube3a expression 
in the input fraction of A3 flies was not detected (Figure 34), suggesting rather a non-
degradative role.  
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4. GFP pulldown assay to monitor protein ubiquitination 
 
The direct in vivo validation by Western blot of identified ubiquitin conjugates and 
carrier proteins from bioUb-eluted material requires specific antibodies to be available. 
However, when this is not possible alternative approaches have to be taken. In order to 
allow validation of ubiquitin substrates in those cases we have developed an alternative 
approach based on high-affinity anti-GFP antibody-coated beads (Chromotek-GmbH). 
Those beads are routinely used in non-denaturing conditions to preserve interactions in 
co-immunoprecipitation experiments, but it has been found in our lab that they also 
withstand very stringent washing conditions. As the isopeptide bond of ubiquitin with 
its substrates is kept intact on denaturing environments, GFP-tagged proteins can be 
successfully isolated in order to further study their ubiquitination (Min et al., 2013; Lee 
et al., 2014; Ramirez et al., 2015). Indeed, these GFP beads had been successfully used 
for this purpose also on U2OS cell lysates (Min et al., 2013). This GFP pulldown assay 
can be used for the validation of protein ubiquitination and ubiquitination sites 
(Ramirez et al., 2015), as well as for the identification of direct E3 ligase targets (Lee et 
al., 2014). 
 
4.1. Validation of ubiquitinated proteins 
 
Previously, our lab identified 47 ubiquitin conjugates from the Drosophila embryonic 
nervous system using the bioUb strategy (Franco et al., 2011). The in vivo ubiquitination 
of some of them was already validated by directly immunoblotting the eluted material 
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with specific antibodies (see Figure 21 and Franco et al., 2011). As an alternative 
approach to validate their ubiquitination, N- and C-terminally GFP-tagged versions of 
these 47 proteins were generated by cloning them into a pAc5.1 vector carrying the GFP 
protein either before or after the multicloning site (Lee et al., 2014; see also Material and 
Methods). Confocal microscopy of transfected BG2 neuron-like cells (Ui et al., 1994) with 
the 47 fusion proteins revealed distinct localization patterns for each of them: seven 
localized in the nucleus, 22 in the cytoplasm and 18 were found in both compartments 
(Figure 35). In addition, 5 proteins also localized at the plasma membrane, while 3 
localized at the nuclear membrane. All confocal images are shown on Figure A6 in 
appendix II.  
 
 
Figure 35. Localization of 47 neuronal ubiquitin substrates. 
Forty-seven GFP-tagged genes were transfected into BG2 cells and protein localization analysed by 
confocal microscopy. Seven proteins localized in the nucleus, 22 in the cytoplasm and 18 in both 
compartments. Proteins also localized to the plasma membrane are inside boxes. Those localized to the 
nuclear membrane are surrounded with a circle. Dotted underlining indicates punctuate expression. All 
confocal images are found in Figure A6 in appendix II. Taken from Lee et al., 2014. 
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Analysis of the ubiquitination of these proteins was performed by transiently co-
transfecting Drosophila BG2 cells with the GFP-tagged proteins together with a FLAG-
tagged version of ubiquitin (Lee et al., 2014). The choice of those neuron-like cells for 
this purpose was due to our intention to perform the assay in a similar cell type where 
the ubiquitination of these proteins had been detected. After incubation of cell lysates 
with GFP-beads in a non-denaturing buffer, supplemented with protease inhibitors and 
NEM to prevent deubiquitination, washes with 8 M Urea and 1 % SDS were applied so all 
non-covalently bound interactors could be discarded. Then immunoblotting was 
performed on the purified material (Figure 36A). Anti-FLAG antibody was used to 
detect the ubiquitinated fraction of the proteins (red channel in Figure 36B), while the 
non-modified fraction was detected with anti-GFP (green channel in Figure 36B). 
Western blot analysis confirmed that 43 out of the 47 proteins are ubiquitinated in 
neuron-like cells, each of them showing a different ubiquitination pattern (Figure 36B 
and Figure A7 in appendix II). Three of them, however, showed no modification and a 
fourth one was not detectable with either of the antibodies. When GFP was expressed 
alone no ubiquitination was detected (Figure 36B), confirming that the ubiquitination 
seen is specific to each protein and not to the added tag. Additionally, cells were treated 
with RNAi to the ubiquitin activating enzyme E1, to further confirm that the 
ubiquitination observed was dependent on the canonical ubiquitination pathway. As 
shown in Figure 36C, RNAi treatment completely abolished the ubiquitination of the 
GFP-tagged proteins. These results establish that the described GFP-pulldown assay can 
be successfully used to characterize the ubiquitination of proteins within those neuron-
like cells. 
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Figure 36. GFP-pulldown based strategy to validate protein ubiquitination in cells.  
A. Schematic illustration of the GFP-pulldown protocol for analysing protein ubiquitination. GFP-tagged 
proteins are co-transfected with FLAG-tagged ubiquitin into Drosophila BG2 neuron-like cells. After 
culturing for three days cells are lysed and lysates are incubated with anti-GFP beads and subjected to 
washes with 8 M Urea and 1 % SDS to discard all interacting proteins. Ubiquitination of purified GFP-
tagged protein can be validated by Western blot to the tagged-ubiquitin. Non-modified fraction can be 
detected by anti-GFP. B. Validation examples of the ubiquitination of some of the identified proteins using 
the GFP-pulldown assay, modified from Lee et al. (2014). Anti-GFP antibody was used to detect the non-
modified forms of the proteins and anti-FLAG to monitor the ubiquitinated fraction. No ubiquitination was 
detected when GFP alone was expressed. Full analysis is shown in Figure A7 in appendix II. C. E1 RNAi 
treatment inhibited ubiquitination of overexpressed GFP-tagged proteins with FLAG-tagged ubiquitin, 
modified from Lee et al. (2014).  Anti-GFP and anti-FLAG antibodies were used to detect the non-modified 
and the ubiquitinated fraction, respectively. E1 enzyme was detected using anti-Uba1 antibody. The 
protein shown in the example is Rad23. Modified from Lee et al., 2014. 
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4.2. Validation of ubiquitination sites 
 
A di-gly remnant on the ubiquitin-modified lysines can be detected by MS analysis of 
ubiquitinated material  (Peng et al., 2003). The GFP-pulldown approach was used to test 
whether identified ubiquitination sites were truly so modified. We applied the GFP-
pulldown strategy to confirm two ubiquitination sites found on neuronal synaptobrevin 
(nSyb), a protein that belongs to the soluble N-ethylmaleimide-sensitive factor 
attachment protein receptor (SNARE) family (Ossig et al., 2000). The selection of nSyb 
as candidate for this purpose was based on the two ubiquitination sites identified in the 
Drosophila eye, K71 and K78 (Table 6), being detected twice in independent bioUb 
pulldowns. Besides, those sites are found in a region of the protein (known as SNARE 
motif) conserved among Drosophila nSyb isoforms as well as in other organism (Figure 
37), including humans (Fasshauer et al., 1998). They are required for the interaction 
and formation of a complex with Syx1A and the Synaptosomal-associated protein 25 
kDa (Snap25) that triggers membrane fusion and exocytosis (Ossig et al., 2000). 
Moreover, the two lysines are surrounding an arginine that is known to be essential for 
the correct performance of exocytosis (Fasshauer et al., 1998; Ossig et al., 2000). 
 
The nSyb gene was amplified from a Drosophila cDNA library and introduced into a 
pAc.5.1 vector carrying either an N-terminally or C-terminally GFP tag. As shown by 
Western blot (Figure 38A) the C-terminally GFP tagged version of nSyb displayed a 
stronger ubiquitination signal as compared with the N- terminal one when purified 
using GFP beads, and was therefore used for the generation of nSyb protein mutants 
carrying either the lysine 71 or the lysine 78 mutated to arginine (K71R or K78R) or
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Figure 37. Homology of the nSyb region where ubiquitination sites were found. 
 
Illustration of the peptides and the ubiquitination sites found in Drosophila melanogaster nSyb. The region 
of the protein where the modified lysines (red) were found, known as SNARE motif, is conserved among 
different species. The conserved amino-acids are shown in grey. Taken from Ramirez et al., 2015. 
 
both (DM: K71R/K78R). Ubiquitination of nSyb mutants was monitored by Western blot 
on GFP-eluted nSyb from transfected BG2 cells. Both K71R and K78R single mutants 
showed reduced ubiquitination when compared to WT nSyb (Figure 38B), confirming 
that they are indeed true ubiquitination sites. Furthermore, there was a very significant 
reduction in the ubiquitinated nSyb levels (p<0001) if both lysines were mutated at the 
same time, when compared to wild type nSyb. The fact that ubiquitination was still 
detectable in nSyb double mutants indicates the presence of additional ubiquitination 
sites, which have been, indeed, previously reported for the mammalian counterpart (Na 
et al., 2012). All together, these results confirm that the GFP-pulldown assay can be 
successfully applied to validate ubiquitination sites.  
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Figure 38. Ubiquitination sites on nSyb. 
A. Anti-Flag (red) and anti-GFP (green) Western blots performed with C-terminally (C) or N-terminally 
(N) GFP-tagged WT nSyb B. nSyb double mutant (DM) showed a significant reduction in its ubiquitinated 
fraction, as shown with anti-Flag antibody western blot (red), compared to the wild type (WT) or the 
single lysine mutated forms (K71R or K78R). The non-modified form of nSyb was detected by GFP 
antibody (green). Quantification of the ubiquitination status of nSyb mutants relative to the non-modified 
form (Y axis: relative ubiquitination) was performed with Image-J. The plot shows relative levels of nSyb 
ubiquitination normalized to the GFP levels (average intensity ± SD). Statistical analysis was performed 
with Prism. One asterisk indicates p-value < to 0.05; two, p < to 0.01; three, p < to 0.0001. C. Confocal 
analysis of wild type (WT) and double lysine mutant (K71R/K78R) nSyb GFP-tagged protein. Scale bars 
indicate 8 µm. Modified from Ramirez et al., 2015. 
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Interestingly, the absence of modification at K71 and K78 did not have a significant 
effect on the total protein nSyb levels, as shown by anti-GFP Western blot (Figure 38B), 
suggesting that the ubiquitination at those sites is not a signal for degradation. In 
addition, confocal images of BG2 cells transfected either with C-terminal GFP-tagged WT 
or the double lysine mutant (K71R/K78R) nSyb proteins, revealed that the localization 
and the expression pattern are neither affected (Figure 38C). Further experiments are 
therefore required in order to elucidate the significance of this ubiquitination.  
 
4.3. Screening for E3 ligase-specific substrates 
 
Among the 47 neuronal ubiquitin proteins identified from the Drosophila brain 
development (Figure 35) the E3 ligase Ube3a was also found, indicating that Ube3a is 
an active ubiquitin ligase throughout this period (Franco et al., 2011). We, therefore, 
reasoned that the ubiquitination of some of those substrates could be regulated by this 
enzyme. GFP-tagged proteins of the 47 candidates were hence transfected into BG2 cells 
in the presence of either an HA-tagged wild type Ube3a (HA-Ube3aWT) or a ligase dead 
version (HA-Ube3aLD) (Figure 39A). The latter was generated by mutating its active site 
cysteine to serine (C941S), which allows the E3 to be charged with ubiquitin but does 
not enable the transfer of the ubiquitin to a lysine residue on the substrate, as the 
oxyester link that is formed is more stable than the usual thioester bond (Levin et al., 
2010).  
 
Initially, whole cell extracts were analysed for changes in total protein levels with 
anti-GFP antibody, in order to elucidate whether any of the 47 GFP fusion proteins were 
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Figure 39. Rpn10 total levels are reduced upon Ube3a overexpression in BG2 cells. 
A. Drosophila Ube3a wild type gene (Ube3aWT) was amplified from a cDNA library and tagged with 
hemagglutinin (HA) at its N-terminus, to monitor by anti-HA antibody its expression. A catalytic inactive 
(or ligase dead) version of Ube3a was generated by the mutation of the active site cysteine residue (C941) 
to serine (HA-Ube3aLD). B. Rpn10 levels were monitored in the presence of HA-Ube3aWT (WT) or the ligase 
dead version (LD). Rpn10 was detected using anti-GFP antibody. Ube3a detection with anti-Ube3a and 
anti-HA antibodies is shown. Rpn10-GFP levels were quantitated using ImageJ software and intensities 
normalized relative to the control sample (pAc5), in which instead of Ube3a an empty pAc5 vector was co-
transfected. Mean and standard deviation of three independent experiments are shown. A t-test was used 
for statistical analysis. Three asterisk indicates p-value < to 0.001. Modified from Lee et al., 2014. 
 
downregulated by Ube3a. Human UBE3A has been reported to generate K48 poly-
ubiquitin chains in vitro (Wang and Pickart, 2005), a modification that targets proteins 
for proteasomal degradation. Direct substrates of Ube3a were hence expected to show 
reduced levels in the presence of HA-Ube3aWT. Upon overexpression of the wild type 
version of this enzyme, a decreased level was only detected for one out of the 47 
proteins, Rpn10 (Figure 39B), suggesting that Ube3a targets this protein for 
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proteasomal degradation. In addition, this drop on the total amount of Rpn10-GFP was 
found to be dependent on the Ube3a ligase activity, as the overexpression of the HA-
Ube3aLD did not cause the same effect, but rather seemed to protect it from degradation; 
total Rpn10 levels were higher in HA-Ube3aLD overexpressing cells than in the control 
sample (Figure 39B). This protein was previously found by MS to be more 
ubiquitinated in the Drosophila photoreceptor cells upon Ube3a overexpression (Figure 
33), which supports the idea that it is a direct ubiquitination substrate of Ube3a.  
 
Changes in protein levels might be caused by different cellular processes, so in order 
to obtain direct evidence of the Rpn10 ubiquitination by Ube3a, BG2 cells expressing 
Rpn10-GFP together with HA-Ube3aWT or HA-Ube3aLD, as well as with FLAG-tagged 
ubiquitin, were subjected to the GFP-pulldown assay. As shown in Figure 40A, Rpn10 
ubiquitination was significantly increased in the presence of wild type Ube3a (WT), as 
compared to cells expressing either the ligase dead E3 (LD) or to those transfected with 
an empty vector (pAc). Besides, a shift of the molecular weight pattern of ubiquitinated 
Rpn10 molecules was also detected in HA-Ube3aWT expressing cells, indicating that 
Rpn10 is highly poly-ubiquitinated in the presence of the active E3 ligase. This effect 
was seen for both N and C-terminally GFP-tagged Rpn10 constructs (Figure A8 in 
appendix II).  
 
The observed increased ubiquitination of Rpn10 by HA-Ube3aWT is masked to some 
degree by the rapid degradation of Rpn10 and its ubiquitinated forms, which resulted in 
reduced total Rpn10-GFP levels (Figure 39B). Whole eluate of cells transfected with 
HA-Ube3aWT was loaded in parallel with decreasing volumes of eluted material from HA-
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Ube3aLD overexpressing cells, in order to compare the ubiquitinated fraction of Rpn10 
for similar amounts of purified Rpn10-GFP protein. For similar total GFP intensities, 
ubiquitinated Rpn10-GFP was very well detected in Ube3aWT expressing sample, while it 
became completely undetectable in Ube3aLD one (Figure 40B), indicating a very clear 
difference between the two samples. In addition, the molecular weight shift caused by a 
higher degree of poly-ubiquitination is much more evident. In the HA-Ube3aLD sample 
the whole range of modifications to which Rpn10 is subjected (i.e., from mono-
ubiquitination to high levels of poly-ubiquitination) were observed. In HA-Ube3aWT, 
however, only a signal above 150 kDa, corresponding to highly poly-ubiquitinated 
Rpn10-GFP, was detected. These results confirm that Rpn10 ubiquitination is highly 
enhanced by Ube3a. 
 
Four ubiquitination sites located on the VWFA of the mammalian Rpn10 homologue, 
S5a, and two on the C-terminal region, where the UIMs are located, have been previously 
reported to be modified in vitro by the mammalian UBE3A (Uchiki et al., 2009), 
suggesting that both regions are subjected to modification. In addition, the region 
containing the UIMs fused to GST has been shown to be enough for recognition and 
ubiquitination by two different E3 ligases, MurF1 and CHIP, in vitro (Uchiki et al., 2009). 
In order to elucidate whether either of the two differentiated halves of Drosophila 
Rpn10 are required or enough for Ube3a-dependent ubiquitination in BG2 cells, the N-
terminal region containing the VWFA domain (∆C, up to the residue 204) and the C-
terminal region carrying three UIMs (∆N, starting at residue 205) were cloned and C-
terminally tagged with GFP (Figure 40C). Despite both halves showing some degree of 
ubiquitination, neither of them were significantly ubiquitinated by endogenous Ube3a, 
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Figure 40. Ube3a directly ubiquitinates Rpn10 in BG2 cells. 
A. Overexpression of Ube3aWT (WT) induced a dramatic increase of Rpn10 ubiquitination, despite the low 
Rpn10-GFP levels detected. The apparent increased ubiquitination seen in Ube3aLD (LD), relatively to pAc, 
is partly to due to higher levels of total Rpn10-GFP in the sample. Ube3a expression was monitored with 
anti-HA antibody in the input fraction. B. In order to compare the ubiquitinated fraction of Rpn10 upon 
Ube3aWT and Ube3aLD expression, we attempted to compare similar Rpn10-GFP levels by loading the full 
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eluate of WT sample and smaller volumes of the eluate for the LD one. When loading 1 μL of the purified 
Rpn10 protein from LD sample, where the amount of Rpn10-GFP is still higher than that purified from WT 
sample, the dramatic increase ubiquitination of Rpn10 in the WT sample is evident. C. Schematic 
illustration of C-terminally GFP-tagged full-length (FL), N-terminal (∆N)  and C-terminal (∆C) truncated 
versions of Rpn10. D. Ubiquitination by endogenous Ube3a of full length Rpn10-GFP protein, as well as C- 
and N- terminally truncated versions, carrying the VWFA domain or the  UIMs, respectively (see panel C), 
was tested. No significant ubiquitination was found for neither of the truncated forms. ΔN: Rpn10 C-
terminal half carrying the UIMs; ΔC: Rpn10 N-terminal half carrying the von Willebrand Factor A domain 
(VWFA); FL: Full length Rpn10 protein; -: empty lane. In panel A, B and D the Rpn10 ubiquitinated fraction 
was detected with anti-FLAG antibody (shown in red), while the non-modified form was detected with 
anti-GFP (shown in green). Taken from Lee et al., 2014. 
 
as compared with the full-length (Figure 40D). Similarly, neither of the partial 
constructs was targeted for degradation upon overexpression of HA-Ube3aWT (Figure 
A7 in appendix II), suggesting that the full-length Rpn10 is required for Ube3a-
dependent ubiquitination and degradation. 
 
Protein modification with K48 poly-ubiquitin chains has been historically linked to 
proteasomal degradation. However, non-proteolytic functions for this type of chain has 
also been reported (Flick et al., 2006). For this reason, although the remaining 46 GFP-
tagged proteins do not appear to be regulated by Ube3a overexpression, the GFP-based 
protocol was also applied to them in order to address if their ubiquitination was 
somehow affected by Ube3a. This way, three more proteasome-interacting proteins, the 
ubiquitin receptor Rngo, the Ubiquitin carboxy-terminal hydrolase L5 orthologue (Uch-
L5) DUB and the product of the gene CG8209, as well as the ribosomal protein S10b 
(Rps10b), were found more ubiquitinated in HA-Ube3aWT expressing cells (Figure 41A).
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Figure 41. GFP-pulldown based screen for Ube3a substrates in BG2 cells. 
 
Overexpression of HA-Ube3aWT (WT) and HA-Ube3aLD (LD) was used to confirm the ubiquitination of 
some proteins by this E3 ligase. Ubiquitination was monitored after GFP pulldown. Levels of Ube3a were 
detected by anti-HA antibody. Mouse anti-GFP antibody was used to detect the non-modified fraction 
(shown in green) of the captured proteins and anti-FLAG antibody (shown in red) to identify the 
ubiquitinated fraction. A. Rngo, Uch-L5, Rps10b and CG8209 were found to be more ubiquitinated upon 
Ube3a overexpression. However, none of them seemed to be targeted for degradation as suggested by the 
fact that total levels were similar in Ube3a WT and LD expressing cells. B. The ubiquitination of the 
remaining proteins was found not to be dependent on Ube3a, as either less or equal ubiquitination was 
found for all of them upon HA-Ube3aWT overexpression. Western to P47, Fax and ATPα are shown as 
examples. Modified from Lee et al., 2014. 
 
Out of those three, Rngo was also found to be more ubiquitinated in vivo in the 
photoreceptor cells of Ube3a overexpressing flies (Figure 34). None of those Ube3a 
substrates seemed to be targeted for proteasomal degradation, as suggested by the fact 
that total protein levels were similar in HA-Ube3aWT and HA-Ube3aLD samples. 
Therefore, their ubiquitination by Ube3a must provide some other non-proteolytic 
function. The fate of these proteins after their ubiquitination by Ube3a, however, is not 
straightforwardly interpreted with the results obtained so far, and hence, further 
experiments are required. Neither of the remaining 42 GFP-tagged proteins showed an 
increase ubiquitination upon HA-Ube3aWT overexpression and even appeared reduced 
in some cases (see three examples in Figure 41B), illustrating that the enhanced poly-
ubiquitination observed for Rpn10, Rngo, Uch-L5, CG8209 and Rps10b is specific to the 
activity of the enzyme and not an artefact caused by the overexpression of the E3 and 
the GFP-tagged ubiquitinated proteins. 
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5. Understanding the in vivo role of protein ubiquitination 
 
Cell culture or in vitro experiments are of great value for the characterization of 
cellular pathways, analysis of protein interaction or, as shown in previous section, study 
of protein ubiquitination. Indeed, the discovery and characterization of the ubiquitin-
proteasome system, as well as all the enzymes involved on it were first achieved on 
rabbit reticulocyte extracts (Hershko et al., 1980; Hough et al., 1987). However, the 
ultimate goal is to be able to understand the role that the different characterized 
pathways have on a living organism, particularly in humans, and in order to advance 
towards such knowledge, the use of in vivo models is required. 
 
In the screening for Ube3a substrates performed on Drosophila BG2 cells five direct 
Ube3a substrates were identified (see Results section 4.3: Screening for E3 ligase-specific 
substrates), two of which have also been identified from neuronal tissue as being more 
ubiquitinated in Ube3a overexpressing flies. One of them, Rpn10, was degraded upon 
ubiquitination by Ube3a, as expected on what has been described so far in the literature 
for ubiquitin chain types formed by UBE3A (Kim and Huibregtse, 2009). We therefore 
decided to use Drosophila melanogaster flies in order to assess the biological significance 
of Rpn10 regulation by the ubiquitin system in vivo. In addition, and as a first attempt 
towards elucidating the role that ubiquitination plays in humans, we generated human 
dental pulp stem cells that constitutively express the bioUb construct. This system should 
provide in the future the opportunity to study ubiquitination from human-derived cells.  
  
Results: in vivo role of ubiquitination 
 
- 204 - 
 
5.1. Ube3a and Rpn10 interaction in vivo affects protein degradation 
 
Rpn10 is an ubiquitin receptor in charge of the transport of poly-ubiquitinated 
proteins to the proteasome for their degradation (Lipinszki et al., 2009). Failure in the 
regulation of Rpn10 levels might therefore have a big impact on the levels of other 
proteins. In order to understand the biological consequences of the degradation of 
Rpn10 by Ube3a in vivo, we generated transgenic flies that overexpress both wild type 
Ube3aA3 and the dominant negative C-terminal half of Rpn10 (Rpn10DN), used earlier 
(see Results section 3.1: bioUb strategy upon interference with proteasomal function), 
under the control of the GMRGAL4 driver.  
 
Overexpression of Ube3a alone did not cause any significant alteration on the levels 
of ubiquitinated material as compared to control flies and those lacking the Ube3a 
protein (Figure 42A), but it caused a degeneration phenotype in the fly eye, which 
becomes more evident in flies carrying two copies of the GMRGAL4 driver (lane 4 and 5 in 
Figure 42B). As expected from previous experiments, overexpression of Rpn10DN alone 
significantly increased the amount of ubiquitinated proteins detected in the Drosophila 
eye (Figure 42A), but in contrast to what is seen with Ube3a, did not cause any 
phenotype in the eye (lane 3 in Figure 42B). Interestingly, when both proteins were co-
expressed together the increase ubiquitination associated to Rpn10DN was significantly 
enhanced (Figure 42A), and additionally, the eye phenotype was completely 
suppressed (lane 6 in Figure 42B). Co-expression of Ube3a with GFP did somehow 
reduce the phenotype obtained by the overexpression of Ube3a using two copies of the 
GAL4-driver (lane 5 and 7 in Figure 42B), but no reduction was observed if the GAL4
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Figure 42. Ube3a and Rpn10 interaction in vivo. 
A. Western blot analysis of ubiquitinated proteins from Drosophila heads whole extracts. Overexpression 
of Rpn10DN (Rpn) causes an accumulation of ubiquitinated material. This effect is highly enhanced when 
Ube3a is co-expressed (A3R), despite the latter having no such effect on its own (A3), indicating an 
interaction between both proteins in vivo. Anti-Ube3a and anti-Rpn10 immunoblots illustrate the samples 
on which Ube3a and Rpn10DN proteins were expressed, respectively. Endogenous Ube3a and Rpn10 (~50 
kDa) were also detected. Ubiquitinated material was monitor with anti-FK2 antibody, which only 
recognizes conjugated ubiquitin. Anti-Syx1A Western is shown as loading control. WT: OregonR; GMR: 
GMRGAL4;TM2/TM6B; 15B: If/CyO;Ube3a15B/Ube3a15B null mutant; A3: GMRGAL4/CyO;UASUbe3aA3/TM6B; Rpn: 
GMRGAL4;UASRpn10DN; A3R: GMRGAL4;UASUbe3aA3,UASRpn10DN/TM6B. B. Overexpression of Rpn10DN in the 
Drosophila eye displays an appearance similar to OregonR wild type flies and flies carrying only the 
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GMRGAL4 driver. Overexpression of Ube3aA3 results on a degenerative phenotype, which is exacerbated 
when two copies of GMRGAL4 are used. When both Ube3aA3 and Rpn10DN constructs are expressed together, 
using two copies of GMRGAL4, the Ube3a phenotype is rescued. This phenotype, however, is not rescue if 
GFP is expressed together with Ube3a, indicating that there is an interaction between Rpn10 and Ube3a in 
vivo. Modified from Lee et al., 2014. 
 
dosage was accounted for (lane 4 and 7 in Figure 42B). However, co-expression with 
Rpn10DN (lane 6 in Figure 42B) did completely abolished either phenotype, indicating 
clearly that this rescue effect was indeed specific to Rpn10DN. The double synergistic 
effect seen in flies suggests that the shuttling of poly-ubiquitinated proteins by Rpn10 
might be regulated by Ube3a and that the eye phenotype reported for Ube3a may be 
linked to the failure in the degradation by the proteasome of those poly-ubiquitinated 
proteins. 
 
With the aim of further testing the increased ubiquitination seen when Ube3a and 
Rpn10DN are co-expressed, flies carrying together both UASUbe3aA3 and UASRpn10DN 
transgenes were combined with GMRGAL4, bioUb ones, so as to be able to analyse the 
ubiquitinated fraction obtained from each line. Overexpression of Rpn10DN produced a 
differential distribution of the ubiquitinated material, as detected by anti-biotin Western 
blot (Figure 43A), presumably because the biotinylated ubiquitin is preferentially found 
attached to poly-ubiquitinated proteins (see Results section 3.1: bioUb strategy upon 
interference with proteasomal function). When the purified material was analysed by 
silver staining an increase in the total amount of isolated proteins was however 
detected, as compared to flies expressing the bioUb construct alone (Figure 43B). This 
effect was not detected when Ube3a was overexpressed, since the signal, as well as
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Figure 43. Ubiquitinated material purified from Ube3a and Rpn10DN co-expressing flies. 
A. Anti-biotin Western blot on the material purified from Drosophila adult samples. Similar amount of 
purified material is observed in the elutions of bioUb, Ube3a mutant (15B) and Ube3a overexpressing (A3) 
flies. In contrast, a differential distribution is detected in the ubiquitinated proteins that are recovered in 
flies that overexpress Rpn10DN alone (Rpn), with a preferential attachment of the biotinylated ubiquitin to 
higher molecular weight proteins. When Ube3a and Rpn10DN are co-expressed (A3R) similar distribution 
as in Rpn is observed for the eluted material, but the signal appeared to be a stronger. BirA: GMRGAL4/CyO; 
UASBirA/TM6B; bioUb: GMRGAL4,UAS(bioUb)6-BirA/CyO; 15B: GMRGAL4,UAS(bioUb)6-BirA/CyO;Ube3a15B/TM6B; A3: 
GMRGAL4,UAS(bioUb)6-BirA/CyO;UASUbe3aA3/TM6B; Rpn: GMRGAL4,UAS(bioUb)6-BirA/CyO;UASRpn10DN/TM6B; A3R: 
GMRGAL4,UAS(bioUb)6-BirA/CyO; UASUbe3aA3,UASRpn10DN/TM6B. B. Silver staining of the proteins isolated from 
Drosophila adult samples. Equal amounts of the eluted material from each of the samples shown in panel 
A were separated by SDS-PAGE and stained with silver. An accumulation of proteins is detected on 
samples from flies overexpressing Rpn10DN (Rpn), as compared to bioUb, 15B and A3 samples. When 
Rpn10DN and Ube3a are co-expressed (A3R) this accumulation is greatly enhanced. 
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distribution, of the proteins found in the elution were similar to those found in bioUb 
flies, or to those carrying the Ube3a deletion (Ube3a15B), either by Western (Figure 43A) 
or by silver staining (Figure 43B). When both construct were expressed together, the 
redistribution of the ubiquitinated material was clearly observed by Western blot 
(Figure 43A). But more importantly, the amount of ubiquitinated material isolated from 
these flies was significantly higher than those isolated from control (bioUb), as well as 
from flies expressing each construct independently (Figure 43B). Similar analyses were 
performed with Drosophila embryos, which yielded similar results (Figure A9 in 
appendix II).  
 
5.2. Future directions: Dental Pulp Stem Cells (DPSCs) 
 
The use of different animal models, such as yeast, Drosophila or mouse is of 
outstanding value. Nevertheless, it is ultimately required to confirm the obtained 
findings in human cells. The lack of easy access to living neuronal tissue from human 
patients, however, is still a major issue. Dental Pulp Stem Cells (DPSCs) are 
mesenchymal stem cells, which can be easily extracted from teeth, and have the ability 
to develop into a variety of cell types, including neurons (Kanafi et al., 2014). Besides, 
they can be obtained by non-invasive techniques, as they fall out on their own or are 
routinely extracted in the paediatric clinics. In collaboration with Dr. Lawrence T. Reiter 
(UTHSC) we, therefore, developed DPSC cell lines from which the ubiquitinated material 
could be easily extracted using the bioUb strategy. 
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5.2.1. Establishment of bioUb system in DPSCs 
 
DPSC cells obtained from a control individual (TP037) were first immortalized by Dr. 
Sarita Goorha (UTHSC), using a virus containing the human telomerase reverse 
transcriptase, with the purpose of generating cell lines that have the ability to grow over 
long time periods. Immortalized cells were then infected with the UAS(bioUb)6-BirA 
transgene carrying six copies of ubiquitin plus BirA enzyme (bioUb), and with BirA alone 
as control. Both construct were cloned into a pBABE retroviral vector carrying 
hygromycin resistance for their stable expression in DPSCs. Cells from the TP037 
control subject were successfully infected with both constructs. These cells properly 
expressed both the BirA standalone construct, as well as the longer poly-ubiquitin 
construct (bioUb), which must have been digested by endogenous DUBs as only one band 
corresponding to free BirA was detected by Western blot with anti-BirA antibody 
(Figure 44A). These cells were further incubated with 50 µM of biotin in order to 
analyse the ability of the modified ubiquitins to be biotinylated and conjugated to 
endogenous proteins. Anti-biotin Western blot revealed the presence of the typical 
smear corresponding to ubiquitinated material, proving that the bioUb is also properly 
biotinylated and conjugated in DPSCs (Figure 44B). A confluent T150 flask expressing 
the bioUb construct was subjected to biotin pulldown as described for flies, so as to 
provide evidence that ubiquitinated material can also be isolated from DPSCs using this 
system. As shown in Figure 44C, the isolation of ubiquitinated material was effectively 
accomplished from bioUb expressing cells, while only those proteins endogenously 
biotinylated were exclusively purified from cells expressing the BirA.  
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Figure 44. Western blot from transduced DPSC cells. 
A. Anti-BirA Western blot showed that construct is properly expressed in DPSC cells and that it is properly 
digested. A band corresponding to the E.coli BirA enzyme is detected in both the BirA and bioUb samples 
but not in the WT cells. B. Anti-biotin Western blot showed that the ectopically expressed ubiquitin is 
biotinylated and conjugated. Cells were cultured in the presence of 50 μM of biotin. C. A pulldown 
performed with DPSC-BirA and DPSC-bioUb cells showed the presence of proteins conjugated with 
biotinylated ubiquitin in the bioUb sample. In the BirA sample only endogenously biotinylated proteins are 
found. WT: Control DPSC cells. BirA: DPSC cells expressing BirA enzyme alone. bioUb: DPSC cells 
expressing the UAS(bioUb)6-BirA construct. 
 
Similar approaches were carried out with DPSCs obtained from two other control 
individuals (TP023 and TP024). Besides, cells obtained from six different patients, three 
of which (TP055, TP059 and TP078) were carrying a deletion on the long arm of the 
maternal chromosome 15 (AS deletion) and the other three (TP041, TP044 and TP058) 
a maternal duplication of the same region (15q duplication syndrome) were used. The 
purpose of this approach was to compare the isolated ubiquitin proteome from control, 
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AS and 15q duplication patients. However, the six-month stay at Dr. Reiter’s lab was not 
enough time to achieve the proper integration of the bioUb and BirA constructs in the 
genome of the different cell lines and to perform the biotin pulldown experiments and 
MS analysis. It will be therefore necessary to follow up those experiments and ongoing 
collaboration with Dr. Reiter in order to fully implement and achieved the expected 
results.
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Ubiquitination regulates a wide range of biological processes in higher eukaryotes, 
which go far beyond the degradation of old or misfolded proteins. In vivo models in 
which the ubiquitin proteome can be analysed under physiological, as well as under 
disturbed, conditions can greatly contribute to the understanding of the roles of this 
post-translational modification. During this Thesis project, we have expanded a strategy 
for the in vivo analysis of ubiquitinated proteins to the Drosophila photoreceptor cells, 
providing an in vivo system in which the proteins that are ubiquitinated in the context of 
a mature neuron can be studied. We have further confirmed that this strategy can be 
employed for the identification of changes in the ubiquitin proteome upon particular 
treatments. While changes due to the blockade of the proteasome were certainly 
expected, we were not sure about being able to detect changes in the ubiquitome upon 
the overexpression of a single E3 ligase. Taking into account that there are more than 
600 E3s, the effect made by just one of them could have remained undetectable using 
available techniques. However, the combination of the bioUb strategy with 
overexpression of the Ube3a E3 ligase has allowed us to identify the first in vivo 
substrate of this E3 ligase in Drosophila. On the other hand, we have developed a GFP-
pulldown assay that allows for the isolation of just a single protein in order to further 
characterize its ubiquitinated fraction, both in physiological conditions and upon 
expression of an E3 ligase. We have applied this new protocol to cell culture but it could 
be exported to any transgenic living organisms. 
 
The fly eye as an in vivo model to study protein ubiquitination 
We tested different promoters for their ability to drive the expression of the bioUb 
construct in the adult fly brain, with the aim of characterizing the ubiquitin landscape of 
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a mature neuron in Drosophila melanogaster. While elavGAL4 was appropriate for the 
study of ubiquitinated material during the embryo nervous system development 
(Franco et al., 2011), it was not strong enough to perform the same approach from the 
adult brain. Among the drivers tested, we found that GMRGAL4, which drives expression 
mostly in photoreceptor cells (Li et al., 2012), did promote a high expression and an 
adequate conjugation of the biotinylated ubiquitin without the need of additional 
stimulus (i.e., heat shock treatment). Using this GAL4 driver, we achieved the isolation 
and subsequent MS identification of 369 ubiquitin conjugates and 21 ubiquitination 
sites from the Drosophila eye, also detecting several enzymes of the UPS (Ramirez et al., 
2015). 
 
Among the proteins identified from the fly photoreceptor cells, there was a significant 
enrichment by GO-Term analysis of proteins involved in synaptic transmission and 
transport functions, preferentially localized to the plasma membrane and synapse. In 
addition, many of the proteins consistently identified as ubiquitin conjugates among MS 
experiments were proteins with a well-known role in synaptic transmission (Table 5). 
For instance, the alpha (Atpα) and beta subunits of the Na+/K+ ATPase (Lebovitz et al., 
1989; Sun and Salvaterra, 1995), the Na+/C2+-exchange protein (Schwarz and Benzer, 
1997) or Eps-15 (Lloyd et al., 2000). These results implicate the UPS in the maintenance 
of neuronal homeostasis and in the communication between neurons in the fly eye. On 
the other hand, about 40 % of the identified proteins from Drosophila photoreceptor 
cells have orthologues that were earlier reported to be ubiquitinated in murine brain 
tissues in vivo (Na et al., 2012; Wagner et al., 2012), suggesting that the pathways 
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controlled by ubiquitination in mature stage neurons are conserved across different 
species.  
 
The Drosophila eye has been widely used for the study of human neurodegenerative 
disorders because it provides a good system to perform unbiased screens and analyse 
complex neural phenotypes (Jackson, 2008). During this Thesis project, we have taken 
advantage of it to develop an in vivo neuronal system in which the ubiquitination events 
on a mature neuron can be successfully identified. The nature of the bioUb strategy 
allows also discerning by Western blot whether such identifications correspond to 
proteins that are mono- or poly-ubiquitinated in vivo. In addition, the fly eye offers 
unique advantages, as particular genes or pathways can be mutated without 
compromising the fertility and viability of the animals. For these reasons, the use 
Drosophila photoreceptor cells as a tool for the study of ubiquitination can greatly 
contribute to our understanding of the mechanisms, conserved along evolution, by 
which this post-translational modification regulates neuronal function. 
 
The ubiquitin proteome depends both on the tissue studied but also on the 
temporal context 
Comparison of the ubiquitinated proteomes isolated from the Drosophila eye and 
from embryonic developing neurons revealed large differences. Only 28 % of the 
proteins identified from the fly photoreceptor cells were detected in embryonic 
developing neurons. Gene ontology analysis showed significant differences on the 
biological processes, cellular compartments and molecular functions targeted by the 
UPS between embryo and adult samples. In embryonic neurons proteins with nuclear 
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and cytoskeleton localization were found to be more represented. In adult neurons, 
synaptic and membrane proteins appeared to be highly enriched. Besides, proteins 
involved in transport and synaptic transmission were much more widespread in the 
adult eye, while cell cycle and developmental processes were more abundant in the 
embryo. Similarly, transporter activity and nucleic acid binding function were 
characteristic of the adult and embryonic neuronal tissues, respectively. 
 
Neuronal function and activity are highly context dependent. For instance, a number 
of molecules involved in growth cone extension during embryonic stages, are no longer 
required once the axons find their final targets (Budnik, 1996; Budnik et al., 1996). On 
the other hand, remodelling of the cytoskeleton and reallocation of the membranes is 
required in order to modulate the synaptic plasticity of the mature neurons (Haydon 
and Drapeau, 1995; Chiba and Keshishian, 1996). Molecules present during the 
embryonic development of the brain, therefore, will be regulated differently from those 
necessary for synaptic transmission once the innervations have been established. Being 
aware that it is difficult to discern between tissue-specific protein expression and tissue-
specific protein ubiquitination without further experiments, our results suggest that 
certain ubiquitination events are specific to each cell type. It appears that embryonic 
proteins more abundantly ubiquitinated are those that need to be regulated in order for 
the neuron to reach a mature stage. In the adult samples, proteins involved in signalling 
and communication between neurons, and therefore located at the cell membrane, 
appeared to be preferentially ubiquitinated. Since specific ubiquitination events are 
tissue-dependent, the choice of the correct system is therefore essential when studying 
the involvement of ubiquitination in a particular pathway. 
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An appropriate promoter and a simultaneous MS analysis of biological replicates 
are important factors in the biotin pulldown assay 
The bioUb approach has been successfully applied during this project for the analysis 
of the ubiquitin landscapes of the embryonic nervous system and the Drosophila 
photoreceptor cells, but it has the potential to be implemented to any fly tissue at any 
stage during the development. Using the heat shock inducible-GAL4 ubiquitous 
promoter we managed to identify about a hundred proteins from the fly head (data not 
shown), suggesting that it could also be used for the identification of the ubiquitin 
proteome of any other extracted organ. Similarly, the bioUb strategy can also be applied 
to mammalian models, such as mice (Lectez et al., 2014) or human cells (Min et al., 2014 
and Figure 44). One technical aspect that should be however kept in mind when setting 
up this approach in a new tissue/organism is the promoter that is used. The expression 
level of the bioUb precursor achieved in a given tissue is very important for the success of 
the assay. While excessively strong expression might lead to lethality, a weak 
expression, such as the one obtained with elavGAL4, OK371GAL4 or TubGAL4,G80ts drivers in 
adult fly heads, will limit the isolation to the endogenously biotinylated proteins 
(Chandler and Ballard, 1985) in detrimental of the ubiquitinated proteome, due to their 
different abundance. Unfortunately, no hint -other than experimental evidence- exists 
for the selection of a good promoter.  
 
Another essential methodological aspect of the bioUb approach is the careful design of 
the MS analysis, so the variability across MS experiments is reduced. There are many 
sources of variability in MS-based proteomics, ranging from the protein extraction 
process to the database or search engine that is used for the protein identification (Bell 
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et al., 2009; Piehowski et al., 2013). Significant variability was detected among embryo 
and adult MS replicates, which correlated with the abundance of the identified proteins. 
Ubiquitin conjugates identified in all MS experiments were those found more 
abundantly (higher LFQ intensity), while those with lower intensity were generally 
detected solely in one analysis. We noticed a bigger variability between samples that 
were analysed by MS in different days, despite being of the same genotype, than 
between samples of different genotypes analysed on the same day. However, if the MS 
analysis is performed in triplicate, with samples analysed on the same batch, variability 
is severely reduced and reproducibility significantly enhanced (Martinez et al., under 
review). 
 
On the other hand, proteins are typically separated in a polyacrylamide gel with the 
in-gel digestion protocol. The gel is cut into slices and proteins are digested with trypsin 
to be converted into peptides (Shevchenko et al., 2006). For embryonic and adult 
samples the gels were cut into two slices in order to avoid the strong avidin bands at 
~14 and ~25 kDa, as they could interfere with the detection by MS of other proteins due 
to its higher abundance. Similarly, there are other abundant proteins in our pulldowns, 
such as the endogenously biotinylated proteins (~130 and ~250 kDa), that could also 
interfere with the analysis. Therefore, removal of these bands prior to MS analysis by 
cutting the gel into more than two slices could also improve the depth of the MS analysis 
and reduce the variability among biological replicates. The excised bands containing 
specific high abundant proteins, as avidin and endogenously biotinylated carboxylases, 
could then be run in the mass spectrometer after all the other samples. It should be 
noted, however, that dividing the ubiquitinated material into too many fractions could 
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also reduce the number of identification, as proteins ubiquitinated with different 
ubiquitin chain length would then be spread across different fractions and might scape -
due to lower peptide concentration- detection by MS. 
 
Overexpression of Rpn10DN results on the presence of highly ubiquitinated 
proteins with a concomitant reduction of mono-ubiquitinated proteins 
Unravelling the roles that ubiquitination plays within cells ultimately requires 
physiological pathways to be perturbed, in order to detect changes that would help 
elucidating the function of particular ubiquitination events. The attachment of ubiquitin 
can among other functions trigger the targeting of proteins for degradation (Komander 
and Rape, 2012). We combined our bioUb flies with a proteasomal shuttling factor 
dominant negative mutant (Rpn10DN), in order to enrich those poly-ubiquitinated 
proteins that should be degraded by the proteasome in Drosophila neuronal tissues. 
Overexpression of Rpn10DN caused an enrichment of high molecular-weight 
ubiquitinated material, in agreement with previous reports (Lipinszki et al., 2009; Lee et 
al., 2014; Ramirez et al., 2015). However, contrary to what we expected, a reduced 
number of proteins were identified by MS analysis in Rpn10DN samples as compared to 
wild type flies. This occurred concomitantly to a reduction in the ubiquitination levels of 
a subset of other proteins, mostly mono-ubiquitinated substrates. In addition, the 
ubiquitination level of just a few proteins was found to be enhanced (i.e., those with a 
LFQ ratio >4). 
 
It has been suggested that longer ubiquitin chains, as well as the attachment of 
multiple chains, might increases the affinity for the proteasome (Thrower et al., 2000; 
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Swatek and Komander, 2016). We therefore hypothesize that the strongest signal 
observed by silver staining and immunoblot when Rpn10DN is overexpressed may be 
due to the generation of longer ubiquitin chains, or the attachment of multiple chains, on 
the same protein, rather than to an increase on the molecular fraction of a given protein 
that is ubiquitinated. This attempt of the cellular machinery to enhance the affinity of 
the ubiquitinated proteins for the proteasome is detected by Western blot and silver 
staining as a stronger signal. The differences in the length or number of ubiquitin chains, 
however, would remain undetectable by MS, as the trypsinization of a substrate 
molecule will display a constant intensity of its intrinsic peptides independently of the 
number of ubiquitin molecules attached to it. 
 
Additionally, the presence of non-degraded highly ubiquitinated proteins (i.e., with 
longer or several ubiquitin chains attached to them) in Rpn10DN, might affect the 
isolation of other ubiquitinated proteins. As poly-ubiquitinated proteins are captured by 
Rpn10DN, they will retain a significant amount of the biotinylated ubiquitin, whose pool 
is limited. These Rpn10DN-bound substrates will neither be processed by the 
proteasome nor by DUBs, as observed upon trapping by other UBDs (Hjerpe et al., 
2009). Therefore, the available biotinylated ubiquitin will be significantly reduced. 
Newly synthesized ubiquitin is supposed to be transported very slowly (3 mm/day) 
throughout the axons (Bizzi et al., 1991), hence, new protein synthesis will most like not 
fully replenish the cells with free biotinylated ubiquitin.  
 
Proteasome inhibition in cultured hippocampal neurons has been reported to affect 
dynamically ubiquitinated proteins (i.e., proteins actively subjected to ubiquitination 
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and deubiquitination events), due to a significant depletion of available free ubiquitin 
(Rinetti and Schweizer, 2010). Under this stressful circumstance, the need of free 
ubiquitin is compensated at the expense of mono-ubiquitinated proteins that are 
deubiquitinated in order to supply the cell with unconjugated ubiquitin (Dantuma et al., 
2006; Groothuis et al., 2006; Kaiser et al., 2011; Wagner et al., 2011). This would explain 
why mono-ubiquitinated proteins, would be significantly reduced in our isolated sample 
of ubiquitinated proteins, and why the total amount of identified ubiquitinated proteins 
is also reduced.  
 
The bioUb system can be used to identify HECT- or RBR-type ubiquitin E3 ligases 
that are active on a given developmental stage or tissue  
One important attribute of our bioUb strategy is that, unlike with other approaches, 
the ubiquitination status of the MS-identified proteins can be directly validated from the 
tissue of study by Western blot (Franco et al., 2011; Lectez et al., 2014; Ramirez et al., 
2015). With the use of specific antibodies it can be discriminated whether a protein is 
being covalently modified with one or additional ubiquitin molecules, as they will show 
a ~10 kDa increase in their molecular weight (or higher if poly-ubiquitinated) in the 
eluted fraction. In whole lysates, on the contrary, only unmodified forms are usually 
detected due to the low stoichiometry at which the ubiquitin-modified proteins are 
encountered. Additionally, proteins that are being modified on cysteine residues (Wang 
et al., 2012), as well as the E1, E2, HECT-type and RBR-type E3 enzymes, all of which 
generate a thioester linkage with ubiquitin at their active cysteine residue, can also be 
distinguished using the bioUb strategy. The thioester linkage of ubiquitin with cysteine 
will break upon elution from the beads of the purified material due to the addition of 
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DTT. The purified protein will, therefore, no longer have ubiquitin attached to it, and 
thus, no shift in the molecular weight would be detected when comparing eluted and 
input samples (Franco et al., 2011; Lectez et al., 2014; Ramirez et al., 2015).  
 
We have validated in the past the ubiquitin-carrier status of some E2 enzymes 
(Franco et al., 2011; Lectez et al., 2014), as well as the ubiquitin conjugation of proteins 
on cysteine residues (Lectez et al., 2014). For this Thesis we aimed to validate the active 
status of those E3 ligases for which antibodies were available. Western blot to Parkin 
and Ube3a, the E3 ligases involved in Parkinson’s disease and Angelman syndrome, 
respectively (Kishino et al., 1997; Shimura et al., 2000), confirmed that these two 
enzymes are being isolated mainly because they were carrying ubiquitin at the moment 
of the purification from the Drosophila eye. In the case of Ube3a, this was also confirmed 
for embryonic samples. These results validate clearly that these two E3 ligases truly 
form a thioester bond with ubiquitin, which actually means that Parkin and Ube3a are 
active during the temporal window being studied. The identification of active E3 ligases 
from in vivo neuronal tissues suggests that some of their physiological substrates must 
also be present within the list of identified ubiquitin conjugates. Combination of the 
biotinylated ubiquitin overexpression together with Parkin or Ube3a mutant flies (see 
below) should help, therefore, in the identification of the proteins regulated in neurons 
by these two E3 ligases. 
 
The bioUb system can be used to identify the substrates of a given E3 ligase in vivo  
UBE3A is an E3 ligase whose substrates have been sought since it was linked to a rare 
neurodevelopmental disorder, the Angelman syndrome (Kishino et al., 1997; Matsuura 
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et al., 1997). Mouse, fly and cellular models in which UBE3A has been overexpressed or 
removed (Reiter et al., 2006; Mishra et al., 2009a; Shimoji et al., 2009; Greer et al., 2010; 
Jensen et al., 2013), have led to the identification of some putative UBE3A substrates 
(Sell and Margolis, 2015). The design of these approaches, however, did only allow for 
detecting interactions or changes in total protein levels, but prevented the identification 
of direct substrates in vivo. In most cases, direct evidence of their in vivo ubiquitination 
by UBE3A remains absent or controversial (Kühnle et al., 2013; Mabb et al., 2014).  
 
The ability of the bioUb strategy to detect changes in the ubiquitinated proteome upon 
the blockade of the proteasome in Drosophila prompted us to generate a fly model in 
which changes in protein ubiquitination upon Ube3a overexpression could be tested. By 
combining Ube3a expressing flies with the bioUb flies we achieved the enrichment of a 
number of proteins whose ubiquitination was found to be up-regulated upon Ube3a 
overexpression (Figure 33). Additionally, we further confirmed by Western blot the 
enhanced ubiquitination of Rngo upon overexpression of Ube3a in Drosophila 
photoreceptor cells. Rngo is found poly-ubiquitinated or multimono-ubiquitinated with 
up to 6 ubiquitins in the eluted fraction. Based on the yield of the biotin pulldowns (~40 
%) and on the percentage of input and elution loaded for Western blot analysis, we 
estimated that ~1 % of Rngo is found conjugated with ubiquitin under physiological 
conditions. When Ube3a is overexpressed the ubiquitinated fraction of Rngo is increased 
up to about 3 %. This result places Rngo as the first Ube3a substrate to be validated in 
vivo in the context of a whole organism. 
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Rngo is the Drosophila homologue of the yeast Dd1/Vsm1 and vertebrate Ddi1/Ddi2 
ubiquitin receptors (Morawe et al., 2011). Yeast Ddi1 has been shown to be involved in 
the transport of a few proteins to the proteasome for degradation (Kaplun et al., 2005; 
Ivantsiv et al., 2006). Conversely, in Drosophila a protective role for Rngo has been 
reported (Morawe et al., 2011), suggested to act by preventing the degradation of 
certain proteins in the germline cells. The Ube3a-dependent ubiquitination of Rngo 
could, therefore, indirectly affect the levels of many other cellular proteins. This opens a 
new perspective for the interpretation of previous identifications of UBE3A substrates 
based on changes in total protein level (further discussed below). How this 
ubiquitination affects Rngo/Ddi1/Ddi2, however, would require further experiments. As 
suggested by the fact that Rngo total levels remained unaffected upon overexpression of 
Ube3a in the fly eye, it would seem that its ubiquitination is not a degradation signal.  
 
On the other hand, the ubiquitination level of a number of proteins was found to be 
reduced upon Ube3a overexpression. The higher activity of the ectopic Ube3a will result 
in the preferential attachment of the biotinylated ubiquitin toward its substrates. 
Therefore, the identification of proteins that are being conjugated with the tagged 
ubiquitin in a lower degree suggests that they are not direct substrates of Ube3a. The 
ubiquitination of one of those proteins, Atpα, had been earlier reported to be enhanced 
by Ube3a in vitro (Jensen et al., 2013). Our results, however, showed the opposite by MS, 
in accordance with other reports (Kaphzan et al., 2011). Moreover, the ubiquitination 
levels of Atpα were not found significantly affected by Ube3a when tested by 
immunoblot, confirming that Atpα is not a direct ubiquitin substrate of Ube3a in vivo in 
the Drosophila eye. 
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We have provided for the first time a list of in vivo ubiquitin candidate substrates of 
Drosophila Ube3a, demonstrating that the bioUb system can be successfully used to 
identify proteins ubiquitinated by a given E3 ligase in vivo. In fact, based on these 
results, similar approaches have been successfully carried out a posteriori in the lab of 
Dr. Mayor to identify the in vivo substrates of Parkin E3 ligase (Martinez et al., under 
review). This opens the door for the generation of mammalian models in which to 
screen for E3 ligase substrates, so further insight can be provided into human diseases 
related to the UPS. 
 
A GFP pulldown approach to confirm the ubiquitination of proteins, validate 
ubiquitination sites and identify/validate E3 ligase specific substrates 
When using the bioUb strategy, Western blot validation of ubiquitin conjugates eluted 
is subject to availability of specific antibodies. For this reason, we developed an 
alternative approach that takes advantage of the highly stringent washes that single 
chain anti-GFP beads (Chromotek) can withstand (Lee et al., 2014). This new 
methodology, relays on the overexpression of GFP-tagged proteins, which can be 
isolated and enriched at the same time the interacting proteins are discarded, allowing 
then for their ubiquitinated fraction to be easily analysed. We confirmed by this strategy 
that 43 fly ubiquitin-conjugates (Franco et al., 2011) are indeed ubiquitinated by 
endogenous E3 ligases in Drosophila BG2 cells (Lee et al., 2014), hence demonstrating 
that the GFP-pulldown is a simple and sensitive assay to study ubiquitination. 
Furthermore, the same approach can also be used to isolate GFP-tagged proteins from 
living organisms (Dr. Maribel Franco and Dr. Ugo Mayor, unpublished results), giving the 
possibility of characterizing the ubiquitination of a given protein in vivo.  
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The GFP-pulldown assay has also proven to be a good alternative to further 
characterize the ubiquitination of individual proteins as well as to identify and/or 
validate E3 ligase specific substrates (see below). By mutating two lysine residues on 
nSyb protein a significant reduction of its ubiquitination levels was detected. These two 
lysines are surrounding an arginine residue found in the core of the complex formed 
with Syx1A and Snap25 (Ossig et al., 2000). Interestingly, when this arginine is mutated 
to a glycine results in defects comparable to the deletion of the gene (Fasshauer et al., 
1998; Ossig et al., 2000). The fact that the identified lysines are so close to this arginine 
suggests that their ubiquitination might play an important role in the exocytosis 
pathway, probably by interfering with the nSyb/Syx1A/Snap25 complex formation. The 
validation of these two ubiquitination sites, therefore, will be useful for future studies on 
nSyb function, both in flies and mammals.  
 
Rngo, Rpn10, Rps10b, Uch-L5 and CG8209 are substrates of Ube3a in Drosophila  
Co-expression of Ube3a E3 ligase allowed the identification of some of its target 
substrates in BG2 cells using the GFP-pulldown approach. Four of the identified proteins 
are interactors of the proteasome: Rpn10 and Rngo, two Drosophila ubiquitin receptors 
that shuttle ubiquitinated proteins to the proteasome for degradation (Lipinszki et al., 
2009; Morawe et al., 2011); Uch-L5, a proteasome-associated DUB enzyme that cleaves 
K48 ubiquitin chains (Yao et al., 2006) and CG8209, which is the Drosophila homologue 
of UBXN1/SAKS, another ubiquitin receptor involved in the proteasome-mediated 
degradation of misfolded glycoproteins (McNeill et al., 2004; Lee et al., 2014). 
Interestingly, Rngo and Rpn10 were also found by MS to be in vivo substrates of Ube3a 
in the fly eye. On the other hand, the ribosomal protein RpS10b, a protein found 
Discussion 
- 229 - 
 
differentially expressed in patients with schizophrenia (Bowden et al., 2006), was also 
identified. 
 
Association of UBE3A with proteasomes in several cell lines (Scanlon et al., 2009; 
Martínez-Noël et al., 2012), as well as in synaptosomes isolated from the rat brain (Tai et 
al., 2010), had been previously reported. However, the nature of this association was not 
yet clear. The identification of four proteasomal proteins that are directly ubiquitinated 
by Ube3a in neuron-like cells suggests that one of the roles carried out by this E3 ligase 
is to actually regulate proteasomal function. Ube3a-dependent changes in the levels of 
proteins, therefore, could be interpreted as the result of a downstream effect caused by 
the proteasomal regulation by Ube3a in neurons, rather than to direct ubiquitination 
events.  
 
Ubiquitination by Ube3a does not necessarily lead to protein degradation  
From several Drosophila Ube3a substrates identified in BG2 cells only Rpn10 appears 
to be itself targeted for degradation upon Ube3a ubiquitination. UBE3A has been 
reported to preferentially catalyse the formation of K48 linked-chains (Kim and 
Huibregtse, 2009). Therefore, it is generally believed that proteins ubiquitinated by 
UBE3A must be targeted for degradation. Rngo, Uch-L5, CG8209 and RpS10b total 
protein levels did, however, not seem to be reduced, suggesting that their ubiquitination 
by Ube3a is probably not a degradative signal.  
 
According to an emerging model for proteasomal degradation, the presence of 
multiple short or branched chains is thought to be a better degradation signal than the 
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classical poly-ubiquitin chain linkage (Swatek and Komander, 2016). Based on this 
model, therefore, a K48-linked chain would not necessarily target proteins to the 
proteasome, unless additional chains are attached to the modified protein or to the 
previously attached chain. In fact, the formation of  K48-linked chains in the yeast 
transcription factor Met4 has been reported to regulate its activity in a proteolysis-
independent manner (Flick et al., 2004). An UBD found in Met4 has been proposed to 
cap the K48-ubiquitin chain inactivating the protein and protecting Met4 from 
degradation (Flick et al., 2006). Similarly, Ube3a-dependent ubiquitination of Rngo, Uch-
L5, CG8209 and RpS10b could also be regulating their activity rather than their levels. 
These results suggest that Ube3a ubiquitination might not always be a degradation 
signal, and hence, the existing dogma for Ube3a function should be revised. 
 
Ube3a and Rpn10DN interact in vivo 
Direct interaction of human UBE3A with the proteasome subunit PSMD4 (the 
homologue of fly Rpn10) has been described in previous reports (Martínez-Noël et al., 
2012; Tomaić and Banks, 2015). The main role of PSMD4/Rpn10 is to shuttle poly-
ubiquitinated proteins to the proteasome for their degradation (Figure 45A). In 
Drosophila the Ube3a-dependent degradation of Rpn10 will, therefore, prevent the 
transport of those proteins to the proteasome, which might remain ubiquitin-conjugated 
or processed by DUBs into their normal forms. When Ube3a is overexpressed in the 
Drosophila photoreceptor cells, the persisting activity of these proteins that should 
under normal conditions be degraded would produce the strong eye phenotype 
observed (Figure 45B). 
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Figure 45. Model for the in vivo interaction between Ube3a and Rpn10. 
A. The main role of Rpn10 is to shuttle poly-ubiquitinated proteins to the proteasome for degradation. 
Rpn10 recognizes poly-ubiquitinated proteins through its ubiquitin interacting motifs (UIMs) and interact 
with the proteasome through the von Willenbrand factor A (VWFA) domain. B. Overexpression of Ube3a 
will target endogenous Rpn10 for degradation. A number of proteins that should have been degraded, 
therefore, will stay active resulting in the degenerated eye phenotype. C. Overexpression of a dominant 
negative version of Rpn10 that lacks the VWFA domain (Rpn10DN) results in the accumulation of poly-
ubiquitinated material. This occurs because poly-ubiquitinated proteins are trapped by Rpn10DN and are 
not transported to the proteasome. In this situation endogenous Rpn10 will remain shuttling some 
proteins to the proteasome. D. If both Rpn10DN and Ube3a are overexpressed, the reduction of the 
endogenous shuttling Rpn10 is compounded by the trapping of ubiquitinated proteins by Rpn10DN. The 
activity of those proteins trapped by Rpn10DN would be blocked, so the eye phenotype associated to their 
misregulation is no longer detectable. 
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The overexpression of a dominant negative mutant of Rpn10 (Rpn10DN) results in 
some of its client proteins being trapped (Figure 45C), so an accumulation of poly-
ubiquitinated material is observed in the fly eye. Under this circumstance, however, the 
endogenous Rpn10 should still shuttle poly-ubiquitinated proteins to the proteasome 
for their degradation. If both Rpn10DN and Ube3a are overexpressed an enhanced 
ubiquitin signal is detected. This is probably due to the inhibition of endogenous Rpn10 
shuttling, due to Ube3a-dependent degradation, being aggravated by the trapping of its 
client ubiquitinated proteins by Rpn10DN (Figure 45D). In this situation, proteins 
trapped by Rpn10DN, however, will probably be protected from DUBs (Hjerpe et al., 
2009) and will not retain their activity, explaining why the eye phenotype associated to 
their misregulation is no longer detectable. This in vivo Ube3a-Rpn10DN synergy strongly 
supports our observation of Rpn10 as an Ube3a substrate, as well as the view of Ube3a 
as a key regulator of neuronal proteasomal function. 
 
The Ube3a dependent degradation of Rpn10, and the ubiquitination of Rngo and 
Uch-L5 protein, place Ube3a as a master regulator of protein homeostasis.  
The bioUb- and GFP-pulldown assays have allowed for the identification and 
validation of five direct Ube3a substrates in Drosophila melanogaster, four of which are 
known interactors of the proteasome. Ubiquitination of proteasomal subunits, including 
PSMD4 and Uch37, the human homologues of the fly Rpn10 and Uch-L5, respectively, 
have been reported to impair the ability of the proteasome to bind, deubiquitinate and 
process ubiquitinated proteins (Jacobson et al., 2014). The fact that four of the validated 
fly Ube3a substrates are interactors of the proteasome places Ube3a as a master 
regulator of protein homeostasis in Drosophila.  
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While the ubiquitination of Rpn10 leads to its degradation, the ubiquitination of 
Rngo, CG8209 and Uch-L5 appears to have a non-degradative role, maybe regulating 
their activity (Flick et al., 2006). In the presence of extra activity of Ube3a, as is the case 
in some ASD patients (Yi et al., 2015), the transport of some ubiquitinated proteins to 
the proteasome, due to Rpn10, Rngo and CG8209 ubiquitination, would therefore be 
blocked. On the other hand, Uch37 (Uch-L5) has been suggested to trim ubiquitin chains 
from substrates, so they are released from the ubiquitin receptor and translocated to the 
proteasome (Liu and Jacobson, 2013). Therefore, the inhibition of this DUB upon 
ubiquitination by Ube3a would also contribute to the impairment of the proteasomal 
function. In AS the situation would, however, be the opposite. That is, since Ube3a 
ubiquitin ligase activity does not function, the absence of Rpn10, Rngo, CG8209 and Uch-
L5 ubiquitination, would probably result in an increased proteasomal activity and a 
premature degradation of a number of proteins. 
 
The view of Ube3a as a regulator of the proteasome opens a new perspective in which 
the ubiquitination of other proteins, and thus their levels or activity, can be affected as a 
downstream effect. This idea is further strengthened by the fact that many of the 
candidate substrates identified by MS in the fly eye are members of the UPS and had 
been linked in their own with several neurological disorders: Uch human homologue 
(UCHL1) is a DUB involved in Parkinson’s and Alzheimer’s diseases (Leroy et al., 1998; 
Choi et al., 2004), as well as in an early-onset neurodegeneration phenotype (Bilguvar et 
al., 2013); the human UBE2H E2 enzyme, homologue of the Drosophila UbcE2H, has 
been associated with autistic disorders (Vourc’h et al., 2003); mutations in Ref(2)P/p62 
were found in patients with Amyotrophic Lateral Sclerosis (Fecto et al., 2011) and its 
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loss of function found to enhance the accumulation of polyQ proteins in a polyQ disease 
Drosophila model (Saitoh et al., 2015); and Rpn10/PSMD4 regulates dendrite 
development in the mammalian brain (Puram et al., 2013).  
 
The application of both bioUb and GFP-pulldown strategies has been useful for the 
identification of ubiquitinated proteins, validation of ubiquitination sites and 
identification of E3 ligase specific substrates. In the future, the application of these 
strategies to mammalian models, will therefore greatly contribute to our understanding 
of the role that ubiquitination plays in the nervous system. This molecular detail will as 
well help to better understand human pathologies in which ubiquitination is involved, 
such as those related to the UBE3A enzyme.  
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1. Drosophila photoreceptor cells can be successfully used as an in vivo system for the 
study of the proteins that are ubiquitinated in mature neurons. 
2. The ubiquitin proteome is not constant and depends both on the tissue studied but 
also on the temporal context.  
3. An appropriate promoter and a simultaneous MS analysis of biological replicates are 
important factors in the biotin pulldown assay. 
4. Overexpression of Rpn10DN results on the presence of highly ubiquitinated proteins 
with a concomitant reduction of mono-ubiquitinated proteins. 
5. The bioUb system can be used to identify HECT- or RBR-type ubiquitin E3 ligases that 
are active on a given developmental stage or tissue.  
6. The bioUb system can be used to identify the substrates of a given E3 ligase in vivo. 
Ubiquitination of Rngo protein was found to be increased upon Ube3a 
overexpression in Drosophila photoreceptor cells. This places Rngo as the first 
Ube3a substrate to be validated in vivo in the context of a whole organism.  
7. A GFP pulldown assay has been developed and found to be a suitable approach to 
confirm the ubiquitination of proteins and to validate their ubiquitination sites. This 
approach can also be used to identify and/or validate E3 ligase specific substrates. 
8. Rngo, Rpn10, Rps10b, Uch-L5 and CG8209 are substrates of Ube3a in Drosophila 
BG2 cells. Of those, Rngo and Rpn10 have also been found to be in vivo substrates of 
Ube3a.  
9. Ubiquitination by Ube3a can lead to degradation (Rpn10) or not (Rngo, Rps10b, 
Uch-L5, CG8209). The existing dogma for Ube3a function requires therefore to be 
revised. 
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10. Ube3a and Rpn10DN interact in vivo. This interaction suppresses the degeneration 
phenotype of the eye caused by Ube3a overexpression and enhances the 
accumulation of ubiquitinated proteins caused by Rpn10DN overexpression.  
11. The Ube3a dependent degradation of Rpn10, and the ubiquitination of Rngo and 
Uch-L5 protein, place Ube3a as a master regulator of protein homeostasis.  
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Mass spectrometry Tables 
Mass spectrometric data tables can be found on the enclosed CD.  
 
Table A1. Proteins purified from Drosophila adult eye. 
 
Table A2. Proteins purified from Drosophila embryonic nervous system. 
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Figure A1. Silver staining of the material purified from adult samples. 
Equal amounts of eluted BirA and bioUb samples were analysed for each pulldown using SDS-
PAGE, and stained with silver. Common bands between BirA and bioUb are expected to be 
composed mainly of endogenously biotinylated material. Thick bands at around 40 kDa and 
below correspond to trimer, dimer and monomer forms on NeutrAvidin. The main high 
molecular weight smear observed in the experimental (bioUb) but not in the control (BirA) 
samples correspond to the isolated ubiquitinated material. For each pulldown experiment the 
number assigned by the MS core facility at the MDC Institute is provided. Taken from Ramirez et 
al., 2015. 
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Figure A2. Silver staining of the material purified from embryo samples. 
Equal amounts of eluted BirA and bioUb samples were analysed for each pulldown using SDS-
PAGE, and stained with silver. Common bands between BirA and bioUb are expected to be 
composed mainly of endogenously biotinylated material. Thick bands at around 40 kDa and 
below correspond to trimer, dimer and monomer forms on NeutrAvidin. The main high 
molecular weight smear observed in the experimental (bioUb) but not in the control (BirA) 
samples correspond to the isolated ubiquitinated material. For each pulldown experiment the 
number assigned by the MS core facility at the MDC Institute is provided. Taken from Ramirez et 
al., 2015. 
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Figure A3. RNA levels of ubiquitin carriers not detected in embryonic samples. 
mRNA levels during the embryo development, measure as reads per kilobase of exon model per 
million mapped reads (RPKM), of the E2 and E3 enzymes not detected in neither of the 
embryonic pulldowns. Horizontal dot lines indicate the expression level threshold used by 
Flybase where (L) is low, (H) high and (VH) very high expression. These data were obtained 
from Flybase (www.flybase.org).  
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Figure A4. Silver staining of the material purified from Rpn10DN and bioUb samples. 
Equal amounts of bioUb and bioUb+Rpn10DN samples were analysed for each pulldown using SDS-
PAGE and stained with silver. Both for embryo (A) and for adult (B) samples an accumulation of 
proteins is detected on samples from flies overexpressing Rpn10DN compared to bioUb flies. For 
each pulldown experiment the number assigned by the MS core facility at the MDC Institute is 
provided. Taken from Ramirez et al., 2015. 
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Figure A5. Proteins found differentially ubiquitinated in embryo Rpn10DN samples. 
Vulcano plots showing the proteins that appear differentially ubiquitinated upon Rpn10DN 
overexpression. LFQ Rpn10DN/bioUb ratio of those proteins identified in at least two independent 
Rpn10DN experiments were calculated for each MS analysis. In order to be able to plot all the 
ratios, in those proteins were LFQ value was not reported, the lowest LFQ value obtained in the 
analysis was given to these proteins. Those proteins with a LFQ ratio bigger than 2 (in log2 scale) 
were considered to be more ubiquitinated, while those with a ratio lower than -2 were 
considered to be less ubiquitinated. For each pulldown experiment the number assigned by the 
MS core facility at the MDC Institute is provided. 
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Figure A6. Localization of 47 neuronal ubiquitination substrates in Drosophila BG2 cells. 
Taken from Lee et al., 2014. 
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Figure A7. Ubiquitination of the 47 candidate substrate in neuronal-like cell culture. 
GFP pulldown assay was applied to all of them. No signal could be detected for Rm62. From the 
remaining 46 proteins, 43 were confirmed to be ubiquitinated by endogenous E3 ligases in BG2 
cells (all except Hsc70Cb, Cyp1 and Hrb27C). Taken from Lee et al., 2014.  
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Figure A8. Rpn10 ubiquitination by Ube3a 
Both N- and C-terminally GFP-tagged Rpn10 are ubiquitinated and targeted for degradation by 
Ube3a-WT. Taken from Lee et al., 2014. 
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Figure A9. Silver staining of material purified from Drosophila embryonic samples. 
Equal amounts of the eluted material from each of the samples were separated by SDS-PAGE 
and stained with silver. An accumulation of proteins is detected on samples from flies 
overexpressing Rpn10DN (Rpn), as compared to control (bioUb), Ube3a mutant (15B) and Ube3a 
overexpression (A3) samples. When Rpn10DN and Ube3a are co-expressed (A3R) this 
accumulation is greatly enhanced. BirA: elavGAL4,UASBirA/CyO; bioUb: elavGAL4,UAS(bioUb)6-BirA/CyO; 
Rpn: elavGAL4,UAS(bioUb)6-BirA/CyO;UASRpn10DN/TM6B; 15B: elavGAL4,UAS(bioUb)6-BirA/CyO;Ube3a15B/ 
TM6B; A3: elavGAL4,UAS(bioUb)6-BirA/CyO;UASUbe3aA3/TM6B; A3R: elavGAL4,UAS(bioUb)6-BirA/CyO; 
UASUbe3aA3,UASRpn10DN/TM6B. 
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